Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,A1BG,Alpha-1B-glycoprotein,44829,305,0.94 [0.50-1.77],0.8376114404688294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AAMDC,Mth938 domain-containing protein,43572,301,1.03 [0.83-1.26],0.811937770232448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AARSD1,Alanyl-tRNA editing protein Aarsd1,51256,329,1.10 [0.93-1.31],0.2723608209574568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABCA2,ATP-binding cassette sub-family A member 2,43292,293,0.87 [0.63-1.20],0.4020612511149972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABHD14B,Protein ABHD14B,50932,326,1.07 [0.90-1.27],0.4541675841577395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABL1,Tyrosine-protein kinase ABL1,51256,329,1.02 [0.88-1.18],0.7790360065852617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABO,Histo-blood group ABO system transferase,44798,305,1.04 [0.96-1.12],0.3030731656397026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABRAXAS2,BRISC complex subunit Abraxas 2,43292,293,1.02 [0.86-1.21],0.7842756000203928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",50282,316,1.01 [0.89-1.14],0.8636822445597951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",43946,299,1.11 [0.97-1.28],0.1323319252396014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",44759,302,1.00 [0.88-1.13],0.9596663093684856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAN,Aggrecan core protein,51002,323,0.85 [0.60-1.21],0.3611011728137001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,44798,305,0.81 [0.54-1.21],0.3070245770455289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE2,Angiotensin-converting enzyme 2,50550,323,1.03 [0.85-1.24],0.782667639701147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACHE,Acetylcholinesterase,43784,299,0.81 [0.57-1.14],0.2193712158204655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOT13,Acyl-coenzyme A thioesterase 13,44569,304,1.03 [0.93-1.13],0.589175479341574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,51493,323,0.97 [0.80-1.18],0.7669211314857942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP1,Low molecular weight phosphotyrosine protein phosphatase,43466,294,0.91 [0.71-1.18],0.4896219556094624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP5,Tartrate-resistant acid phosphatase type 5,51717,333,0.95 [0.70-1.28],0.7295036827984129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP6,Lysophosphatidic acid phosphatase type 6,51855,330,1.06 [0.91-1.22],0.4723097902647308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRBP,Acrosin-binding protein,44551,301,0.99 [0.75-1.31],0.94971938984073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRV1,Acrosomal protein SP-10,43466,294,1.02 [0.89-1.16],0.8268552765285032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACSL1,Long-chain-fatty-acid--CoA ligase 1,43292,293,1.04 [0.77-1.39],0.8055101739611568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTA2,"Actin, aortic smooth muscle",50550,323,1.06 [0.85-1.32],0.61074247350668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,43292,293,1.38 [1.18-1.62],6.031932637680089e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN4,Alpha-actinin-4,50524,322,1.18 [0.90-1.55],0.2406158079517503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACVRL1,Serine/threonine-protein kinase receptor R3,51008,326,1.07 [0.72-1.59],0.7366297394634412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY1,Aminoacylase-1,51493,323,0.93 [0.79-1.10],0.3866972946284754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,43292,293,0.95 [0.77-1.16],0.6087142922078348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACYP1,Acylphosphatase-1,43620,299,1.03 [0.87-1.22],0.732363673365378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA,Adenosine deaminase,52056,330,1.12 [0.86-1.47],0.3881671973602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA2,Adenosine deaminase 2,51193,330,1.05 [0.84-1.32],0.653616066668117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,43466,294,1.01 [0.72-1.42],0.942005828849008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,50550,323,1.04 [0.76-1.43],0.8063614740953516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,51093,326,0.99 [0.75-1.30],0.9434156752786572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,52056,330,1.25 [0.94-1.67],0.1223402241081884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,51860,330,0.88 [0.63-1.23],0.4536014278207455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,44569,304,0.96 [0.67-1.39],0.8302410678076342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,43466,294,0.80 [0.55-1.17],0.2491407705987117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,52128,334,0.90 [0.60-1.36],0.621623417091993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,51256,329,0.94 [0.75-1.17],0.5620654879848577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,50550,323,1.26 [0.98-1.62],0.0732720579701584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,43466,294,1.01 [0.74-1.38],0.9545431393128264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,51651,329,0.69 [0.56-0.86],0.0006473977267382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL2,ADAMTS-like protein 2,44764,304,1.15 [0.83-1.59],0.4039766126395602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL4,ADAMTS-like protein 4,43572,301,0.70 [0.44-1.11],0.1323903646904901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL5,ADAMTS-like protein 5,44759,302,0.85 [0.65-1.13],0.2693394264208505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,50282,316,1.00 [0.75-1.34],0.9882136194927718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADD1,Alpha-adducin,43784,299,1.01 [0.86-1.18],0.8848545278325283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRB3,Adhesion G protein-coupled receptor B3,51008,326,1.08 [0.81-1.44],0.612102755911945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRD1,Adhesion G-protein coupled receptor D1,43784,299,1.01 [0.76-1.35],0.9341917185474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE1,Adhesion G protein-coupled receptor E1,44569,304,0.95 [0.78-1.16],0.6089074238671403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE2,Adhesion G protein-coupled receptor E2,51715,329,0.99 [0.70-1.40],0.942907419741394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE5,Adhesion G protein-coupled receptor E5,51876,332,0.82 [0.59-1.14],0.2405153542228601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,44759,302,0.75 [0.51-1.11],0.153307359990779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG1,Adhesion G-protein coupled receptor G1,51256,329,1.02 [0.90-1.16],0.7631074822481735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG2,Adhesion G-protein coupled receptor G2,51493,323,0.88 [0.61-1.27],0.492516234142295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRV1,Adhesion G-protein coupled receptor V1,43318,298,0.96 [0.82-1.13],0.6426913916439383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH1B,All-trans-retinol dehydrogenase,43784,299,1.05 [0.90-1.21],0.5484777742258443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,50550,323,1.01 [0.90-1.14],0.8122326937478265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADIPOQ,Adiponectin,44829,305,1.04 [0.89-1.22],0.622064957545049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADM,Pro-adrenomedullin,51932,332,1.00 [0.69-1.45],0.9903899472361531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADRA2A,Alpha-2A adrenergic receptor,43292,293,1.00 [0.86-1.17],0.9574883297287128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFAP1,Actin filament-associated protein 1,43784,299,1.06 [0.93-1.21],0.3777971433626906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFM,Afamin,44829,305,0.64 [0.37-1.10],0.107601459099608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFP,Alpha-fetoprotein,50925,325,0.97 [0.84-1.13],0.7284862266265955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGBL2,Cytosolic carboxypeptidase 2,43318,298,0.88 [0.79-0.99],0.027974507564418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGER,Advanced glycosylation end product-specific receptor,51376,329,0.94 [0.74-1.20],0.6237407769244567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR2,Anterior gradient protein 2 homolog,49877,321,1.01 [0.91-1.12],0.8362766606593044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR3,Anterior gradient protein 3,50197,316,0.90 [0.76-1.07],0.2467611719454878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRN,Agrin,51715,329,1.07 [0.81-1.42],0.6458770351476932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRP,Agouti-related protein,52056,330,1.21 [1.00-1.45],0.0512735632836268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGT,Angiotensinogen,44798,305,1.31 [0.82-2.08],0.2559677647370371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGXT,Serine--pyruvate aminotransferase,51493,323,1.02 [0.89-1.16],0.7972415152007815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHCY,Adenosylhomocysteinase,51493,323,1.00 [0.87-1.16],0.9936422333307549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,43572,301,0.59 [0.41-0.85],0.0048770025995411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK2,Protein AHNAK2,43572,301,1.04 [0.71-1.51],0.8458599061547889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,44551,301,0.97 [0.82-1.14],0.6891281117640141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSG,Alpha-2-HS-glycoprotein,44798,305,0.73 [0.50-1.07],0.1037042764164824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSP,Alpha-hemoglobin-stabilizing protein,51421,328,1.00 [0.89-1.12],0.9733952122391488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIDA,"Axin interactor, dorsalization-associated protein",43533,300,0.94 [0.82-1.08],0.4145745413940819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1,Allograft inflammatory factor 1,50282,316,1.04 [0.86-1.26],0.6617834945849453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1L,Allograft inflammatory factor 1-like,43572,301,1.01 [0.83-1.23],0.9206003281265348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",51172,328,1.01 [0.92-1.11],0.7943910365171647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK1,Adenylate kinase isoenzyme 1,51493,323,1.04 [0.89-1.21],0.610942755008625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK2,"Adenylate kinase 2, mitochondrial",44654,304,0.99 [0.89-1.10],0.8278295135019791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKAP12,A-kinase anchor protein 12,43784,299,0.71 [0.40-1.23],0.2192202706262645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B1,Aldo-keto reductase family 1 member B1,50282,316,1.13 [0.99-1.29],0.0707254779868386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B10,Aldo-keto reductase family 1 member B10,43533,300,0.86 [0.71-1.04],0.1167295957557359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1C4,Aldo-keto reductase family 1 member C4,50550,323,0.95 [0.79-1.16],0.6268276641659178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR7L,Aflatoxin B1 aldehyde reductase member 4,43466,294,0.98 [0.83-1.16],0.848053334269024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT1S1,Proline-rich AKT1 substrate 1,50288,323,1.07 [0.93-1.25],0.344699891276564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT2,RAC-beta serine/threonine-protein kinase,44680,305,1.01 [0.92-1.10],0.8590710148883843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT3,RAC-gamma serine/threonine-protein kinase,50043,315,1.09 [0.92-1.30],0.3164458734274527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALCAM,CD166 antigen,52128,334,0.90 [0.54-1.47],0.6644204047218294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH1A1,Retinal dehydrogenase 1,51506,328,0.99 [0.82-1.18],0.875109760976419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH2,"Aldehyde dehydrogenase, mitochondrial",44551,301,0.92 [0.73-1.16],0.4891084658720155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",51334,328,1.14 [0.99-1.30],0.0604301771276951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",44680,305,1.12 [0.90-1.41],0.3030664316764634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALMS1,Alstrom syndrome protein 1,43946,299,0.81 [0.62-1.07],0.1398284080808049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPI,Intestinal-type alkaline phosphatase,43466,294,0.94 [0.86-1.04],0.2205982924535216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPP,"Alkaline phosphatase, placental type",51256,329,0.95 [0.86-1.04],0.2365625201807197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBN,Ameloblastin,50524,322,0.91 [0.62-1.33],0.6196348751997515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBP,Protein AMBP,51858,331,1.21 [0.75-1.95],0.4424936623847058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,44764,304,0.67 [0.45-1.01],0.0586250903540294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMFR,E3 ubiquitin-protein ligase AMFR,50288,323,0.96 [0.82-1.12],0.6146233843237773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO1,Amphoterin-induced protein 1,43533,300,0.82 [0.64-1.05],0.1219148848522997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO2,Amphoterin-induced protein 2,51256,329,1.12 [0.74-1.71],0.5896042538888252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMN,Protein amnionless,50524,322,0.96 [0.78-1.19],0.7099925510441963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOT,Angiomotin,43784,299,0.85 [0.64-1.14],0.2782640084736583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOTL2,Angiomotin-like protein 2,44381,301,1.17 [0.95-1.44],0.130564660863735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMPD3,AMP deaminase 3,44654,304,1.05 [0.90-1.22],0.5082210002852537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,41968,276,0.99 [0.79-1.25],0.9478205103862494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2A,Pancreatic alpha-amylase,49510,318,0.96 [0.78-1.19],0.7243411250064102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2B,Alpha-amylase 2B,47995,309,0.96 [0.78-1.18],0.6772126220650784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANG,Angiogenin,51361,330,1.01 [0.76-1.35],0.9565651973877626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT1,Angiopoietin-1,51304,329,1.01 [0.90-1.13],0.8997691847202752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT2,Angiopoietin-2,51932,332,1.12 [0.87-1.44],0.3974113448187772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL1,Angiopoietin-related protein 1,50742,319,1.20 [0.85-1.69],0.3012775301011965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL2,Angiopoietin-related protein 2,51547,328,0.91 [0.71-1.16],0.4239932132112347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL3,Angiopoietin-related protein 3,51530,331,1.04 [0.79-1.36],0.8020602645606274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL4,Angiopoietin-related protein 4,51631,329,0.98 [0.79-1.21],0.8227777173639504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL7,Angiopoietin-related protein 7,51932,332,1.02 [0.78-1.33],0.8756674775903064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANK2,Ankyrin-2,43292,293,1.08 [0.93-1.25],0.297867895631148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,43466,294,1.00 [0.87-1.15],0.9727088705696252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRA2,Ankyrin repeat family A protein 2,43160,294,0.94 [0.76-1.15],0.5378978478588914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRD54,Ankyrin repeat domain-containing protein 54,50282,316,0.94 [0.79-1.13],0.5090967378891704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,43572,301,1.04 [0.80-1.36],0.7747080140680793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANPEP,Aminopeptidase N,51615,331,1.28 [0.92-1.80],0.1461854902953818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA1,Annexin A1,43536,296,1.09 [0.86-1.39],0.4839949384491711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA10,Annexin A10,50288,323,0.99 [0.88-1.11],0.8329729055802935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA11,Annexin A11,51338,328,1.04 [0.89-1.20],0.6398253981572077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA2,Annexin A2,42914,299,0.95 [0.81-1.11],0.5001488022780962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA3,Annexin A3,51860,330,1.08 [0.94-1.23],0.2946598497940919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA4,Annexin A4,51250,322,1.04 [0.91-1.19],0.5778270671508243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA5,Annexin A5,50121,319,1.24 [0.90-1.70],0.1918669761128184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC1,Amiloride-sensitive amine oxidase [copper-containing],50524,322,1.10 [0.94-1.29],0.2396015874723835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC3,Membrane primary amine oxidase,51698,331,1.15 [0.83-1.59],0.4145100750894441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP1G2,AP-1 complex subunit gamma-like 2,44551,301,0.96 [0.83-1.10],0.5179518682214569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP2B1,AP-2 complex subunit beta,43533,300,0.94 [0.75-1.19],0.6283518925082625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3B1,AP-3 complex subunit beta-1,44569,304,1.01 [0.87-1.16],0.9096703872808232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3S2,AP-3 complex subunit sigma-2,44654,304,1.02 [0.81-1.28],0.8556758020557345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,51256,329,1.00 [0.80-1.23],0.9637327915139018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,44428,305,0.85 [0.62-1.17],0.326595936825131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,51770,329,1.00 [0.85-1.18],0.9661502574436204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APLP1,Amyloid-like protein 1,51493,323,0.80 [0.66-0.97],0.0263482647626126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,44829,305,0.77 [0.50-1.18],0.225200162554406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA2,Apolipoprotein A-II,44798,305,0.83 [0.67-1.04],0.1123697546532842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,44829,305,0.67 [0.48-0.94],0.0201044500630382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOB,Apolipoprotein B-100,44798,305,0.89 [0.56-1.44],0.6429223533719487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOBR,Apolipoprotein B receptor,43572,301,1.04 [0.80-1.36],0.7426614089154431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOC1,Apolipoprotein C-I,44744,305,0.92 [0.68-1.24],0.5630477781743023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOD,Apolipoprotein D,42815,283,0.98 [0.74-1.30],0.9049658128935488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOE,Apolipoprotein E,44829,305,1.00 [0.86-1.17],0.9931875596521376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOF,Apolipoprotein F,44798,305,1.16 [0.73-1.84],0.5383573606553232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOH,Beta-2-glycoprotein 1,51506,328,0.99 [0.76-1.30],0.9549165949578672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOL1,Apolipoprotein L1,44798,305,0.89 [0.73-1.09],0.2588299100001963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOM,Apolipoprotein M,51615,331,1.00 [0.71-1.41],0.9881043270985768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,51428,327,0.95 [0.82-1.10],0.5042401458059889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APPL2,DCC-interacting protein 13-beta,43784,299,1.01 [0.91-1.12],0.8373022308219094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APRT,Adenine phosphoribosyltransferase,51010,325,1.20 [0.97-1.48],0.0894064991688405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARAF,Serine/threonine-protein kinase A-Raf,43946,299,0.97 [0.82-1.14],0.6873464200079372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,51256,329,1.33 [1.09-1.64],0.0060533292808853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARF6,ADP-ribosylation factor 6,44569,304,1.02 [0.92-1.13],0.757390538107749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,44680,305,0.96 [0.82-1.13],0.6152515225183351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG1,Arginase-1,51184,326,0.96 [0.80-1.16],0.6812100996978836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG2,"Arginase-2, mitochondrial",44551,301,0.92 [0.71-1.21],0.5586901156650859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP1,Rho GTPase-activating protein 1,50282,316,1.15 [0.92-1.43],0.2109563610956871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP25,Rho GTPase-activating protein 25,50282,316,1.13 [0.96-1.32],0.1348098909689452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP30,Rho GTPase-activating protein 30,43946,299,0.86 [0.63-1.17],0.3319652781716371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP45,Rho GTPase-activating protein 45,43784,299,0.98 [0.85-1.12],0.754070347155952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP5,Rho GTPase-activating protein 5,43160,294,1.05 [0.91-1.21],0.5288822176286128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF1,Rho guanine nucleotide exchange factor 1,44654,304,1.00 [0.89-1.13],0.9870137976788572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF10,Rho guanine nucleotide exchange factor 10,44680,305,0.97 [0.86-1.09],0.5519693594323309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF12,Rho guanine nucleotide exchange factor 12,51419,328,1.03 [0.94-1.13],0.5359495545478816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF5,Rho guanine nucleotide exchange factor 5,43318,298,1.00 [0.86-1.16],0.9902485128374616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID3A,AT-rich interactive domain-containing protein 3A,43318,298,0.95 [0.72-1.26],0.7422764650551893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID4B,AT-rich interactive domain-containing protein 4B,50288,323,0.96 [0.75-1.22],0.7244878392951954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL13B,ADP-ribosylation factor-like protein 13B,43292,293,1.00 [0.85-1.17],0.9630195891028336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,43292,293,1.02 [0.78-1.35],0.8627173306250554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARMCX2,Armadillo repeat-containing X-linked protein 2,43318,298,0.86 [0.70-1.06],0.1508685189509048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNT,Aryl hydrocarbon receptor nuclear translocator,50524,322,0.92 [0.70-1.21],0.5454378705719287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,43292,293,1.11 [0.91-1.35],0.2970100042775511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSA,Arylsulfatase A,51506,328,1.05 [0.85-1.31],0.6522515132979162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSB,Arylsulfatase B,51256,329,0.97 [0.81-1.16],0.7405582893544528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,51698,331,0.52 [0.40-0.69],3.401874627580291e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART5,Ecto-ADP-ribosyltransferase 5,43318,298,0.93 [0.76-1.12],0.4291253129085343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARTN,Artemin,50524,322,1.14 [0.94-1.38],0.1864630665616616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,44350,303,0.85 [0.66-1.08],0.1849980438739517
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH2,Neutral ceramidase,51093,326,1.00 [0.84-1.21],0.9688391267739116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR1,Asialoglycoprotein receptor 1,51093,326,1.08 [0.78-1.50],0.6377362032778444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR2,Asialoglycoprotein receptor 2,44798,305,0.90 [0.59-1.36],0.6092570034883049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPN,Asporin,44759,302,0.93 [0.62-1.39],0.720319324893212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPSCR1,Tether containing UBX domain for GLUT4,44680,305,1.03 [0.88-1.22],0.6901151882172414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASRGL1,Isoaspartyl peptidase/L-asparaginase,43572,301,0.99 [0.89-1.11],0.9025728712857064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASS1,Argininosuccinate synthase,43292,293,0.94 [0.82-1.09],0.4408550698973311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF2,Cyclic AMP-dependent transcription factor ATF-2,50288,323,0.92 [0.78-1.08],0.3092016893086083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF4,Cyclic AMP-dependent transcription factor ATF-4,43160,294,0.83 [0.58-1.17],0.2840108990201975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG16L1,Autophagy-related protein 16-1,44569,304,0.99 [0.87-1.13],0.894517302487949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG4A,Cysteine protease ATG4A,50282,316,1.08 [0.91-1.27],0.3797049357387986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATOX1,Copper transport protein ATOX1,51651,329,1.04 [0.90-1.19],0.6179120582507402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,43292,293,0.88 [0.68-1.14],0.3382345421227115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,43292,293,0.92 [0.64-1.32],0.6482378829303466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,43292,293,0.91 [0.67-1.23],0.5279585959310241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B4,Protein ATP1B4,43160,294,0.96 [0.73-1.26],0.7566648559799152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP2B4,Plasma membrane calcium-transporting ATPase 4,43292,293,1.03 [0.87-1.22],0.7440363735870116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5F1D,"ATP synthase subunit delta, mitochondrial",43292,293,0.84 [0.66-1.08],0.1839446301217786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5IF1,"ATPase inhibitor, mitochondrial",51715,329,1.00 [0.92-1.09],0.9791969275951486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5PO,"ATP synthase subunit O, mitochondrial",50288,323,1.21 [0.98-1.48],0.0752956780135491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6AP2,Renin receptor,50282,316,0.96 [0.75-1.24],0.7642932662898788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1D,V-type proton ATPase subunit D,51256,329,0.92 [0.63-1.35],0.6784552569153897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1F,V-type proton ATPase subunit F,50203,323,0.96 [0.83-1.12],0.6187464080663376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G1,V-type proton ATPase subunit G 1,43572,301,1.10 [0.94-1.27],0.2330569893272212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G2,V-type proton ATPase subunit G 2,43292,293,0.97 [0.86-1.09],0.5960733242736989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRAID,All-trans retinoic acid-induced differentiation factor,44569,304,1.00 [0.69-1.45],0.9989673137338598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRN,"Attractin, Isoform 2",44829,305,0.68 [0.35-1.31],0.2477162149699878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN10,Ataxin-10,50288,323,1.02 [0.89-1.17],0.742707789408194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2,Ataxin-2,43318,298,0.94 [0.84-1.05],0.2832007094827719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2L,Ataxin-2-like protein,44680,305,1.21 [0.98-1.49],0.0736897619916059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN3,Ataxin-3,44654,304,1.02 [0.86-1.22],0.8008010246607957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXIN1,Axin-1,51419,328,1.03 [0.93-1.15],0.5203296506744021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXL,Tyrosine-protein kinase receptor UFO,51698,331,0.99 [0.69-1.41],0.9486059461388264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZI2,5-azacytidine-induced protein 2,44680,305,1.02 [0.84-1.24],0.8673670906217192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZU1,Azurocidin,49934,317,1.11 [0.99-1.25],0.0790371129468377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B2M,Beta-2-microglobulin,44829,305,1.02 [0.73-1.43],0.9193844661789584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,43292,293,1.26 [0.75-2.13],0.3757749023162464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",43572,301,1.23 [0.91-1.67],0.1733539312455463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GALT1,"Beta-1,4-galactosyltransferase 1",51715,329,1.18 [0.83-1.68],0.3532756918618073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GAT1,"Beta-1,4-glucuronyltransferase 1",51506,328,0.85 [0.57-1.26],0.4133905769232657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BABAM1,BRISC and BRCA1-A complex member 1,43466,294,0.94 [0.64-1.40],0.7775136622196235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BACH1,Transcription regulator protein BACH1,51419,328,1.00 [0.88-1.15],0.9507455733299616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG3,BAG family molecular chaperone regulator 3,51008,326,0.97 [0.76-1.24],0.8288030541528549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,43466,294,0.90 [0.71-1.14],0.368131894527824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG6,Large proline-rich protein BAG6,50550,323,1.05 [0.80-1.38],0.7201590070001186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,50282,316,0.96 [0.82-1.12],0.5925225745185857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAMBI,BMP and activin membrane-bound inhibitor homolog,50282,316,1.07 [0.76-1.49],0.7046402383711095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BANK1,B-cell scaffold protein with ankyrin repeats,51419,328,1.00 [0.91-1.10],0.9840328791575172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAP18,Chromatin complexes subunit BAP18,44654,304,0.95 [0.81-1.12],0.5376863626501611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BATF,Basic leucine zipper transcriptional factor ATF-like,43533,300,0.93 [0.81-1.08],0.3481859114033786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAX,Apoptosis regulator BAX,50203,322,1.03 [0.92-1.15],0.5755594881900696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAM,Basal cell adhesion molecule,51506,328,1.46 [0.99-2.16],0.0564769634282847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAN,Brevican core protein,51093,326,0.72 [0.54-0.96],0.0240263132965662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",44759,302,0.70 [0.48-1.03],0.0678089520811547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",43318,298,1.11 [0.92-1.34],0.2693314558913714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCHE,Cholinesterase,43968,298,1.11 [0.74-1.66],0.6260763037579222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2,Apoptosis regulator Bcl-2,44569,304,0.98 [0.80-1.21],0.878723872863292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L1,Bcl-2-like protein 1,44654,304,1.00 [0.90-1.12],0.9815522035457293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",51419,328,1.07 [0.85-1.34],0.5832636749782587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L15,Bcl-2-like protein 15,43466,294,0.87 [0.71-1.07],0.1760603746490259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7A,B-cell CLL/lymphoma 7 protein family member A,43160,294,1.09 [0.92-1.28],0.3226905078932819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7B,B-cell CLL/lymphoma 7 protein family member B,44551,301,1.06 [0.84-1.34],0.6257633355722382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCR,Breakpoint cluster region protein,51419,328,1.02 [0.92-1.13],0.7186264946256842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,44764,304,0.97 [0.85-1.10],0.6302772017450137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BECN1,Beclin-1,43572,301,1.06 [0.88-1.27],0.5202012632533318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BEX3,Protein BEX3,43160,294,0.77 [0.58-1.02],0.0662052145300289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGLAP,Osteocalcin,44764,304,0.98 [0.86-1.10],0.6924125138223445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGN,Biglycan,50199,315,0.92 [0.84-1.00],0.0435015262287964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHLHE40,Class E basic helix-loop-helix protein 40,43318,298,1.07 [0.93-1.25],0.3457223467420972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,43292,293,0.97 [0.63-1.50],0.8929881792078848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BID,BH3-interacting domain death agonist,51419,328,0.98 [0.85-1.14],0.8060204632826914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIN2,Bridging integrator 2,51506,328,0.96 [0.86-1.07],0.4718292432025273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIRC2,Baculoviral IAP repeat-containing protein 2,50282,316,1.05 [0.90-1.23],0.5445185275403587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,52128,334,0.85 [0.62-1.14],0.2776272228785169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLNK,B-cell linker protein,43466,294,0.98 [0.73-1.30],0.8698232648488804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,43318,298,1.05 [0.91-1.21],0.4797266183188412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,44654,304,0.95 [0.72-1.25],0.696008565792303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLVRB,Flavin reductase,51506,328,1.06 [0.92-1.23],0.3914269416826251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP10,Bone morphogenetic protein 10,43784,299,0.87 [0.59-1.28],0.4887421587644881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP4,Bone morphogenetic protein 4,51008,326,0.95 [0.77-1.18],0.6546067290460712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,50469,323,0.81 [0.64-1.03],0.0806093349598447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMPER,BMP-binding endothelial regulator protein,43784,299,0.98 [0.60-1.60],0.9338639255359826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,44759,302,0.91 [0.65-1.26],0.5658026256792353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,43466,294,0.95 [0.74-1.23],0.7161149880907247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOC,Brother of CDO,50550,323,1.37 [0.90-2.08],0.1473749628307854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA1,BolA-like protein 1,43318,298,1.12 [0.93-1.36],0.2372362743509096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA2_BOLA2B,BolA-like protein 2,43572,301,1.01 [0.83-1.24],0.9105414227432514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFA2,BPI fold-containing family A member 2,42031,284,0.99 [0.89-1.10],0.8638279950508894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB1,BPI fold-containing family B member 1,51381,332,0.88 [0.76-1.03],0.1090358981692104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB2,BPI fold-containing family B member 2,44674,301,1.11 [0.95-1.31],0.1964287108750016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRAP,BRCA1-associated protein,44158,303,1.01 [0.91-1.12],0.8476704237749417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,43946,299,1.22 [0.87-1.71],0.2414814954377671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD2,Bromodomain-containing protein 2,43318,298,0.83 [0.58-1.17],0.2839838036005843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD3,Bromodomain-containing protein 3,43292,293,0.98 [0.77-1.24],0.8382117301889873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRDT,Bromodomain testis-specific protein,43292,293,1.13 [0.83-1.52],0.4421721057339361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,50288,323,0.99 [0.79-1.23],0.9046038386444368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRME1,Break repair meiotic recombinase recruitment factor 1,43318,298,1.20 [0.96-1.50],0.1111888768829423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRSK2,Serine/threonine-protein kinase BRSK2,44680,305,0.87 [0.65-1.18],0.3736682924183347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSG,Basigin,51971,328,0.82 [0.52-1.29],0.3829445481146015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSND,Barttin,43160,294,0.99 [0.71-1.37],0.9373453577903568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,51944,331,0.99 [0.81-1.21],0.9304056546524444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST2,Bone marrow stromal antigen 2,51944,331,0.99 [0.81-1.19],0.8854232378155298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTC,Probetacellulin,50282,316,1.12 [0.99-1.27],0.0683303893445526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTD,Biotinidase,44829,305,0.75 [0.45-1.26],0.2823942104831327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTLA,B- and T-lymphocyte attenuator,43160,294,0.96 [0.83-1.10],0.5185347530181924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN1A1,Butyrophilin subfamily 1 member A1,44466,300,1.00 [0.76-1.33],0.9808475731744069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN2A1,Butyrophilin subfamily 2 member A1,51715,329,0.98 [0.68-1.42],0.9284551833530498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN3A2,Butyrophilin subfamily 3 member A2,51419,328,1.09 [0.84-1.40],0.5266755092284164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTNL10,Butyrophilin-like protein 10,43160,294,0.89 [0.66-1.21],0.4702777817980034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C19orf12,Protein C19orf12,50288,323,0.99 [0.85-1.16],0.9095264887842176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1GALT1C1,C1GALT1-specific chaperone 1,43292,293,0.90 [0.63-1.28],0.5493695077147016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QA,Complement C1q subcomponent subunit A,51801,327,1.37 [0.89-2.11],0.1507677278785234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",44680,305,1.01 [0.86-1.17],0.9463780971931304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QL2,Complement C1q-like protein 2,43466,294,0.79 [0.61-1.04],0.0939331138968215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,51698,331,1.00 [0.79-1.25],0.9720274333544912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,43784,299,0.84 [0.63-1.12],0.2353817412883664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,44680,305,0.84 [0.58-1.20],0.3399842213542872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,43704,298,0.85 [0.68-1.06],0.1403129112165098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1R,Complement C1r subcomponent,44829,305,0.84 [0.45-1.55],0.5741585704573731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1RL,Complement C1r subcomponent-like protein,44751,305,1.24 [0.71-2.19],0.4477825639883562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,44829,305,0.82 [0.49-1.38],0.4521901116600414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,51615,331,0.91 [0.61-1.36],0.6559281424980448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2CD2L,Phospholipid transfer protein C2CD2L,50203,323,0.86 [0.67-1.09],0.2112799458902032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2orf69,UPF0565 protein C2orf69,43533,300,1.00 [0.83-1.21],0.9910699897016372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,42528,289,0.86 [0.65-1.13],0.2848626522323607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C4BPB,C4b-binding protein beta chain,51651,329,1.08 [0.85-1.38],0.5102382755922008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C5,Complement C5,44829,305,0.83 [0.40-1.74],0.6200945819545247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7,Complement component C7,43753,294,1.28 [0.90-1.82],0.1688161501942341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7orf50,Uncharacterized protein C7orf50,44654,304,0.81 [0.48-1.36],0.4205266809198343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C8B,Complement component C8 beta chain,44829,305,1.12 [0.78-1.61],0.5362307333129971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9,Complement component C9,44798,305,1.12 [0.91-1.38],0.2652813638818206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9orf40,Uncharacterized protein C9orf40,44569,304,1.02 [0.90-1.17],0.7370635690505979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA1,Carbonic anhydrase 1,50357,321,1.00 [0.85-1.17],0.9758319023316876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA11,Carbonic anhydrase-related protein 11,50282,316,1.04 [0.77-1.41],0.7915278372377968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA12,Carbonic anhydrase 12,51256,329,0.91 [0.67-1.23],0.5257425487077173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA13,Carbonic anhydrase 13,50920,316,1.01 [0.92-1.11],0.8308569455199197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,51932,332,0.65 [0.50-0.86],0.0021392500118669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA2,Carbonic anhydrase 2,51337,328,1.00 [0.87-1.15],0.9941483324975112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,52044,332,1.38 [1.19-1.59],2.106138191513333e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA4,Carbonic anhydrase 4,52128,334,0.74 [0.50-1.11],0.1505068862255563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA5A,"Carbonic anhydrase 5A, mitochondrial",50550,323,0.94 [0.84-1.05],0.240042259098653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA6,Carbonic anhydrase 6,51346,328,0.95 [0.81-1.10],0.476372562492952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA7,Carbonic anhydrase 7,43946,299,0.85 [0.61-1.20],0.3635701065452683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA8,Carbonic anhydrase-related protein,43466,294,0.76 [0.47-1.25],0.2844838254751828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA9,Carbonic anhydrase 9,51932,332,0.90 [0.73-1.12],0.3556608936000455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CABP2,Calcium-binding protein 2,43533,300,0.92 [0.77-1.10],0.3849784755779684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,43318,298,0.93 [0.66-1.33],0.7065891912801203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,43292,293,0.97 [0.79-1.18],0.7395021041792194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,43318,298,0.93 [0.77-1.13],0.4538301578299765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,44680,305,1.00 [0.88-1.14],0.98727199697847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACYBP,Calcyclin-binding protein,43704,299,1.00 [0.90-1.11],0.9988479721651128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CADPS,Calcium-dependent secretion activator 1,43533,300,0.86 [0.64-1.14],0.2915944603669534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB1,Calbindin,51256,329,1.13 [0.90-1.42],0.2762336058341219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB2,Calretinin,50288,323,1.27 [0.96-1.67],0.0917193196444816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCA,Calcitonin,51008,326,1.13 [0.97-1.31],0.1142873333485727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCB,Calcitonin gene-related peptide 2,44654,304,1.32 [1.05-1.66],0.0160996921930995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,51770,329,0.99 [0.90-1.09],0.8406302235789826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,43572,301,1.02 [0.89-1.18],0.7520842129214733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALY,Neuron-specific vesicular protein calcyon,43292,293,0.99 [0.74-1.34],0.9638740042363736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,50282,316,1.14 [0.92-1.41],0.2400085969857007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,43533,300,0.95 [0.77-1.17],0.6150109000381072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,44680,305,1.01 [0.91-1.12],0.8528560054737762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CANT1,Soluble calcium-activated nucleotidase 1,51337,323,0.81 [0.49-1.31],0.3836021367828082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPG,Macrophage-capping protein,51113,327,1.00 [0.84-1.17],0.9564184421363576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,44551,301,1.46 [1.18-1.80],0.0004709561510395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPS,Calcyphosin,44654,304,0.95 [0.84-1.07],0.4085582722352598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CARHSP1,Calcium-regulated heat-stable protein 1,50288,323,1.04 [0.86-1.25],0.6891257927877916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASC3,Protein CASC3,43533,300,1.01 [0.77-1.31],0.9548823795631254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP1,Caspase-1,50288,323,0.97 [0.84-1.12],0.6593670470860098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP10,Caspase-10,50288,323,1.01 [0.88-1.15],0.9364868197374558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP2,Caspase-2,51419,328,1.02 [0.89-1.18],0.756240536052943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP3,Caspase-3,52128,334,1.04 [0.93-1.16],0.4878505793745324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP4,Caspase-4,43946,299,0.97 [0.91-1.04],0.4368507921439162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP7,Caspase-7,44654,304,1.02 [0.89-1.16],0.8073610688870496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP8,Caspase-8,51781,329,1.04 [0.90-1.22],0.5854325408529333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP9,Caspase-9,43466,294,1.07 [0.90-1.28],0.4344018495377528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASQ2,Calsequestrin-2,43292,293,0.92 [0.72-1.18],0.5141685070193484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAT,Catalase,44131,303,1.07 [0.88-1.31],0.4913303218785563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLIF,Cobalamin binding intrinsic factor,51417,323,0.99 [0.87-1.13],0.8747245539604617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN1,Cerebellin-1,43318,298,1.00 [0.89-1.12],0.958534459027253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN4,Cerebellin-4,51932,332,0.94 [0.69-1.27],0.666234924251494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBS,Cystathionine beta-synthase,43572,301,0.99 [0.80-1.23],0.9283831546379252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBX2,Chromobox protein homolog 2,43292,293,0.87 [0.64-1.19],0.3920980180034933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,51093,326,1.00 [0.88-1.14],0.9879346964140509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCAR2,Cell cycle and apoptosis regulator protein 2,44654,304,0.83 [0.66-1.06],0.1381067796758882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC134,Coiled-coil domain-containing protein 134,44551,301,0.86 [0.68-1.09],0.2064943453869251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC28A,Coiled-coil domain-containing protein 28A,43533,300,1.01 [0.69-1.46],0.9773670992967745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC50,Coiled-coil domain-containing protein 50,44680,305,1.10 [0.97-1.25],0.1400670855299947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC80,Coiled-coil domain-containing protein 80,51493,323,1.21 [0.93-1.59],0.1564671350386558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,43572,301,1.03 [0.86-1.23],0.74686827814257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL11,Eotaxin,52056,330,0.91 [0.70-1.18],0.4822494930545052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL13,C-C motif chemokine 13,51971,330,1.06 [0.92-1.22],0.4019059530880161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL14,C-C motif chemokine 14,51361,330,1.28 [1.03-1.61],0.0295354151770641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL15,C-C motif chemokine 15,52128,334,1.05 [0.84-1.30],0.6909085635415921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL16,C-C motif chemokine 16,52128,334,0.87 [0.73-1.04],0.1189806270354363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL17,C-C motif chemokine 17,51378,328,1.03 [0.93-1.15],0.5300611133055804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL18,C-C motif chemokine 18,50790,327,1.08 [0.94-1.23],0.2798839130361114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL19,C-C motif chemokine 19,51944,331,1.09 [1.01-1.16],0.0170718242254216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL2,C-C motif chemokine 2,51008,326,1.05 [0.87-1.26],0.630429528286049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL20,C-C motif chemokine 20,52056,330,0.96 [0.86-1.08],0.5074978499629219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL21,C-C motif chemokine 21,51715,329,1.15 [0.92-1.43],0.2185331173784091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL22,C-C motif chemokine 22,50964,326,0.98 [0.82-1.19],0.8750916534034281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL23,C-C motif chemokine 23,51715,329,1.14 [0.90-1.43],0.2807596290202584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL24,C-C motif chemokine 24,51631,329,0.96 [0.86-1.08],0.5091275122357284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL25,C-C motif chemokine 25,52056,330,0.86 [0.71-1.05],0.1391946627320975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL26,C-C motif chemokine 26,51419,328,1.02 [0.91-1.13],0.7796650957227842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL27,C-C motif chemokine 27,51493,323,0.94 [0.80-1.10],0.4387668023577504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,51250,328,0.96 [0.81-1.13],0.5952817487060865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL3,C-C motif chemokine 3,51419,328,1.10 [0.94-1.27],0.231487798460274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL4,C-C motif chemokine 4,51547,328,1.11 [0.98-1.26],0.1087905178724289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL5,C-C motif chemokine 5,51698,331,1.02 [0.93-1.12],0.6547005062993061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL7,C-C motif chemokine 7,51419,328,1.19 [1.03-1.38],0.0188745138309664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL8,C-C motif chemokine 8,51858,331,1.16 [0.98-1.36],0.0776990145758533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN1,CCN family member 1,51172,328,1.02 [0.89-1.16],0.7773002342672559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN2,CCN family member 2,51462,329,1.08 [0.91-1.27],0.4039457010375855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,52043,334,1.44 [1.10-1.89],0.0078472629395582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN4,CCN family member 4,51932,332,1.03 [0.80-1.31],0.837194324536977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN5,CCN family member 5,51506,328,1.01 [0.78-1.30],0.9574039939328072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,43946,299,0.65 [0.52-0.82],0.0003126009275288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCNE1,G1/S-specific cyclin-E1,43466,294,0.83 [0.71-0.98],0.0288592957035278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCS,Copper chaperone for superoxide dismutase,51093,326,1.06 [0.86-1.30],0.5821687800238371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCT5,T-complex protein 1 subunit epsilon,50282,316,1.03 [0.82-1.28],0.8113316023914604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD101,Immunoglobulin superfamily member 2,44569,304,0.93 [0.72-1.20],0.5727941004265504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD109,CD109 antigen,51506,328,0.93 [0.69-1.24],0.6191033468924481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD14,Monocyte differentiation antigen CD14,50452,326,1.04 [0.82-1.32],0.7502768543500885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD160,CD160 antigen,52056,330,0.93 [0.75-1.14],0.4738794947264866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD163,Scavenger receptor cysteine-rich type 1 protein M130,51698,331,1.07 [0.85-1.34],0.557599151225536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164,Sialomucin core protein 24,51506,328,1.04 [0.73-1.49],0.811071621958514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164L2,CD164 sialomucin-like 2 protein,43533,300,0.83 [0.60-1.13],0.2360127904287193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD177,CD177 antigen,51421,328,0.96 [0.89-1.03],0.2389994240323904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD1C,T-cell surface glycoprotein CD1c,51651,329,0.92 [0.62-1.37],0.6854223799648107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2,T-cell surface antigen CD2,43292,293,0.91 [0.66-1.23],0.5299228417115338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200,OX-2 membrane glycoprotein,51419,328,1.03 [0.72-1.49],0.864822440369138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200R1,Cell surface glycoprotein CD200 receptor 1,51250,328,0.94 [0.71-1.25],0.6766396265531038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD207,C-type lectin domain family 4 member K,50370,320,1.11 [0.86-1.44],0.4069217677127024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD209,CD209 antigen,51625,329,0.91 [0.71-1.17],0.4756701012989073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD22,B-cell receptor CD22,52056,330,1.01 [0.81-1.27],0.9110075478466952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,43466,294,0.73 [0.56-0.96],0.0229512732249485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD244,Natural killer cell receptor 2B4,52056,330,1.00 [0.70-1.42],0.9854540186602796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,44764,304,0.57 [0.43-0.74],3.607011252644702e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD27,CD27 antigen,51651,329,0.96 [0.76-1.22],0.7615175699046499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD274,Programmed cell death 1 ligand 1,51093,326,0.90 [0.67-1.21],0.4786542888442643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,51461,329,1.72 [1.30-2.27],0.0001301887594465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD28,T-cell-specific surface glycoprotein CD28,50282,316,0.98 [0.74-1.28],0.8598314678635133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2AP,CD2-associated protein,51493,323,0.96 [0.82-1.12],0.6133267204374941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300A,CMRF35-like molecule 8,43784,299,0.87 [0.60-1.26],0.4532722534553401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300C,CMRF35-like molecule 6,51944,331,0.97 [0.73-1.28],0.8084548372832602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,51765,332,0.95 [0.75-1.21],0.6716485773939747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LF,CMRF35-like molecule 1,51932,332,0.97 [0.83-1.14],0.7145470252479302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LG,CMRF35-like molecule 9,51506,328,0.87 [0.67-1.13],0.2832651279462786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD302,CD302 antigen,51256,329,1.04 [0.76-1.43],0.805677713388941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD33,Myeloid cell surface antigen CD33,51651,329,1.07 [0.95-1.21],0.2762860126781179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD34,Hematopoietic progenitor cell antigen CD34,51780,330,0.83 [0.55-1.24],0.3682873870105808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,43466,294,0.80 [0.62-1.04],0.0957921848427809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,51256,329,0.73 [0.54-0.99],0.0432789570761493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3D,T-cell surface glycoprotein CD3 delta chain,43318,298,1.01 [0.73-1.40],0.9440281145939112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3E,T-cell surface glycoprotein CD3 epsilon chain,43946,299,1.00 [0.73-1.36],0.9934701397545034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3G,T-cell surface glycoprotein CD3 gamma chain,43466,294,0.99 [0.87-1.13],0.880093604888885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD4,T-cell surface glycoprotein CD4,51335,328,0.99 [0.71-1.37],0.9296174618786548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,51463,328,0.96 [0.79-1.17],0.6903385532840799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40LG,CD40 ligand,52056,330,1.05 [0.93-1.19],0.4128593499384511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD46,Membrane cofactor protein,51193,329,1.14 [0.81-1.60],0.4469964740887128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD48,CD48 antigen,51631,329,0.83 [0.60-1.15],0.2519295144530843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5,T-cell surface glycoprotein CD5,51858,331,1.02 [0.77-1.35],0.8717116786085858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD55,Complement decay-accelerating factor,49697,319,0.91 [0.62-1.35],0.6422581744940232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD58,Lymphocyte function-associated antigen 3,51377,329,0.98 [0.56-1.70],0.9384359721734924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD59,CD59 glycoprotein,49633,321,0.70 [0.44-1.12],0.1335920123210416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5L,CD5 antigen-like,44583,305,1.12 [0.89-1.41],0.3310469675717304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD6,T-cell differentiation antigen CD6,51971,328,0.91 [0.76-1.10],0.3421091415618358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,51008,326,0.97 [0.80-1.17],0.7287040404761812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD69,Early activation antigen CD69,51240,322,0.98 [0.88-1.10],0.7467752778712006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD7,T-cell antigen CD7,43382,293,0.97 [0.75-1.25],0.7997083099801374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD70,CD70 antigen,51419,328,0.86 [0.69-1.08],0.203488892866893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD72,B-cell differentiation antigen CD72,43784,299,1.10 [0.85-1.43],0.4583910307992577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD74,HLA class II histocompatibility antigen gamma chain,51944,331,1.25 [0.95-1.65],0.108982285170741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD79B,B-cell antigen receptor complex-associated protein beta chain,52056,330,1.03 [0.83-1.27],0.8081407017495641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD80,T-lymphocyte activation antigen CD80,44759,302,1.19 [0.87-1.64],0.2753656961932914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD82,CD82 antigen,43946,299,1.26 [1.01-1.57],0.039282869131835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD83,CD83 antigen,51419,328,1.09 [0.82-1.45],0.5597410815699597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD84,SLAM family member 5,51419,328,1.17 [0.86-1.60],0.3142439527770718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD86,T-lymphocyte activation antigen CD86,44569,304,0.81 [0.56-1.16],0.2422313206038738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD8A,T-cell surface glycoprotein CD8 alpha chain,51944,331,0.98 [0.81-1.19],0.8426892612382317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD93,Complement component C1q receptor,49553,318,0.95 [0.69-1.32],0.7707052638588495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99,CD99 antigen,51506,328,0.97 [0.59-1.60],0.912064773334756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99L2,CD99 antigen-like protein 2,51506,328,1.05 [0.70-1.58],0.8049503783684988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDA,Cytidine deaminase,44674,302,1.04 [0.83-1.30],0.7591444016742835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDAN1,Codanin-1,44654,304,0.90 [0.55-1.47],0.6771047136823274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC123,Cell division cycle protein 123 homolog,43160,294,1.00 [0.84-1.19],0.993588240893872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,43160,294,0.78 [0.57-1.06],0.1086541980755787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC26,Anaphase-promoting complex subunit CDC26,44484,304,1.01 [0.86-1.18],0.934540784215492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC27,Cell division cycle protein 27 homolog,50282,316,0.98 [0.83-1.16],0.7964184306387784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC37,Hsp90 co-chaperone Cdc37,51651,329,1.02 [0.91-1.14],0.755995846205094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC42BPB,Serine/threonine-protein kinase MRCK beta,44569,304,0.98 [0.88-1.09],0.7448297025189948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDCP1,CUB domain-containing protein 1,51093,326,1.02 [0.85-1.23],0.8146238339811194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH1,Cadherin-1,49782,320,1.04 [0.81-1.34],0.7366553894876151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH15,Cadherin-15,51859,331,1.02 [0.87-1.20],0.7994233337525114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH17,Cadherin-17,51493,323,1.01 [0.88-1.17],0.8733996914344409
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH2,Cadherin-2,51493,323,1.09 [0.82-1.44],0.5527962587343477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH22,Cadherin-22,43946,299,0.77 [0.51-1.16],0.2104954059223573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH23,Cadherin-23,44654,304,0.70 [0.45-1.07],0.1010231919221158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH3,Cadherin-3,51944,331,1.15 [0.88-1.49],0.3137439179546709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH4,Cadherin-4,43318,298,0.89 [0.70-1.15],0.3790945961766702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH5,Cadherin-5,52128,334,0.84 [0.60-1.16],0.2776728016554945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH6,Cadherin-6,51493,323,1.09 [0.85-1.42],0.4905382082130899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR1,Cadherin-related family member 1,50288,323,1.06 [0.85-1.33],0.6128201535291777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR2,Cadherin-related family member 2,51256,329,1.05 [0.91-1.20],0.5118431518740231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR5,Cadherin-related family member 5,51493,323,1.03 [0.80-1.34],0.7929823158998522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK1,Cyclin-dependent kinase 1,43160,294,0.83 [0.61-1.12],0.219305533829092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,44680,305,1.01 [0.84-1.22],0.9123372973059826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKL5,Cyclin-dependent kinase-like 5,43318,298,0.85 [0.68-1.08],0.1827158127644712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN1A,Cyclin-dependent kinase inhibitor 1,51256,329,1.02 [0.93-1.12],0.6799063576327744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,51256,329,1.03 [0.93-1.14],0.580791147025257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,51256,329,0.82 [0.61-1.12],0.2149223426225899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,51546,329,0.85 [0.59-1.23],0.4001463284594175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDSN,Corneodesmosin,51894,329,1.05 [0.84-1.31],0.6799832981143442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,51570,329,0.83 [0.54-1.28],0.401663609470155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,44569,304,0.93 [0.81-1.06],0.2679897231727519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,43946,299,0.98 [0.83-1.16],0.8285012856468048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,44569,304,0.95 [0.72-1.25],0.6944602697671449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,43946,299,1.07 [0.84-1.36],0.5717727485644707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,51419,328,1.03 [0.92-1.15],0.5993685376137959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,50282,316,0.93 [0.75-1.15],0.5080170046786658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,49633,314,0.94 [0.80-1.10],0.4164653768645741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,44764,304,1.09 [0.83-1.43],0.5233934715325204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,50550,323,1.12 [0.92-1.35],0.2675562064718998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPA,CCAAT/enhancer-binding protein alpha,43466,294,0.78 [0.55-1.12],0.1811992386048779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPB,CCAAT/enhancer-binding protein beta,50550,323,1.06 [0.82-1.36],0.6732719836542078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA2A,Chymotrypsin-like elastase family member 2A,44764,304,0.95 [0.79-1.13],0.5327447234735927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,52043,334,0.92 [0.78-1.08],0.2944408475051348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,43784,299,0.81 [0.55-1.19],0.2874927431485129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEMIP2,Cell surface hyaluronidase,43466,294,0.82 [0.56-1.20],0.3056810820644943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEND1,Cell cycle exit and neuronal differentiation protein 1,43318,298,1.09 [0.92-1.29],0.3387280471744087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPF,Centromere protein F,43946,299,0.95 [0.78-1.17],0.640071200228125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPJ,Centromere protein J,43946,299,0.88 [0.74-1.04],0.1303277869266008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP112,Centrosomal protein of 112 kDa,43292,293,0.95 [0.73-1.23],0.6892667432342946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,43160,294,0.84 [0.64-1.12],0.2338567906702717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP164,Centrosomal protein of 164 kDa,50524,322,1.06 [0.92-1.22],0.4455689693023683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP170,Centrosomal protein of 170 kDa,43572,301,1.00 [0.87-1.16],0.984347374484673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP20,Centrosomal protein 20,50282,316,0.99 [0.87-1.13],0.9045010508731468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,43946,299,0.71 [0.56-0.92],0.0091302525120055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP350,Centrosome-associated protein 350,43160,294,0.91 [0.67-1.24],0.5547650168209937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP43,Centrosomal protein 43,50149,321,1.03 [0.89-1.19],0.692678121568176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP85,Centrosomal protein of 85 kDa,50282,316,0.97 [0.83-1.14],0.7398660139850719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CERT,Ceramide transfer protein,50288,323,1.07 [0.91-1.26],0.3986612027428931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES1,Liver carboxylesterase 1,51621,330,1.06 [0.94-1.19],0.3420795741443396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES2,Cocaine esterase,51256,329,0.89 [0.74-1.07],0.2028582967780455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES3,Carboxylesterase 3,51256,329,1.02 [0.89-1.17],0.7726938254014096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN2,Centrin-2,50288,323,1.01 [0.88-1.17],0.8560420907590459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN3,Centrin-3,44569,304,0.97 [0.84-1.12],0.7114539125420614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFB,Complement factor B,44010,300,0.99 [0.70-1.39],0.9545887135871316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,50282,316,0.73 [0.57-0.92],0.0086823279164807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFD,Complement factor D,44829,305,0.71 [0.40-1.25],0.2312544345854887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFH,Complement factor H,42211,287,0.85 [0.52-1.40],0.5327521458042583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR2,Complement factor H-related protein 2,44498,304,1.04 [0.86-1.26],0.6894761093971826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR4,Complement factor H-related protein 4,44744,304,1.14 [0.98-1.33],0.0920714399997341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR5,Complement factor H-related protein 5,44211,302,1.05 [0.80-1.37],0.7420665375430655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFI,Complement factor I,44829,305,0.93 [0.54-1.62],0.8062924962517353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFP,Properdin,44829,305,0.85 [0.52-1.42],0.5416777043721988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGA,Glycoprotein hormones alpha chain,51506,328,1.04 [0.90-1.19],0.6149106406783174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,44798,305,1.18 [0.93-1.50],0.1727205725749834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGN,Cingulin,43533,300,1.15 [0.89-1.48],0.2837940121970549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGREF1,Cell growth regulator with EF hand domain protein 1,51493,323,0.86 [0.68-1.09],0.2051007653214359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,50282,316,1.07 [0.91-1.26],0.4420696618904441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAD,Chondroadherin,43784,299,0.88 [0.71-1.09],0.2297955961599532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",44654,304,1.25 [0.97-1.61],0.0851503000497253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD6,MICOS complex subunit MIC25,44551,301,0.87 [0.57-1.31],0.5038822181063441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHEK2,Serine/threonine-protein kinase Chk2,50550,323,1.10 [0.82-1.48],0.523935128692961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGA,Chromogranin-A,44764,304,1.06 [0.94-1.19],0.3595278357978639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGB,Secretogranin-1,51774,331,0.86 [0.68-1.09],0.2161045482136349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHI3L1,Chitinase-3-like protein 1,50362,326,0.98 [0.87-1.11],0.800319234572314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHIT1,Chitotriosidase-1,51708,331,1.01 [0.95-1.07],0.7826889624907534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHL1,Neural cell adhesion molecule L1-like protein,51617,331,0.97 [0.71-1.34],0.8686395511609137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHM,Rab proteins geranylgeranyltransferase component A 1,43533,300,0.95 [0.79-1.14],0.5915998814562089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP1A,Charged multivesicular body protein 1a,51093,326,1.06 [0.93-1.20],0.3729847703842494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP6,Charged multivesicular body protein 6,44759,302,0.96 [0.79-1.16],0.6621976126968645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHP1,Calcineurin B homologous protein 1,43318,298,0.88 [0.75-1.04],0.1382502933711477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL1,Chordin-like protein 1,51631,329,1.11 [0.82-1.52],0.496658934029167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL2,Chordin-like protein 2,51493,323,0.92 [0.76-1.12],0.4110656004078724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRM1,Muscarinic acetylcholine receptor M1,43533,300,0.74 [0.53-1.04],0.0870396313674908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIAPIN1,Anamorsin,51651,329,1.04 [0.89-1.22],0.586955562101207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CILP,Cartilage intermediate layer protein 1,44764,304,1.06 [0.86-1.29],0.5999625487760125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CINP,Cyclin-dependent kinase 2-interacting protein,43946,299,0.84 [0.64-1.11],0.2277798454128012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIRBP,Cold-inducible RNA-binding protein,44569,304,1.02 [0.91-1.14],0.7848918026196591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIT,Citron Rho-interacting kinase,43533,300,0.74 [0.57-0.97],0.0268477155281389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKAP4,Cytoskeleton-associated protein 4,51804,327,1.02 [0.71-1.45],0.9186912392062996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKB,Creatine kinase B-type,44764,304,1.12 [0.93-1.35],0.2197949903884535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",51294,328,0.87 [0.76-0.98],0.0253873652098698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLASP1,CLIP-associating protein 1,43160,294,1.03 [0.88-1.19],0.7459530972441792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLC,Galectin-10,51415,323,0.94 [0.81-1.09],0.4398450062908703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC10A,C-type lectin domain family 10 member A,51093,326,0.90 [0.68-1.18],0.4291186647142855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC11A,C-type lectin domain family 11 member A,51421,328,0.87 [0.71-1.07],0.1809026682458297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC12A,C-type lectin domain family 12 member A,43466,294,0.72 [0.41-1.28],0.2644832902440153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC14A,C-type lectin domain family 14 member A,51506,328,0.88 [0.65-1.20],0.43085340300089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,50550,323,0.86 [0.64-1.16],0.323518146367793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,51944,331,0.98 [0.88-1.08],0.6426215030071181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC2L,C-type lectin domain family 2 member L,43533,300,0.98 [0.79-1.22],0.8565442113033779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,43779,298,0.62 [0.36-1.05],0.0768507192406734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4A,C-type lectin domain family 4 member A,51419,328,0.71 [0.55-0.93],0.0129077115448971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4C,C-type lectin domain family 4 member C,51419,328,0.91 [0.74-1.11],0.3583993528332218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4D,C-type lectin domain family 4 member D,51419,328,1.12 [0.96-1.31],0.1569139759828765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,51419,328,1.48 [1.10-1.97],0.0084739973110237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4M,C-type lectin domain family 4 member M,44687,304,0.93 [0.74-1.16],0.4990003304250254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC5A,C-type lectin domain family 5 member A,51325,322,1.18 [0.85-1.63],0.3347082855395711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC6A,C-type lectin domain family 6 member A,50282,316,1.07 [0.87-1.33],0.5081580112879056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC7A,C-type lectin domain family 7 member A,52056,330,1.03 [0.87-1.22],0.7336690499338558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLGN,Calmegin,43533,300,0.88 [0.68-1.13],0.3091297706055226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIC5,Chloride intracellular channel protein 5,43533,300,0.70 [0.47-1.03],0.0716631585299503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLINT1,Clathrin interactor 1,43160,294,0.98 [0.77-1.25],0.8821615358180104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIP2,CAP-Gly domain-containing linker protein 2,51419,328,1.02 [0.93-1.11],0.7019187116909387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLMP,CXADR-like membrane protein,51932,332,0.98 [0.62-1.55],0.9393289119631166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLNS1A,Methylosome subunit pICln,43533,300,1.04 [0.75-1.43],0.829882780812765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",51008,326,1.00 [0.90-1.11],0.9855316262266064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPS,Colipase,51421,328,0.94 [0.82-1.08],0.3841994204756827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSPN,Claspin,50203,323,1.10 [0.85-1.42],0.4815315181135035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,50288,323,1.13 [0.95-1.34],0.1719904475654037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN2,Calsyntenin-2,52056,330,1.03 [0.80-1.31],0.8266533216646453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN3,Calsyntenin-3,44654,304,0.78 [0.54-1.13],0.1943118445609146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLTA,Clathrin light chain A,50550,323,1.11 [0.91-1.36],0.2901977433028546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLU,Clusterin,44829,305,0.97 [0.66-1.41],0.8607109491275914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,51409,323,0.83 [0.67-1.04],0.1020284859069343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMC1,COX assembly mitochondrial protein homolog,44759,302,1.01 [0.89-1.14],0.9084080103620776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMIP,C-Maf-inducing protein,44551,301,0.98 [0.86-1.12],0.8123616457477977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNDP1,Beta-Ala-His dipeptidase,51698,331,0.91 [0.74-1.12],0.3660060216469032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNGB3,Cyclic nucleotide-gated cation channel beta-3,43318,298,1.00 [0.82-1.23],0.986213638684026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",43492,301,1.01 [0.88-1.17],0.853171798819643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY2,Protein canopy homolog 2,50550,323,1.11 [0.96-1.29],0.1444328816120935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY4,Protein canopy homolog 4,51256,329,1.07 [0.94-1.22],0.3042796444724884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNST,Consortin,51493,323,0.98 [0.90-1.08],0.7004889599041815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTF,Ciliary neurotrophic factor,43318,298,0.85 [0.61-1.18],0.3236996515305123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN1,Contactin-1,52128,334,0.95 [0.67-1.35],0.7569820093406469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN2,Contactin-2,51932,332,1.03 [0.83-1.28],0.7662590065308013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN3,Contactin-3,51506,328,0.89 [0.66-1.22],0.475050625406976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN4,Contactin-4,51506,328,1.07 [0.71-1.61],0.7442189138874717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN5,Contactin-5,51617,330,0.88 [0.68-1.15],0.3535779172496537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP2,Contactin-associated protein-like 2,51419,328,0.89 [0.70-1.12],0.3183105195751072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP4,Contactin-associated protein-like 4,43533,300,0.92 [0.81-1.03],0.1482716439252359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,44759,302,0.80 [0.63-1.02],0.0746211624251056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL15A1,Collagen alpha-1(XV) chain,44764,304,0.96 [0.64-1.45],0.8567729229019952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL18A1,Collagen alpha-1(XVIII) chain,51709,331,0.85 [0.56-1.28],0.4293996004823198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL1A1,Collagen alpha-1(I) chain,52128,334,0.80 [0.54-1.18],0.2532371892826585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL24A1,Collagen alpha-1(XXIV) chain,44569,304,1.01 [0.83-1.22],0.9463880527669452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL28A1,Collagen alpha-1(XXVIII) chain,43533,300,0.92 [0.79-1.07],0.2799843207588396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL2A1,Collagen alpha-1(II) chain,43572,301,0.96 [0.83-1.10],0.5598924514251034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,44764,304,0.70 [0.44-1.12],0.136312213450346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A1,Collagen alpha-1(IV) chain,51493,323,1.02 [0.79-1.31],0.8792857105976045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A4,Collagen alpha-4(IV) chain,43874,299,0.94 [0.77-1.16],0.5748268970424081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL5A1,Collagen alpha-1(V) chain,43784,299,1.10 [0.84-1.45],0.4784517343391024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL6A3,Collagen alpha-3(VI) chain,52128,334,1.25 [0.95-1.63],0.1086063924770256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A1,Collagen alpha-1(IX) chain,51419,328,0.90 [0.73-1.11],0.3344442461853449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A2,Collagen alpha-2(IX) chain,43946,299,1.11 [0.89-1.40],0.3604633353402411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COLEC12,Collectin-12,51461,329,0.98 [0.68-1.42],0.9242522399209158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD1,COMM domain-containing protein 1,43572,301,0.99 [0.83-1.19],0.9518864992302184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD9,COMM domain-containing protein 9,44551,301,0.95 [0.72-1.26],0.71247094286698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMP,Cartilage oligomeric matrix protein,50947,328,1.16 [0.87-1.55],0.3166257562661257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMT,Catechol O-methyltransferase,50001,318,1.07 [0.95-1.21],0.2534357593462716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPB2,Coatomer subunit beta',43292,293,0.93 [0.71-1.21],0.5655135078738276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPE,Coatomer subunit epsilon,50288,323,0.94 [0.75-1.17],0.5745699644338572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",43572,301,0.95 [0.73-1.23],0.6859358114340959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO1A,Coronin-1A,50455,321,0.96 [0.86-1.08],0.5174321944160781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,43318,298,1.47 [1.15-1.87],0.0018663745656956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",51256,329,1.08 [0.94-1.24],0.2657429881239531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX6B1,Cytochrome c oxidase subunit 6B1,44759,302,1.24 [0.90-1.73],0.1885486989958957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,52128,334,0.80 [0.69-0.94],0.005949743371796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA2,Carboxypeptidase A2,51774,329,0.86 [0.74-1.00],0.0534499482000049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA4,Carboxypeptidase A4,42910,293,0.94 [0.72-1.22],0.6260826227472118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,52128,334,0.82 [0.69-0.96],0.0158981606722485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,44744,305,0.86 [0.53-1.40],0.5454111140973508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPE,Carboxypeptidase E,51531,329,0.81 [0.64-1.03],0.0817162009154881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPLX2,Complexin-2,43160,294,0.99 [0.69-1.42],0.960072689684168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPM,Carboxypeptidase M,51691,330,0.88 [0.66-1.17],0.3641826668051173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",43466,294,0.73 [0.47-1.12],0.1439157998151555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPPED1,Serine/threonine-protein phosphatase CPPED1,51944,331,1.04 [0.90-1.20],0.6264252041033986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPQ,Carboxypeptidase Q,44682,304,1.16 [0.85-1.59],0.3354089284235339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPTP,Ceramide-1-phosphate transfer protein,43292,293,1.01 [0.76-1.34],0.952077378221966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPVL,Probable serine carboxypeptidase CPVL,51847,331,1.20 [0.94-1.53],0.1342644034217805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM1,Probable carboxypeptidase X1,51651,329,1.00 [0.87-1.14],0.9447401425862368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM2,Inactive carboxypeptidase-like protein X2,44759,302,0.97 [0.63-1.49],0.8899715023856922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR1,Complement receptor type 1,44629,304,0.99 [0.73-1.35],0.9566989233699978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR2,Complement receptor type 2,51698,331,1.19 [0.97-1.46],0.1046662004431065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,50282,316,1.01 [0.90-1.13],0.9001710840787729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRADD,Death domain-containing protein CRADD,51008,326,1.07 [0.94-1.22],0.327452410299904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREB3,Cyclic AMP-responsive element-binding protein 3,43160,294,0.92 [0.74-1.14],0.4289328868458499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,43160,294,0.62 [0.39-0.98],0.0403154200925292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREG1,Protein CREG1,50827,328,1.03 [0.80-1.33],0.7903355756295923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD1,Protein disulfide isomerase CRELD1,43784,299,0.85 [0.63-1.15],0.289851843483784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD2,Protein disulfide isomerase CRELD2,51631,329,1.04 [0.86-1.25],0.6739570076063508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRH,Corticoliberin,50198,315,1.00 [0.89-1.13],0.954516463343074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHBP,Corticotropin-releasing factor-binding protein,51461,329,0.86 [0.60-1.21],0.3822238345372617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHR1,Corticotropin-releasing factor receptor 1,50550,323,0.98 [0.84-1.16],0.8445546850177817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIM1,Cysteine-rich motor neuron 1 protein,51715,329,0.88 [0.54-1.44],0.6220552436068197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIP2,Cysteine-rich protein 2,51093,326,0.86 [0.65-1.13],0.2741561114755595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP2,Cysteine-rich secretory protein 2,51932,332,1.00 [0.84-1.18],0.9749317390622112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP3,Cysteine-rich secretory protein 3,44381,300,0.95 [0.63-1.42],0.7920852854267746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRKL,Crk-like protein,51547,329,1.05 [0.95-1.15],0.3497333890049935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRLF1,Cytokine receptor-like factor 1,51715,329,1.15 [0.78-1.69],0.4769398096315839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRNN,Cornulin,50020,318,1.13 [0.98-1.31],0.0958454782776396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAC1,Cartilage acidic protein 1,52128,334,0.80 [0.58-1.09],0.1612795947199694
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAM,Cytotoxic and regulatory T-cell molecule,51093,326,1.12 [0.93-1.36],0.2402850167627592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAP,Cartilage-associated protein,43533,300,0.84 [0.65-1.08],0.1757980015479336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,50550,323,1.04 [0.96-1.14],0.3406934299620505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB1,Beta-crystallin B1,44759,302,1.04 [0.87-1.23],0.6870063631992573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB2,Beta-crystallin B2,44654,304,0.96 [0.81-1.12],0.5834682466349509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYGD,Gamma-crystallin D,44654,304,0.98 [0.88-1.10],0.7689044410729277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYM,Ketimine reductase mu-crystallin,43318,298,1.06 [0.92-1.22],0.416733428835908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYZL1,Quinone oxidoreductase-like protein 1,43572,301,1.03 [0.91-1.16],0.6728833662171267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSDE1,Cold shock domain-containing protein E1,43292,293,0.95 [0.86-1.05],0.2778136533806211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1,Macrophage colony-stimulating factor 1,51715,329,1.20 [0.84-1.71],0.3233357997312078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1R,Macrophage colony-stimulating factor 1 receptor,44798,305,0.96 [0.73-1.27],0.7720390275112539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2,Granulocyte-macrophage colony-stimulating factor,43292,293,0.80 [0.58-1.11],0.1743747474788425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,51093,326,0.99 [0.85-1.16],0.920013184114787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RB,Cytokine receptor common subunit beta,43466,294,0.87 [0.67-1.13],0.3047661074390719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3,Granulocyte colony-stimulating factor,50524,322,0.92 [0.75-1.13],0.4378679509287179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3R,Granulocyte colony-stimulating factor receptor,43466,294,0.84 [0.57-1.25],0.3933198554855495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSH1,Chorionic somatomammotropin hormone 1,44798,305,0.89 [0.61-1.30],0.5607716466589386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK1D,Casein kinase I isoform delta,43466,294,0.90 [0.75-1.08],0.2459470675523154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK2A1,Casein kinase II subunit alpha,44680,305,1.09 [0.86-1.39],0.4667449786180672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG4,Chondroitin sulfate proteoglycan 4,44764,304,0.77 [0.55-1.07],0.1168370440262345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG5,Chondroitin sulfate proteoglycan 5,43318,298,1.06 [0.85-1.32],0.5933465762627308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,43292,293,1.28 [1.17-1.40],5.0577556231116614e-08
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST1,Cystatin-SN,38862,263,1.00 [0.89-1.13],0.9759080798997604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST3,Cystatin-C,51613,330,1.21 [0.87-1.70],0.2588140275361831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST5,Cystatin-D,50522,325,0.90 [0.75-1.07],0.2319875864296376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST6,Cystatin-M,50140,324,1.22 [1.00-1.49],0.0515220209905225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST7,Cystatin-F,51547,328,1.03 [0.94-1.14],0.5034597707737045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSTB,Cystatin-B,50791,330,1.18 [0.95-1.48],0.1421605780783696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTAG1A_CTAG1B,Cancer/testis antigen 1,43862,299,0.95 [0.76-1.19],0.6620964228429818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTBS,Di-N-acetylchitobiase,44145,303,0.98 [0.65-1.48],0.9237635223102604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTF1,Cardiotrophin-1,50550,323,0.98 [0.87-1.11],0.7848064807270622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTHRC1,Collagen triple helix repeat-containing protein 1,44764,304,1.18 [0.80-1.73],0.404271143598132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTLA4,Cytotoxic T-lymphocyte protein 4,44764,304,0.90 [0.62-1.31],0.5917636228331455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTNNA1,Catenin alpha-1,43318,298,1.04 [0.76-1.41],0.8063744584690762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRB1,Chymotrypsinogen B,51506,328,0.91 [0.77-1.09],0.2993789577075888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,51464,329,0.84 [0.72-0.98],0.0228742504050992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRL,Chymotrypsin-like protease CTRL-1,44654,304,0.95 [0.81-1.11],0.4982272685235909
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSB,Cathepsin B,51544,331,0.96 [0.80-1.16],0.6972093619817894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSC,Dipeptidyl peptidase 1,51377,328,1.07 [0.86-1.34],0.5338918398672599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSD,Cathepsin D,48138,307,1.11 [0.87-1.41],0.415607444986465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSE,Cathepsin E,43784,299,0.97 [0.78-1.20],0.7804697628305568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSF,Cathepsin F,51651,329,0.97 [0.76-1.23],0.7810925457550899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSH,Pro-cathepsin H,50382,322,1.00 [0.88-1.14],0.9912174630442792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSL,Cathepsin L1,51493,323,1.46 [0.98-2.16],0.0627232482216865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSO,Cathepsin O,52056,330,1.15 [0.84-1.58],0.3831452441933283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSS,Cathepsin S,40464,242,1.34 [0.80-2.24],0.2654101157211154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSV,Cathepsin L2,51763,331,0.93 [0.73-1.18],0.5468117692732914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSZ,Cathepsin Z,51531,331,1.14 [0.84-1.55],0.3973797976973912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CUZD1,CUB and zona pellucida-like domain-containing protein 1,43533,300,0.94 [0.69-1.28],0.6941060860379149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CWC15,Spliceosome-associated protein CWC15 homolog,44315,302,0.98 [0.82-1.17],0.8081804393746752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CX3CL1,Fractalkine,51093,326,1.11 [0.83-1.48],0.4766135426996625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXADR,Coxsackievirus and adenovirus receptor,51419,328,0.94 [0.77-1.14],0.5155152845462869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL1,Growth-regulated alpha protein,51384,327,0.98 [0.88-1.09],0.6892892416173902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL10,C-X-C motif chemokine 10,51715,329,1.07 [0.93-1.23],0.3620180254202754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL11,C-X-C motif chemokine 11,51944,331,1.01 [0.89-1.14],0.9215949833975988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL12,Stromal cell-derived factor 1,50524,322,1.24 [0.97-1.58],0.0793656684332994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL13,C-X-C motif chemokine 13,51944,331,1.12 [0.97-1.29],0.1193834449696915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL14,C-X-C motif chemokine 14,50524,322,0.93 [0.78-1.12],0.4497560830530683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,52043,334,0.74 [0.49-1.12],0.1527984969491937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL17,C-X-C motif chemokine 17,52056,330,0.98 [0.78-1.23],0.8325720062788134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL3,C-X-C motif chemokine 3,51463,328,0.99 [0.89-1.09],0.7765384550370888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL5,C-X-C motif chemokine 5,51325,322,1.02 [0.94-1.11],0.656823844999128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL6,C-X-C motif chemokine 6,52056,330,1.07 [0.94-1.21],0.3076229620505487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL8,Interleukin-8,51100,328,0.95 [0.82-1.10],0.4874886167985002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL9,C-X-C motif chemokine 9,51715,329,1.10 [0.95-1.26],0.1885780523418186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5A,Cytochrome b5,43160,294,0.97 [0.83-1.14],0.7250720908210255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5R2,NADH-cytochrome b5 reductase 2,44069,303,1.03 [0.85-1.25],0.7678141406262218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",43292,293,1.01 [0.89-1.15],0.8228868500315072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,43160,294,0.84 [0.71-1.00],0.0476317974951552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTL1,Cytokine-like protein 1,44764,304,0.85 [0.54-1.33],0.4744101344081153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAAM1,Disheveled-associated activator of morphogenesis 1,43784,299,0.99 [0.87-1.14],0.9397935073910104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAB2,Disabled homolog 2,51932,332,1.04 [0.95-1.13],0.414251021686699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAG1,Dystroglycan,51715,329,1.05 [0.85-1.28],0.6683159051216556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAND5,DAN domain family member 5,43466,294,0.96 [0.79-1.17],0.6963495684989452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPK2,Death-associated protein kinase 2,43466,294,0.86 [0.70-1.07],0.1773093698801441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,51419,328,1.04 [0.95-1.13],0.3930455711896465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DARS1,"Aspartate--tRNA ligase, cytoplasmic",51008,326,1.07 [0.93-1.22],0.352909071065869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBH,Dopamine beta-hydroxylase,44713,305,0.95 [0.86-1.04],0.284620971697344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBI,Acyl-CoA-binding protein,51261,326,1.10 [0.97-1.24],0.1516736631690865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBN1,Drebrin,43466,294,0.92 [0.73-1.15],0.4484496978650728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBNL,Drebrin-like protein,51715,329,1.02 [0.92-1.13],0.7000624180501975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",51651,329,0.93 [0.70-1.22],0.5870029299892785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCC,Netrin receptor DCC,43533,300,0.99 [0.60-1.62],0.9724654272682216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCDC2C,Doublecortin domain-containing protein 2C,43160,294,0.96 [0.80-1.16],0.6993634696026414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCLRE1C,Protein artemis,43160,294,0.97 [0.67-1.39],0.8666400868559105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCN,Decorin,50550,323,0.92 [0.60-1.42],0.7172675556293092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTD,Deoxycytidylate deaminase,43784,299,1.03 [0.91-1.15],0.6724384511941406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN1,Dynactin subunit 1,51932,332,1.06 [0.91-1.22],0.4763188070601202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN2,Dynactin subunit 2,51256,329,1.02 [0.92-1.14],0.6563870420312338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN6,Dynactin subunit 6,50288,323,1.01 [0.88-1.16],0.8909279237013098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,51493,323,0.76 [0.56-1.04],0.0882287414241251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D1,DCN1-like protein 1,43318,298,0.93 [0.80-1.09],0.3877273171748111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D2,DCN1-like protein 2,43160,294,1.00 [0.87-1.15],0.9662376513827476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCXR,L-xylulose reductase,51651,329,1.01 [0.84-1.22],0.8952949871472415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDA1,DET1- and DDB1-associated protein 1,43292,293,1.04 [0.79-1.37],0.7931639565349602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",51256,329,1.16 [0.94-1.43],0.1763652022752205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDC,Aromatic-L-amino-acid decarboxylase,51417,323,0.93 [0.76-1.15],0.5215262192586898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDHD2,Phospholipase DDHD2,44680,305,0.98 [0.83-1.15],0.7949867339261508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDI2,Protein DDI1 homolog 2,43784,299,0.93 [0.81-1.08],0.3413187843775548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDR1,Epithelial discoidin domain-containing receptor 1,51944,331,1.59 [1.06-2.38],0.0254450571876289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDT,D-dopachrome decarboxylase,44764,304,0.99 [0.76-1.29],0.9456948064691756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX1,ATP-dependent RNA helicase DDX1,44569,304,0.97 [0.78-1.21],0.7896497195361784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX25,ATP-dependent RNA helicase DDX25,43533,300,1.01 [0.76-1.36],0.9240485443262336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX39A,ATP-dependent RNA helicase DDX39A,43466,294,0.71 [0.42-1.19],0.1954017002906363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX4,Probable ATP-dependent RNA helicase DDX4,43466,294,1.08 [0.89-1.31],0.4115408380607951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX53,Probable ATP-dependent RNA helicase DDX53,43533,300,1.03 [0.76-1.40],0.8651374028145142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX58,Antiviral innate immune response receptor RIG-I,50282,316,0.94 [0.78-1.12],0.4674738624249969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",51419,328,1.05 [0.94-1.16],0.3905253936937535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFA1_DEFA1B,Neutrophil defensin 1,50448,328,1.10 [0.92-1.30],0.3011095700297537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB103A_DEFB103B,Beta-defensin 103,43137,293,1.18 [0.93-1.48],0.1753588302915567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,43318,298,1.17 [0.98-1.40],0.0798474326216954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB116,Beta-defensin 116,43318,298,1.13 [0.99-1.28],0.0720054579842016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB118,Beta-defensin 118,43318,298,0.85 [0.67-1.07],0.1590495785111417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB4A_DEFB4B,Beta-defensin 4A,50767,324,1.02 [0.95-1.09],0.5846267928028884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENND2B,DENN domain-containing protein 2B,43292,293,1.07 [0.86-1.32],0.539322714167265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENR,Density-regulated protein,43466,294,1.01 [0.83-1.23],0.9225653885096649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DFFA,DNA fragmentation factor subunit alpha,52056,330,1.07 [0.93-1.23],0.3415895438271079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGCR6,Protein DGCR6,43318,298,0.87 [0.66-1.15],0.3340684086045137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKA,Diacylglycerol kinase alpha,43466,294,0.96 [0.78-1.18],0.7198174345035293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKZ,Diacylglycerol kinase zeta,50524,322,1.04 [0.79-1.37],0.7704466450449277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHODH,Dihydroorotate dehydrogenase,43292,293,0.92 [0.72-1.19],0.536716261784101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHPS,Deoxyhypusine synthase,44551,301,0.85 [0.63-1.13],0.2654277172095071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,44654,304,1.02 [0.81-1.28],0.8604185574476122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIABLO,"Diablo homolog, mitochondrial",51325,322,1.00 [0.91-1.09],0.9366365454477495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,43533,300,0.87 [0.66-1.15],0.3403691404282091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,43784,299,0.68 [0.46-1.01],0.0587025467445166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,51944,331,0.94 [0.80-1.10],0.4391450846087181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK3,Dickkopf-related protein 3,52128,334,0.72 [0.52-1.00],0.0484560504859027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK4,Dickkopf-related protein 4,51009,326,0.92 [0.74-1.14],0.4454402362865428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKKL1,Dickkopf-like protein 1,51256,329,1.08 [0.96-1.21],0.2153189261795765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLG4,Disks large homolog 4,44654,304,0.96 [0.82-1.12],0.6011753909674047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLGAP5,Disks large-associated protein 5,44680,305,1.03 [0.84-1.26],0.8063402733227066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLK1,Protein delta homolog 1,52128,334,0.90 [0.76-1.07],0.2349114352908311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL1,Delta-like protein 1,51651,329,1.26 [0.92-1.74],0.1494907358518655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL4,Delta-like protein 4,43572,301,0.95 [0.83-1.10],0.5032406373328229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMD,Dystrophin,43572,301,1.24 [1.02-1.50],0.0270791885572739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMP1,Dentin matrix acidic phosphoprotein 1,43572,301,0.83 [0.70-0.99],0.0359690287382474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,43160,294,0.69 [0.52-0.92],0.0114803459626644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA2,DnaJ homolog subfamily A member 2,51889,329,1.03 [0.91-1.16],0.6274715251060758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA4,DnaJ homolog subfamily A member 4,44654,304,1.03 [0.89-1.20],0.6824708750396768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB1,DnaJ homolog subfamily B member 1,51256,329,1.04 [0.93-1.16],0.5317394477946737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB14,DnaJ homolog subfamily B member 14,44569,304,0.94 [0.79-1.12],0.5041226095879171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB2,DnaJ homolog subfamily B member 2,43784,299,1.06 [0.87-1.30],0.5526214154244327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB6,DnaJ homolog subfamily B member 6,43375,296,1.03 [0.90-1.17],0.7052782005242545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB8,DnaJ homolog subfamily B member 8,50550,323,1.09 [0.93-1.28],0.3105473500930434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC21,DnaJ homolog subfamily C member 21,44654,304,0.98 [0.74-1.30],0.8693872234610449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC6,Putative tyrosine-protein phosphatase auxilin,43572,301,1.08 [0.94-1.23],0.2682911411504119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC9,DnaJ homolog subfamily C member 9,44569,304,1.00 [0.86-1.15],0.9586673249458668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNER,Delta and Notch-like epidermal growth factor-related receptor,51379,329,0.71 [0.48-1.04],0.0755522376449386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNLZ,DNL-type zinc finger protein,43318,298,0.95 [0.83-1.09],0.4763817315550299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM1,Dynamin-1,44569,304,1.04 [0.94-1.14],0.4524983665466102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM3,Dynamin-3,44680,305,1.01 [0.82-1.23],0.9590305423304104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNMBP,Dynamin-binding protein,51093,326,0.93 [0.79-1.09],0.3736074339209471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,44654,304,0.86 [0.71-1.03],0.1078589903078189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,51631,329,1.00 [0.83-1.21],0.9936423271791944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOC2B,Double C2-like domain-containing protein beta,43533,300,0.86 [0.61-1.20],0.3751141988686297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOCK9,Dedicator of cytokinesis protein 9,43318,298,1.02 [0.94-1.12],0.5998465282685423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK1,Docking protein 1,44654,304,1.01 [0.93-1.10],0.7875898449034558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK2,Docking protein 2,51493,323,1.01 [0.93-1.09],0.8385748086809091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP1,Dipeptidase 1,51008,326,1.16 [0.95-1.43],0.1526749012637148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP2,Dipeptidase 2,51256,329,1.22 [0.88-1.70],0.2372213829863327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP10,Inactive dipeptidyl peptidase 10,51419,328,0.97 [0.73-1.28],0.8166558861003665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP4,Dipeptidyl peptidase 4,50534,325,0.98 [0.70-1.38],0.9273204438147872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP6,Dipeptidyl aminopeptidase-like protein 6,51256,329,0.91 [0.68-1.22],0.531091163385783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,51078,321,0.89 [0.76-1.05],0.1710984483006807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPT,Dermatopontin,52128,334,0.79 [0.55-1.13],0.1937020797112373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPY30,Protein dpy-30 homolog,51770,329,0.95 [0.80-1.12],0.5071340106698343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRAXIN,Draxin,51093,326,1.02 [0.81-1.28],0.8731398310032927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRG2,Developmentally-regulated GTP-binding protein 2,51256,329,1.03 [0.87-1.23],0.7130233262741237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSC2,Desmocollin-2,50929,326,1.12 [0.85-1.49],0.4234910184401186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,44680,305,1.39 [1.03-1.88],0.0308650450957353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG2,Desmoglein-2,51506,328,1.08 [0.75-1.55],0.6700695670794475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG3,Desmoglein-3,51762,330,1.03 [0.78-1.37],0.8131193679903701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG4,Desmoglein-4,51093,327,0.97 [0.80-1.19],0.7961481358780687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTD1,D-aminoacyl-tRNA deacylase 1,43784,299,1.04 [0.92-1.18],0.5534164005681987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,44466,301,1.49 [1.19-1.87],0.000471900739017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX2,Probable E3 ubiquitin-protein ligase DTX2,43533,300,1.06 [0.89-1.25],0.5121809946186981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX3,Probable E3 ubiquitin-protein ligase DTX3,51256,329,1.03 [0.69-1.54],0.8723642160168688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTYMK,Thymidylate kinase,44759,302,1.00 [0.85-1.18],0.9746505073590108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUOX2,Dual oxidase 2,50550,323,0.99 [0.86-1.13],0.8460429540596548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP13,Dual specificity protein phosphatase 13 isoform A,44551,301,0.74 [0.56-0.98],0.0352853546047454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP29,Dual specificity phosphatase 29,43533,300,1.12 [0.96-1.30],0.1370141778806966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,50288,323,0.89 [0.78-1.01],0.0688915811523317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",44569,304,1.00 [0.90-1.11],0.9304294559297588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DXO,Decapping and exoribonuclease protein,44654,304,1.02 [0.80-1.29],0.8833994849599759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,44551,301,0.77 [0.59-1.02],0.0670303638097723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT1,Dynein light chain Tctex-type 1,43533,300,0.95 [0.83-1.10],0.4842156910044054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,44551,301,0.92 [0.72-1.19],0.5384105324170205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,51093,326,1.03 [0.93-1.14],0.5449802832648469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,51855,330,1.48 [1.09-2.01],0.0128257376329996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECE1,Endothelin-converting enzyme 1,50288,323,0.81 [0.61-1.07],0.1438395764723843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",44759,302,0.94 [0.81-1.10],0.4468755075165354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHS1,"Enoyl-CoA hydratase, mitochondrial",43572,301,1.01 [0.90-1.14],0.8266476006036392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECI2,Enoyl-CoA delta isomerase 2,43292,293,1.01 [0.84-1.21],0.914613610640606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECM1,Extracellular matrix protein 1,43602,296,0.92 [0.68-1.24],0.5788308340965851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECSCR,Endothelial cell-specific chemotaxis regulator,43318,298,1.01 [0.82-1.25],0.9199811256321424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,51932,332,1.82 [1.45-2.29],3.590271438899539e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDAR,Tumor necrosis factor receptor superfamily member EDAR,51419,328,1.03 [0.93-1.15],0.5474015833456221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,44551,301,0.87 [0.70-1.07],0.1872621426827748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,43292,293,1.12 [0.85-1.49],0.4243079396478098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDF1,Endothelial differentiation-related factor 1,44680,305,0.93 [0.79-1.10],0.4118797597804372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,50550,323,0.90 [0.68-1.21],0.4956855832160739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDN1,Endothelin-1,43572,301,1.16 [0.79-1.69],0.4429130383688664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDNRB,Endothelin receptor type B,43466,294,0.77 [0.57-1.04],0.0835424081342008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EEF1D,Elongation factor 1-delta,44759,302,0.96 [0.85-1.08],0.4914939173742414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB14,EF-hand calcium-binding domain-containing protein 14,44569,304,0.79 [0.52-1.20],0.2692308086123898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB2,Dynein regulatory complex protein 8,43946,299,0.99 [0.72-1.36],0.9342174706094982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,51614,331,0.98 [0.72-1.34],0.9044255870875532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFHD1,EF-hand domain-containing protein D1,44680,305,1.03 [0.75-1.40],0.8548063351073765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA1,Ephrin-A1,51421,326,1.36 [0.97-1.89],0.074050453400408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA4,Ephrin-A4,51008,326,1.01 [0.73-1.40],0.934125038454922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNB2,Ephrin-B2,43533,300,1.03 [0.85-1.24],0.7653289922172715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGF,Pro-epidermal growth factor,51381,328,1.03 [0.94-1.13],0.5439226899432497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFL7,Epidermal growth factor-like protein 7,50282,316,0.94 [0.73-1.21],0.6368917322103329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,44569,304,0.44 [0.30-0.65],3.3152410596852895e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFR,Epidermal growth factor receptor,52128,334,0.59 [0.33-1.06],0.0768080946716606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGLN1,Egl nine homolog 1,51419,328,1.06 [0.90-1.25],0.4951326863992827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHBP1,EH domain-binding protein 1,44759,302,1.00 [0.86-1.16],0.979489413725294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHD3,EH domain-containing protein 3,43572,301,1.02 [0.93-1.12],0.6758868780487542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",44654,304,0.87 [0.70-1.08],0.2164595040648898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",44402,303,1.01 [0.91-1.12],0.8541736027433315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,43292,293,0.99 [0.83-1.18],0.8980982119505992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,43572,301,1.03 [0.79-1.33],0.8413740427627011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4B,Eukaryotic translation initiation factor 4B,51093,326,1.00 [0.84-1.19],0.998780681896704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4E,Eukaryotic translation initiation factor 4E,43466,294,0.97 [0.86-1.10],0.6330610905062144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,51493,323,1.02 [0.88-1.18],0.8201810838923045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,52056,330,1.03 [0.93-1.13],0.609786080188599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,44680,305,0.93 [0.78-1.10],0.3951127647534472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5,Eukaryotic translation initiation factor 5,43292,293,1.19 [0.95-1.50],0.1356071689618832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5A,Eukaryotic translation initiation factor 5A-1,50524,322,1.40 [1.07-1.84],0.0155433365132953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAC1,Zinc phosphodiesterase ELAC protein 1,44680,305,1.01 [0.89-1.15],0.8907840100838218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAVL4,ELAV-like protein 4,43318,298,1.04 [0.92-1.19],0.5304707779093532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELN,Elastin,44759,302,1.28 [0.94-1.74],0.1206804266312154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOA,Elongin-A,51256,329,0.94 [0.78-1.13],0.5134276062731069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOB,Elongin-B,43292,293,1.11 [0.84-1.45],0.4651192526125457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENAH,Protein enabled homolog,50524,322,1.03 [0.84-1.27],0.7889345912004087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,41325,287,1.14 [0.92-1.41],0.2191623499415236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENG,Endoglin,52128,334,0.69 [0.39-1.21],0.196326074697857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO1,Alpha-enolase,51436,328,1.07 [0.95-1.22],0.2571768649728949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO2,Gamma-enolase,51944,331,1.01 [0.87-1.17],0.9310354367090417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO3,Beta-enolase,43572,301,1.13 [0.95-1.35],0.1649949823004148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOPH1,Enolase-phosphatase E1,44551,301,1.00 [0.82-1.23],0.9795369178058796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,43292,293,1.02 [0.68-1.52],0.927375288176504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPEP,Glutamyl aminopeptidase,43292,293,0.94 [0.72-1.22],0.6288497823483259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,52128,334,0.89 [0.62-1.28],0.5355188001552444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,51715,329,0.98 [0.78-1.22],0.8280469625444288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,43572,301,0.89 [0.66-1.20],0.4400276754606286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,49903,320,0.97 [0.86-1.09],0.5884316010043311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENSA,Alpha-endosulfine,44551,301,1.09 [0.89-1.33],0.4031729724285834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,50282,316,1.09 [0.86-1.36],0.4806959547511691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,50550,323,1.05 [0.66-1.67],0.8241456797820609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,50550,323,1.03 [0.72-1.48],0.8550946488453968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTR1,Endosome-associated-trafficking regulator 1,43572,301,1.00 [0.83-1.21],0.984157461598018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EP300,Histone acetyltransferase p300,43466,294,0.75 [0.51-1.10],0.138117509167678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPB41L5,Band 4.1-like protein 5,43533,300,0.95 [0.79-1.14],0.5812423464479897
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPCAM,Epithelial cell adhesion molecule,51461,328,0.91 [0.83-1.01],0.0778421727697536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPGN,Epigen,44551,301,1.24 [1.03-1.49],0.0199256339533318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA1,Ephrin type-A receptor 1,51631,329,0.71 [0.53-0.95],0.0220670019725544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA10,Ephrin type-A receptor 10,50288,323,1.05 [0.91-1.21],0.5354751448960947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA2,Ephrin type-A receptor 2,49633,325,0.96 [0.69-1.32],0.7850819863269047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA4,Ephrin type-A receptor 4,43784,299,0.78 [0.53-1.15],0.2103548484707255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB4,Ephrin type-B receptor 4,52128,334,0.93 [0.63-1.38],0.7322499369754163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB6,Ephrin type-B receptor 6,51008,326,1.01 [0.75-1.38],0.9319902919088598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHX2,Bifunctional epoxide hydrolase 2,50550,323,1.16 [1.01-1.33],0.0411199638914511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPN1,Epsin-1,43946,299,0.88 [0.67-1.16],0.370941518150587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPO,Erythropoietin,51419,328,0.96 [0.83-1.10],0.5148997609755356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPPK1,Epiplakin,43572,301,1.03 [0.88-1.20],0.7043504581458374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,51847,331,0.62 [0.44-0.86],0.0042969525255025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB2,Receptor tyrosine-protein kinase erbB-2,51651,329,0.79 [0.53-1.17],0.2348107243248706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB3,Receptor tyrosine-protein kinase erbB-3,51294,328,0.94 [0.57-1.56],0.8183409449287213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB4,Receptor tyrosine-protein kinase erbB-4,51651,329,1.13 [0.75-1.70],0.5537340012880942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBIN,Erbin,51256,329,1.02 [0.93-1.13],0.6236882156375401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERC2,ERC protein 2,43533,300,0.96 [0.82-1.12],0.6205147900552999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,43160,294,0.98 [0.70-1.38],0.9089613760512943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EREG,Proepiregulin,51008,326,1.06 [0.94-1.20],0.3317617905173243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERI1,3'-5' exoribonuclease 1,43946,299,1.07 [0.77-1.47],0.6969383579954311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERMAP,Erythroid membrane-associated protein,43466,294,1.03 [0.80-1.32],0.8455854827928808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,44551,301,0.84 [0.62-1.13],0.2521154144066697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP29,Endoplasmic reticulum resident protein 29,43784,299,1.01 [0.92-1.11],0.7658521695686866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP44,Endoplasmic reticulum resident protein 44,51172,328,1.08 [0.74-1.58],0.678040611158162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,43292,293,0.89 [0.68-1.16],0.3739931694147942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESAM,Endothelial cell-selective adhesion molecule,52128,334,0.90 [0.66-1.22],0.4819500401860263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESM1,Endothelial cell-specific molecule 1,51461,329,0.89 [0.67-1.19],0.4418294779792271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESPL1,Separin,43160,294,0.90 [0.72-1.11],0.3207837802401228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESR1,Estrogen receptor,43466,294,0.85 [0.68-1.07],0.1657874336213136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESYT2,Extended synaptotagmin-2,44654,304,0.99 [0.87-1.13],0.90581590201906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI2B,Protein EVI2B,43160,294,0.71 [0.51-1.00],0.0528201345969693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI5,Ecotropic viral integration site 5 protein homolog,43466,294,0.94 [0.83-1.07],0.3488729560773561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVPL,Envoplakin,43946,299,0.98 [0.70-1.37],0.8878602375078216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXOSC10,Exosome component 10,43292,293,0.99 [0.82-1.20],0.913322473632354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXTL1,Exostosin-like 1,43292,293,0.86 [0.67-1.12],0.2596465409533594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EZR,Ezrin,51944,331,0.79 [0.53-1.19],0.2644532655736105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,44798,305,0.80 [0.54-1.19],0.2675295394637603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11,Coagulation factor XI,44182,301,1.09 [0.77-1.54],0.6221764819226505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11R,Junctional adhesion molecule A,51506,328,1.01 [0.85-1.20],0.9192731620400774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F12,Coagulation factor XII,44829,305,1.04 [0.80-1.36],0.7611879396128612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F13B,Coagulation factor XIII B chain,44583,305,0.80 [0.52-1.21],0.2887358715879985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2,Prothrombin,44829,305,0.72 [0.35-1.48],0.3726910857495835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2R,Proteinase-activated receptor 1,51631,329,1.01 [0.85-1.20],0.88762053399061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F3,Tissue factor,51615,327,0.77 [0.53-1.12],0.1696672944105097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F7,Coagulation factor VII,51613,330,1.12 [0.82-1.55],0.4710780036597806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F9,Coagulation factor IX,51615,331,1.31 [0.77-2.23],0.3269564924657257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",51461,329,0.86 [0.77-0.96],0.0054104931417268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP2,"Fatty acid-binding protein, intestinal",51493,323,0.87 [0.76-0.98],0.0281174840289022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",44759,302,1.37 [1.13-1.67],0.0012110592447381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP4,"Fatty acid-binding protein, adipocyte",52128,334,0.97 [0.80-1.18],0.753686147299613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP5,Fatty acid-binding protein 5,51776,329,1.09 [0.95-1.26],0.2091491698032359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP6,Gastrotropin,50470,322,0.91 [0.76-1.09],0.3187089316003523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP9,Fatty acid-binding protein 9,51419,328,0.99 [0.83-1.17],0.8687081862010905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FADD,FAS-associated death domain protein,51493,323,1.05 [0.93-1.20],0.415350570004358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM13A,Protein FAM13A,44569,304,0.95 [0.81-1.13],0.5759645254540402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171A2,Protein FAM171A2,44680,305,1.00 [0.93-1.07],0.9878615367852438
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171B,Protein FAM171B,44551,301,1.00 [0.67-1.50],0.9964168635619608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM172A,Cotranscriptional regulator FAM172A,43572,301,1.00 [0.83-1.20],0.9932576628287444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM20A,Pseudokinase FAM20A,44759,302,1.15 [0.78-1.70],0.4673392748136911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3B,Protein FAM3B,51256,329,0.80 [0.61-1.06],0.1183449938397691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,51417,323,0.72 [0.51-1.00],0.051477097781294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3D,Protein FAM3D,44569,304,1.00 [0.88-1.14],0.9902818226145276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAP,Prolyl endopeptidase FAP,52128,334,1.32 [0.93-1.88],0.1259026424314582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FARSA,Phenylalanine--tRNA ligase alpha subunit,43533,300,1.05 [0.90-1.22],0.5510397070329899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAS,Tumor necrosis factor receptor superfamily member 6,51958,333,0.93 [0.69-1.27],0.6638954451047198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FASLG,Tumor necrosis factor ligand superfamily member 6,52056,330,0.86 [0.66-1.11],0.2474915182607154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBLN2,Fibulin-2,44764,304,0.76 [0.53-1.08],0.1298355067880798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBN2,Fibrillin-2,43533,300,1.13 [0.94-1.36],0.2027529021342796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBP1,"Fructose-1,6-bisphosphatase 1",51493,323,0.94 [0.82-1.07],0.3425819983888162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,44759,302,0.95 [0.82-1.11],0.5408066209466267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,51419,328,0.90 [0.73-1.10],0.2977610840510574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,44680,305,0.81 [0.51-1.28],0.3619976527030595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER2,Low affinity immunoglobulin epsilon Fc receptor,51506,328,1.05 [0.87-1.26],0.6272915136168195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,51277,328,1.02 [0.86-1.20],0.8552206541837591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,50282,316,1.01 [0.85-1.20],0.9293999882355234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,51531,329,0.89 [0.73-1.08],0.2439778574889806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,44713,305,0.91 [0.76-1.09],0.3127761176501506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN2,Ficolin-2,51280,330,1.19 [0.93-1.52],0.1651760562675197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL1,Fc receptor-like protein 1,51493,323,1.06 [0.86-1.31],0.5926376447884873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL2,Fc receptor-like protein 2,51809,329,0.95 [0.78-1.16],0.6226028470407554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,50524,322,0.94 [0.79-1.13],0.5385970559461644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,51506,328,0.83 [0.70-0.98],0.0274221195687825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL6,Fc receptor-like protein 6,51419,328,1.00 [0.86-1.15],0.9640487511219772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRLB,Fc receptor-like B,50282,316,1.03 [0.88-1.21],0.7152509972989369
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX1,"Adrenodoxin, mitochondrial",43292,293,0.96 [0.80-1.16],0.6636230558477354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX2,"Ferredoxin-2, mitochondrial",43292,293,1.02 [0.83-1.24],0.8728162691461652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FEN1,Flap endonuclease 1,50282,316,0.95 [0.81-1.11],0.5131508959465642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FES,Tyrosine-protein kinase Fes/Fps,50282,316,1.00 [0.81-1.23],0.985276820106191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FETUB,Fetuin-B,51615,331,1.08 [0.80-1.45],0.6271026990034568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGA,Fibrinogen alpha chain,43768,296,1.19 [0.83-1.71],0.3475108812280151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",44680,305,0.98 [0.85-1.12],0.7603055640853803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF12,Fibroblast growth factor 12,43466,294,0.92 [0.71-1.21],0.5635653877567506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF16,Fibroblast growth factor 16,43466,294,0.89 [0.69-1.14],0.3479359179171799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF19,Fibroblast growth factor 19,51715,329,1.00 [0.88-1.14],0.972012056766015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF2,Fibroblast growth factor 2,51419,328,1.06 [0.92-1.22],0.3990946738435533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF20,Fibroblast growth factor 20,43466,294,0.99 [0.76-1.28],0.9097829540021702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF21,Fibroblast growth factor 21,51855,330,1.06 [0.98-1.15],0.1751802672618781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF23,Fibroblast growth factor 23,51847,331,1.14 [0.97-1.34],0.1208106910865924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF3,Fibroblast growth factor 3,43466,294,0.98 [0.67-1.43],0.9220431347885754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF5,Fibroblast growth factor 5,50524,322,1.25 [0.94-1.68],0.1235594937258854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF6,Fibroblast growth factor 6,43466,294,1.06 [0.82-1.37],0.6541108331708776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF7,Fibroblast growth factor 7,43160,294,0.96 [0.83-1.11],0.5795726087479343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF9,Fibroblast growth factor 9,43082,294,0.87 [0.66-1.14],0.3017740794538157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP1,Fibroblast growth factor-binding protein 1,51651,329,0.92 [0.69-1.24],0.5992975995806381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP2,Fibroblast growth factor-binding protein 2,44764,304,0.93 [0.75-1.16],0.5158643525848963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,44654,304,0.67 [0.50-0.91],0.0095126398834746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR2,Fibroblast growth factor receptor 2,51651,329,0.92 [0.59-1.44],0.7275384599594618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR4,Fibroblast growth factor receptor 4,43784,299,0.94 [0.76-1.16],0.5500965767855788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGL1,Fibrinogen-like protein 1,44798,305,1.09 [0.92-1.30],0.3027476636423223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGR,Tyrosine-protein kinase Fgr,50288,323,1.08 [0.93-1.25],0.3351048601111456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FH,"Fumarate hydratase, mitochondrial",43318,298,1.05 [0.92-1.19],0.4624505988463271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIP2A,FHF complex subunit HOOK interacting protein 2A,43292,293,0.82 [0.64-1.06],0.1380694944288437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIT,Bis(5'-adenosyl)-triphosphatase,50288,323,1.06 [0.93-1.22],0.3789860652253735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FIS1,Mitochondrial fission 1 protein,51463,328,1.04 [0.92-1.18],0.5521365732676116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,44680,305,1.00 [0.90-1.12],0.9584250154523846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,51643,325,1.02 [0.93-1.11],0.7241027658185097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,51093,326,1.13 [0.90-1.41],0.2880702313840664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,51093,326,1.07 [0.97-1.19],0.1882329282755209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,50203,323,1.08 [0.89-1.31],0.4420406219385639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBPL,FK506-binding protein-like,44569,304,1.03 [0.86-1.24],0.7237473310317721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLI1,Friend leukemia integration 1 transcription factor,50282,316,1.00 [0.91-1.10],0.9959515012228032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,51093,326,1.22 [0.87-1.72],0.2559787405879786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT1,Vascular endothelial growth factor receptor 1,51171,329,0.92 [0.58-1.44],0.7028839605648471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3,Receptor-type tyrosine-protein kinase FLT3,50282,316,0.86 [0.61-1.21],0.3818145040433101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3LG,Fms-related tyrosine kinase 3 ligand,52056,330,0.96 [0.73-1.28],0.797617714364828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,51651,329,0.85 [0.64-1.13],0.2725701110613571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMNL1,Formin-like protein 1,50288,323,1.01 [0.87-1.17],0.923383260628546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMR1,Synaptic functional regulator FMR1,50282,316,1.16 [0.87-1.53],0.3104601084952137
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FN1,Fibronectin,44829,305,0.69 [0.46-1.04],0.0771114005907204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNDC1,Fibronectin type III domain-containing protein 1,44654,304,1.12 [0.89-1.42],0.3280513934349246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,44551,301,1.10 [0.81-1.49],0.5372478440112023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLH1,Glutamate carboxypeptidase 2,43466,294,0.93 [0.82-1.05],0.2253900188018016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR1,Folate receptor alpha,51414,328,1.22 [0.87-1.70],0.2427429890225453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR2,Folate receptor beta,51944,331,1.51 [1.09-2.09],0.0127533742088543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR3,Folate receptor gamma,51487,326,1.01 [0.96-1.06],0.7415278557813026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOS,Proto-oncogene c-Fos,43082,294,0.89 [0.65-1.22],0.4615411603917326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOSB,Protein fosB,50288,323,0.94 [0.72-1.23],0.6526726348224947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXJ3,Forkhead box protein J3,43466,294,0.94 [0.73-1.22],0.6554547765483505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO1,Forkhead box protein O1,51419,328,1.01 [0.90-1.13],0.8465311777844896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO3,Forkhead box protein O3,50282,316,0.93 [0.83-1.04],0.1867337338100179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD4B,FERM domain-containing protein 4B,43292,293,1.02 [0.87-1.20],0.7895765566463823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD7,FERM domain-containing protein 7,43533,300,1.00 [0.71-1.39],0.9764357162365508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRZB,Secreted frizzled-related protein 3,50924,326,1.22 [0.82-1.80],0.3262267152154576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSHB,Follitropin subunit beta,43572,301,1.11 [0.92-1.33],0.278041142305206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FST,Follistatin,51631,329,0.96 [0.79-1.17],0.6983100361511689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL1,Follistatin-related protein 1,43572,301,1.01 [0.62-1.64],0.9801674108248324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL3,Follistatin-related protein 3,51380,329,0.95 [0.70-1.30],0.7474677157896064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FTCD,Formimidoyltransferase-cyclodeaminase,44569,304,0.96 [0.84-1.09],0.5008889782454944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUCA1,Tissue alpha-L-fucosidase,51802,333,1.02 [0.91-1.15],0.7489561527817399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUOM,Fucose mutarotase,43784,299,0.96 [0.80-1.15],0.6460747043596851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FURIN,Furin,51651,329,1.04 [0.77-1.39],0.8006769943237614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUS,RNA-binding protein FUS,50198,315,1.05 [0.82-1.35],0.6990339097470564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",43862,299,1.09 [0.92-1.28],0.3118701794941698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,51944,331,0.98 [0.80-1.22],0.883398025776047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT8,"Alpha-(1,6)-fucosyltransferase",51093,326,1.04 [0.88-1.23],0.6650422206037856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXN,"Frataxin, mitochondrial",51932,332,1.06 [0.93-1.20],0.4134493664613987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXYD5,FXYD domain-containing ion transport regulator 5,50524,322,1.03 [0.89-1.20],0.700468978324051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FYB1,FYN-binding protein 1,51421,328,0.99 [0.89-1.10],0.9114732654932898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD10,Frizzled-10,43533,300,0.98 [0.81-1.19],0.8381509722855677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD8,Frizzled-8,43318,298,1.02 [0.79-1.31],0.8967182079117729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAP,Gamma-aminobutyric acid receptor-associated protein,44551,301,1.04 [0.83-1.30],0.7289042841756508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,43946,299,0.97 [0.81-1.15],0.7089977748688706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,43318,298,1.07 [0.91-1.26],0.3984042409053435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD1,Glutamate decarboxylase 1,43160,294,0.69 [0.45-1.06],0.0882762846382138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD2,Glutamate decarboxylase 2,43466,294,0.82 [0.62-1.08],0.1581373194268679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,43946,299,0.91 [0.71-1.17],0.4625344567422684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,43572,301,1.08 [0.88-1.33],0.4682116721374586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAGE2A,G antigen 2A,43160,294,0.93 [0.77-1.12],0.4367394876048991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,51715,329,1.17 [1.01-1.36],0.0369791954962946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,51256,329,1.01 [0.71-1.44],0.9384262644029018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,51932,332,0.53 [0.37-0.76],0.0006439331573572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,50524,322,1.09 [0.87-1.37],0.4546453923000081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,44759,302,1.38 [0.94-2.02],0.1025225333510099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT7,N-acetylgalactosaminyltransferase 7,51256,329,0.83 [0.52-1.32],0.4324653991817587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAMT,Guanidinoacetate N-methyltransferase,43292,293,0.98 [0.72-1.34],0.9130817657765332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,42824,292,1.17 [0.81-1.67],0.4030476359018392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GART,Trifunctional purine biosynthetic protein adenosine-3,44680,305,0.71 [0.45-1.12],0.1430440031231991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS2,Growth arrest-specific protein 2,43946,299,0.88 [0.70-1.12],0.301836660448148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS6,Growth arrest-specific protein 6,51792,332,0.83 [0.56-1.21],0.3283946630560995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GASK1A,Golgi-associated kinase 1A,43292,293,1.06 [0.82-1.38],0.6371793690647192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAST,Gastrin,44654,304,1.02 [0.94-1.11],0.5848397874633795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,43160,294,0.75 [0.49-1.15],0.1927277922911538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",43572,301,1.01 [0.87-1.16],0.9450130033270554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBA,Lysosomal acid glucosylceramidase,43533,300,0.84 [0.69-1.04],0.1100956566751754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,44572,303,0.87 [0.74-1.02],0.0917311883395112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP2,Guanylate-binding protein 2,50524,322,1.11 [0.94-1.30],0.2200108848667065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP4,Guanylate-binding protein 4,50288,323,0.99 [0.81-1.22],0.9595023318328963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP6,Guanylate-binding protein 6,43292,293,1.02 [0.79-1.30],0.9019136430446048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GC,Vitamin D-binding protein,44829,305,1.41 [0.93-2.13],0.1065307296679131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCC1,GRIP and coiled-coil domain-containing protein 1,44654,304,0.99 [0.90-1.10],0.8706783304407685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCG,Pro-glucagon,50282,316,1.01 [0.93-1.09],0.8738579103968465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,42710,292,0.91 [0.72-1.15],0.4273940994397355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCLM,Glutamate--cysteine ligase regulatory subunit,43292,293,1.14 [0.92-1.43],0.2352984585933113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",51256,329,1.01 [0.77-1.34],0.9226547765252654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF15,Growth/differentiation factor 15,52128,334,1.20 [0.97-1.47],0.0931812133851456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF2,Growth/differentiation factor 2,51493,323,0.95 [0.72-1.26],0.7285856622631935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDNF,Glial cell line-derived neurotrophic factor,50288,323,1.00 [0.77-1.30],0.9996233418450008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GET3,ATPase GET3,44759,302,1.09 [0.90-1.32],0.3626697185179668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFAP,Glial fibrillary acidic protein,50201,316,1.00 [0.81-1.24],0.988616601771915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFER,FAD-linked sulfhydryl oxidase ALR,50282,316,1.07 [0.92-1.25],0.3838848079097967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,50282,316,1.00 [0.92-1.08],0.9859954472533528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,51855,330,1.67 [1.20-2.32],0.0021590014372974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA2,GDNF family receptor alpha-2,51256,329,1.28 [0.81-2.04],0.2909487370911202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA3,GDNF family receptor alpha-3,50934,324,0.87 [0.61-1.24],0.4331202157340312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRAL,GDNF family receptor alpha-like,43323,295,0.94 [0.78-1.12],0.4826667926669005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGA1,ADP-ribosylation factor-binding protein GGA1,50288,323,1.00 [0.87-1.16],0.9557014233007012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGACT,Gamma-glutamylaminecyclotransferase,44759,302,1.00 [0.86-1.17],0.9865106128973882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,44676,302,0.97 [0.77-1.22],0.7963709638334353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGH,Gamma-glutamyl hydrolase,50623,326,1.29 [0.98-1.70],0.0714365918392682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT1,Glutathione hydrolase 1 proenzyme,51421,326,1.05 [0.87-1.28],0.5989632495326076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT5,Glutathione hydrolase 5 proenzyme,51093,326,1.31 [0.87-1.99],0.1984816847446106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH1,Somatotropin,51417,323,1.04 [0.98-1.10],0.1948053137754504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH2,Growth hormone variant,50282,316,0.98 [0.93-1.05],0.6302506220440706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHR,Growth hormone receptor,43784,299,0.89 [0.60-1.32],0.5614868866578453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRHR,Growth hormone-releasing hormone receptor,50288,323,0.99 [0.83-1.19],0.9250630866582716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRL,Appetite-regulating hormone,51493,323,0.94 [0.84-1.06],0.3335108020266585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GID8,Glucose-induced degradation protein 8 homolog,44680,305,0.97 [0.69-1.36],0.8476324535809449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIGYF2,GRB10-interacting GYF protein 2,44680,305,1.00 [0.87-1.16],0.9662834467091034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP7,GTPase IMAP family member 7,43784,299,0.80 [0.56-1.16],0.2477025629864521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP8,GTPase IMAP family member 8,43160,294,1.05 [0.85-1.30],0.6559867757110839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIP,Gastric inhibitory polypeptide,43572,301,1.11 [0.91-1.35],0.2979062227250915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC2,PDZ domain-containing protein GIPC2,44654,304,0.94 [0.65-1.36],0.7519874100169053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC3,PDZ domain-containing protein GIPC3,44569,304,0.98 [0.87-1.09],0.6757967637159918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPR,Gastric inhibitory polypeptide receptor,43466,294,0.89 [0.68-1.15],0.3705144101490795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIT1,ARF GTPase-activating protein GIT1,43466,294,1.01 [0.90-1.13],0.8706717171841459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GJA8,Gap junction alpha-8 protein,43160,294,0.98 [0.82-1.18],0.8516676432627468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GKN1,Gastrokine-1,49317,314,0.96 [0.67-1.39],0.8355906664611221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLA,Alpha-galactosidase A,43704,299,0.99 [0.73-1.33],0.944486986729118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLB1,Beta-galactosidase,51093,326,0.98 [0.77-1.24],0.857880948418174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLI2,Zinc finger protein GLI2,43466,294,0.70 [0.47-1.02],0.0658155662440341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLO1,Lactoylglutathione lyase,50550,323,1.15 [0.98-1.36],0.0943428500760816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLOD4,Glyoxalase domain-containing protein 4,51379,328,1.11 [0.84-1.47],0.4487049247704348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLP1R,Glucagon-like peptide 1 receptor,43318,298,1.11 [0.84-1.46],0.4777059648115722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX,Glutaredoxin-1,51162,320,1.01 [0.85-1.20],0.9207424244707936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",43784,299,1.03 [0.91-1.16],0.6816746882873925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,50288,323,1.03 [0.84-1.27],0.7671364065858917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLYR1,Putative oxidoreductase GLYR1,44551,301,0.86 [0.70-1.06],0.1513832614115985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GM2A,Ganglioside GM2 activator,43679,297,1.08 [0.82-1.43],0.5675649449698039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMFG,Glia maturation factor gamma,44759,302,0.98 [0.84-1.14],0.7892635613593748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR,GMP reductase 1,52056,330,0.98 [0.81-1.19],0.8587577733746165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR2,GMP reductase 2,43784,299,1.04 [0.88-1.23],0.6119122451867851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNAS,Neuroendocrine secretory protein 55,44680,305,0.99 [0.87-1.12],0.8171229181012616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,50282,316,1.10 [0.94-1.27],0.2229933083994144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,43533,300,0.93 [0.74-1.17],0.5297805335373307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNLY,Granulysin,51506,328,0.84 [0.70-1.01],0.0698100848893748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA1,Glucosamine-6-phosphate isomerase 1,43572,301,0.90 [0.64-1.28],0.5757521895824248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA2,Glucosamine-6-phosphate isomerase 2,43784,299,0.91 [0.67-1.23],0.5259006525157499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLGA3,Golgin subfamily A member 3,44680,305,1.07 [0.93-1.23],0.3547795965436923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLM2,Protein GOLM2,51944,331,1.10 [0.72-1.69],0.6600993634408181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,51419,328,1.05 [0.95-1.15],0.3531402123589608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GORASP2,Golgi reassembly-stacking protein 2,44569,304,0.92 [0.73-1.16],0.4924177458895463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOT1,"Aspartate aminotransferase, cytoplasmic",44764,304,0.91 [0.70-1.19],0.4896384553497459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BA,Platelet glycoprotein Ib alpha chain,51280,331,1.08 [0.80-1.45],0.6089829126130606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BB,Platelet glycoprotein Ib beta chain,43292,293,0.95 [0.80-1.12],0.5449892968640686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,49899,317,0.98 [0.87-1.10],0.7334568287614467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP5,Platelet glycoprotein V,43784,299,1.00 [0.73-1.35],0.984742753795862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP6,Platelet glycoprotein VI,51421,328,1.04 [0.93-1.16],0.4970295525980779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,51256,329,0.94 [0.88-1.01],0.1001793322749819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC1,Glypican-1,51932,332,1.10 [0.79-1.53],0.5577248363654654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC5,Glypican-5,51093,326,0.90 [0.76-1.07],0.2478016537686219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPD1,Glycerol-3-phosphate dehydrogenase,44551,301,0.98 [0.79-1.21],0.8306774343508572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPHA2,Glycoprotein hormone alpha-2,44569,304,0.98 [0.77-1.25],0.899556126200246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPI,Glucose-6-phosphate isomerase,44798,305,0.96 [0.76-1.21],0.7315288104115412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,44569,304,0.95 [0.81-1.10],0.4618977602282924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPKOW,G-patch domain and KOW motifs-containing protein,50288,323,0.95 [0.67-1.33],0.7548740311200589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPNMB,Transmembrane glycoprotein NMB,50097,317,1.00 [0.71-1.42],0.997918488811348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR101,Probable G-protein coupled receptor 101,43318,298,1.01 [0.84-1.21],0.9301572719119569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR158,Probable G-protein coupled receptor 158,44680,305,0.81 [0.58-1.13],0.2184067096822488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR15L,Protein GPR15L,44569,304,1.04 [0.87-1.25],0.6355635082581077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR37,Prosaposin receptor GPR37,50550,323,1.09 [0.94-1.26],0.2791983111446592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPRC5C,G-protein coupled receptor family C group 5 member C,44551,301,0.94 [0.76-1.15],0.5387308706424419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRAP2,GRB2-related adapter protein 2,51493,323,1.02 [0.95-1.10],0.5671557507904319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,44759,302,1.02 [0.86-1.21],0.8109246431308077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIK2,"Glutamate receptor ionotropic, kainate 2",44680,305,0.99 [0.76-1.28],0.930024571606259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",43318,298,1.02 [0.84-1.24],0.8512868356544625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRK5,G protein-coupled receptor kinase 5,50550,323,0.96 [0.78-1.17],0.6678626465251885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRN,Progranulin,51252,326,0.99 [0.66-1.48],0.9524830063583462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRP,Gastrin-releasing peptide,43572,301,0.90 [0.74-1.11],0.3359651033997535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRPEL1,"GrpE protein homolog 1, mitochondrial",51256,329,1.07 [0.92-1.26],0.3845168000879829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRSF1,G-rich sequence factor 1,42926,293,0.95 [0.82-1.09],0.4473382915263033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSAP,Gamma-secretase-activating protein,50282,316,1.05 [0.94-1.17],0.3626469051073999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSN,Gelsolin,44629,302,0.71 [0.41-1.22],0.2191236981081244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",44545,304,0.90 [0.55-1.47],0.6674928591620789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA1,Glutathione S-transferase A1,51415,323,0.94 [0.83-1.06],0.2792577848693115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA3,Glutathione S-transferase A3,50282,316,0.99 [0.87-1.13],0.9034773181166644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTM4,Glutathione S-transferase Mu 4,43292,293,1.07 [0.92-1.23],0.3926977241811332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTP1,Glutathione S-transferase P,49969,320,1.06 [0.92-1.21],0.4460025413363112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTT2B,Glutathione S-transferase theta-2B,44654,304,0.99 [0.94-1.03],0.62743380988907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,43946,299,0.98 [0.83-1.15],0.7999536653810386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTPBP2,GTP-binding protein 2,43533,300,0.99 [0.86-1.14],0.8880251321358728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCA2A,Guanylin,51254,328,0.99 [0.75-1.32],0.9641754927120456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCY2C,Heat-stable enterotoxin receptor,43946,299,0.94 [0.81-1.09],0.4016868642036911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUK1,Guanylate kinase,43292,293,1.11 [0.85-1.44],0.435303248733295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUSB,Beta-glucuronidase,51717,333,0.86 [0.73-1.01],0.0656109890583638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GYS1,"Glycogen [starch] synthase, muscle",50550,323,1.03 [0.92-1.14],0.6164830155507515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMA,Granzyme A,52056,330,0.95 [0.72-1.26],0.7447037727935555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMB,Granzyme B,51419,328,0.91 [0.78-1.06],0.2280649082434509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMH,Granzyme H,50550,323,0.92 [0.80-1.05],0.2084157446936037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,H2AP,Huntingtin-interacting protein M,43160,294,0.99 [0.79-1.24],0.900218253579701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",43292,293,1.13 [0.98-1.30],0.0869239626430651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",51781,329,0.98 [0.86-1.12],0.7993897363961994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAO1,Hydroxyacid oxidase 1,51932,332,0.98 [0.90-1.06],0.5608154260432449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HARS1,"Histidine--tRNA ligase, cytoplasmic",51506,328,1.02 [0.90-1.16],0.7061512766973818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR1,Hepatitis A virus cellular receptor 1,51858,331,1.09 [0.94-1.27],0.2658476998241558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR2,Hepatitis A virus cellular receptor 2,51506,328,1.06 [0.80-1.40],0.6833280414079391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBEGF,Proheparin-binding EGF-like growth factor,51781,329,1.01 [0.88-1.15],0.8812313418718489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBQ1,Hemoglobin subunit theta-1,51932,332,0.94 [0.80-1.10],0.428891624113479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBZ,Hemoglobin subunit zeta,44759,302,1.08 [0.98-1.20],0.1265012538264506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCG22,Protein PBMUCL2,43292,293,1.03 [0.84-1.25],0.7931732152497453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCLS1,Hematopoietic lineage cell-specific protein,52056,330,1.09 [0.92-1.30],0.3179807293869652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC8,Histone deacetylase 8,43466,294,0.95 [0.79-1.15],0.6162224375081817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC9,Histone deacetylase 9,43318,298,1.01 [0.86-1.20],0.8812179434215643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDDC2,5'-deoxynucleotidase HDDC2,44569,304,1.14 [0.89-1.45],0.2982430171605397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGF,Hepatoma-derived growth factor,51857,332,0.96 [0.87-1.07],0.4618176282136058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGFL2,Hepatoma-derived growth factor-related protein 2,44654,304,0.98 [0.83-1.17],0.8567918774410332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEBP1,Heme-binding protein 1,50550,323,1.05 [0.88-1.25],0.5991201809102296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,43784,299,0.70 [0.46-1.05],0.0868142917574931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPACAM2,HEPACAM family member 2,44654,304,0.91 [0.70-1.18],0.4849858978372722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPH,Hephaestin,44759,302,0.91 [0.61-1.37],0.6646172169498121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEXIM1,Protein HEXIM1,51419,328,1.04 [0.92-1.17],0.5114831370301648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGF,Hepatocyte growth factor,52056,330,1.23 [0.94-1.63],0.133817381132278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGFAC,Hepatocyte growth factor activator,44374,302,0.72 [0.52-1.01],0.0576780567753293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,50282,316,1.07 [0.94-1.21],0.3274116653635424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HHEX,Hematopoietically-expressed homeobox protein HHEX,44654,304,1.06 [0.92-1.22],0.4437114708837795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIF1A,Hypoxia-inducible factor 1-alpha,43466,294,0.83 [0.67-1.02],0.076750730713364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1,Huntingtin-interacting protein 1,43292,293,0.65 [0.44-0.97],0.0331348244179421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1R,Huntingtin-interacting protein 1-related protein,44570,304,0.88 [0.68-1.15],0.3571903819321859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HJV,Hemojuvelin,44680,305,0.86 [0.66-1.12],0.2725534607789975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HK2,Hexokinase-2,50550,323,1.18 [0.83-1.67],0.3608780092363914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",44680,305,1.02 [0.73-1.42],0.9237201045400736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",51260,328,0.97 [0.74-1.26],0.7999085912702956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",51419,328,0.88 [0.62-1.24],0.4658474412643389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMBS,Porphobilinogen deaminase,51932,332,0.96 [0.77-1.20],0.7370524104499825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMCN2,Hemicentin-2,43705,298,0.94 [0.78-1.14],0.557480110455212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",43572,301,0.96 [0.77-1.21],0.7559628153623588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",43292,293,1.19 [0.94-1.50],0.1428655331904341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMMR,Hyaluronan mediated motility receptor,43076,294,1.07 [0.86-1.33],0.5388270585957338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX1,Heme oxygenase 1,50912,320,0.94 [0.76-1.16],0.5667342021802615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX2,Heme oxygenase 2,50288,323,0.91 [0.73-1.14],0.4306863109449607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNF1A,Hepatocyte nuclear factor 1-alpha,43533,300,0.94 [0.79-1.11],0.4420292543741007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNMT,Histamine N-methyltransferase,50850,325,0.95 [0.77-1.17],0.5974292359737838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,50387,322,1.03 [0.91-1.17],0.6209516229613197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,44680,305,1.04 [0.84-1.29],0.7172112809009333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPCAL1,Hippocalcin-like protein 1,52056,330,1.07 [0.94-1.22],0.3022451506728195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPGDS,Hematopoietic prostaglandin D synthase,50282,316,0.84 [0.64-1.10],0.2137149125326316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,44176,300,1.01 [0.90-1.14],0.8404369557330715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRAS,GTPase Hras,43864,298,0.92 [0.81-1.04],0.1889701036322093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,43572,301,1.07 [0.79-1.46],0.6612144827986242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRG,Histidine-rich glycoprotein,44583,305,0.98 [0.69-1.38],0.8907154585127355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS1BP3,HCLS1-binding protein 3,43572,301,1.02 [0.90-1.16],0.7204223051819403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,51256,329,1.01 [0.78-1.30],0.9688366056171538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,51932,332,0.92 [0.69-1.22],0.5419972960252641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,43466,294,1.79 [1.34-2.40],9.057610874387088e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSBP1,Heat shock factor-binding protein 1,43572,301,1.08 [0.96-1.22],0.1753743465926848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,51419,328,0.93 [0.73-1.19],0.5598242310878594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,44654,304,1.07 [0.90-1.27],0.4701867854055255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B3,Testosterone 17-beta-dehydrogenase 3,43292,293,1.06 [0.85-1.33],0.611579185890806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,43572,301,0.93 [0.74-1.18],0.5532363414949932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSP90B1,Endoplasmin,50041,321,0.98 [0.84-1.15],0.8332579101600437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA1A,Heat shock 70 kDa protein 1A,51631,329,1.01 [0.88-1.15],0.9201037163920248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,44551,301,1.49 [1.16-1.92],0.001775863354794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB1,Heat shock protein beta-1,50672,320,1.10 [0.95-1.28],0.1961607856499177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,51932,332,1.79 [1.44-2.24],2.658698344618989e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,51110,327,1.06 [0.73-1.55],0.743364844898813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1A,5-hydroxytryptamine receptor 1A,43318,298,0.97 [0.84-1.13],0.720004402842054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1B,5-hydroxytryptamine receptor 1B,43318,298,0.78 [0.59-1.04],0.0902378946232664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",51651,329,1.00 [0.85-1.17],0.9526407722555807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYAL1,Hyaluronidase-1,51207,330,0.94 [0.61-1.43],0.759566575066129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYOU1,Hypoxia up-regulated protein 1,52128,334,0.87 [0.57-1.34],0.5315298764974963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICA1,Islet cell autoantigen 1,50524,322,1.06 [0.93-1.19],0.3948857408702652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM1,Intercellular adhesion molecule 1,51276,330,1.35 [0.97-1.88],0.075711030764475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM2,Intercellular adhesion molecule 2,52128,334,0.95 [0.71-1.28],0.751591349018703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,52128,334,0.68 [0.47-0.99],0.0431937361833158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM4,Intercellular adhesion molecule 4,51419,328,0.99 [0.83-1.20],0.949407266509822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM5,Intercellular adhesion molecule 5,51493,323,0.88 [0.71-1.09],0.2296531342592911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICOSLG,ICOS ligand,51256,329,0.91 [0.55-1.52],0.7288368214901859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ID4,DNA-binding protein inhibitor ID-4,43946,299,0.96 [0.74-1.25],0.7736111993622508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDI2,Isopentenyl-diphosphate delta-isomerase 2,50288,323,1.15 [0.95-1.40],0.1583685734813876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDO1,"Indoleamine 2,3-dioxygenase 1",43572,301,0.92 [0.77-1.10],0.3552310249213118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDS,Iduronate 2-sulfatase,52056,330,1.19 [0.39-3.61],0.7604040831068817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDUA,Alpha-L-iduronidase,51932,332,1.04 [0.85-1.28],0.6907938916534431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,43492,300,0.90 [0.67-1.20],0.4610228023736342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,43946,299,1.03 [0.84-1.28],0.7660898721529313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,43946,299,1.03 [0.77-1.37],0.8522818930220412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNAR1,Interferon alpha/beta receptor 1,44569,304,1.04 [0.68-1.59],0.8427146516484092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNG,Interferon gamma,50524,322,1.02 [0.94-1.11],0.6271716800236339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR1,Interferon gamma receptor 1,51715,329,0.84 [0.53-1.35],0.4794545081510424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR2,Interferon gamma receptor 2,51093,326,0.92 [0.76-1.12],0.3980234409176375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL1,Interferon lambda-1,50288,323,0.97 [0.78-1.21],0.8145198240306684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL2,Interferon lambda-2,43318,298,0.96 [0.80-1.16],0.6666118366476925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,51419,328,0.75 [0.56-1.01],0.0557332337757775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNW1,Interferon omega-1,43292,293,1.03 [0.76-1.39],0.8708175159620202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFT20,Intraflagellar transport protein 20 homolog,43533,300,0.86 [0.66-1.13],0.2756922095701649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGBP1,Immunoglobulin-binding protein 1,44680,305,1.02 [0.85-1.22],0.8210729269367175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,43318,298,1.02 [0.81-1.27],0.8891051232078098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,44764,304,1.48 [0.98-2.23],0.0607474256469481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF1R,Insulin-like growth factor 1 receptor,51256,329,0.77 [0.49-1.23],0.2795806517097919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,43292,293,0.88 [0.68-1.15],0.3462598893118803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2R,Cation-independent mannose-6-phosphate receptor,51506,328,0.91 [0.60-1.38],0.6585874902502087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP1,Insulin-like growth factor-binding protein 1,52044,332,0.97 [0.89-1.05],0.4016651145606156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP2,Insulin-like growth factor-binding protein 2,52046,333,1.14 [0.97-1.34],0.1023241061495861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP3,Insulin-like growth factor-binding protein 3,51698,331,1.23 [0.89-1.71],0.2102741127626313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP4,Insulin-like growth factor-binding protein 4,50846,325,1.11 [0.89-1.38],0.3752029185152649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP6,Insulin-like growth factor-binding protein 6,51276,329,0.96 [0.69-1.33],0.7926880799324278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP7,Insulin-like growth factor-binding protein 7,52128,334,0.94 [0.68-1.30],0.7207578801037287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBPL1,Insulin-like growth factor-binding protein-like 1,51493,323,0.97 [0.72-1.30],0.8197378891943695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,43466,294,1.11 [0.98-1.26],0.1132402479839054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGHMBP2,DNA-binding protein SMUBP-2,43292,293,0.87 [0.70-1.07],0.1905171654138369
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLC2,Immunoglobulin lambda constant 2,44750,304,0.85 [0.53-1.38],0.5177619148342124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,43160,294,0.86 [0.74-1.00],0.0515243783456193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF21,Immunoglobulin superfamily member 21,43572,301,1.06 [0.81-1.39],0.6838688029589016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF3,Immunoglobulin superfamily member 3,51256,329,0.94 [0.70-1.25],0.6605633314365373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,51493,323,1.00 [0.72-1.38],0.9850816394179596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,44759,302,0.97 [0.85-1.11],0.6506445258363671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKBKG,NF-kappa-B essential modulator,51419,328,1.02 [0.91-1.13],0.7486509790448126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKZF2,Zinc finger protein Helios,50282,316,0.98 [0.87-1.10],0.7220445692308437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10,Interleukin-10,50524,322,1.04 [0.93-1.17],0.4955618101259921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RA,Interleukin-10 receptor subunit alpha,50524,322,0.88 [0.73-1.07],0.2038069543903965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RB,Interleukin-10 receptor subunit beta,51715,329,1.01 [0.72-1.42],0.9373345531675868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL11,Interleukin-11,50524,322,1.11 [0.96-1.28],0.1577750594320863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12A_IL12B,Interleukin-12,51256,329,1.04 [0.92-1.18],0.5592124042872484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12B,Interleukin-12 subunit beta,52056,330,1.06 [0.89-1.27],0.490997239513113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB1,Interleukin-12 receptor subunit beta-1,50524,322,1.16 [0.89-1.50],0.2722734741446014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB2,Interleukin-12 receptor subunit beta-2,43466,294,0.92 [0.70-1.22],0.5677106777379598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13,Interleukin-13,50524,322,0.97 [0.79-1.20],0.7793293676447582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA1,Interleukin-13 receptor subunit alpha-1,50854,322,0.91 [0.59-1.41],0.6646202365527056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,43318,298,0.73 [0.50-1.07],0.1029521932604915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15,Interleukin-15,51419,328,1.11 [0.83-1.49],0.4901068649651016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15RA,Interleukin-15 receptor subunit alpha,50524,322,0.91 [0.69-1.21],0.5323594413841094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL16,Pro-interleukin-16,52056,330,0.93 [0.73-1.17],0.5141733345346478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17A,Interleukin-17A,50446,322,1.05 [0.85-1.31],0.6399848098743529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17C,Interleukin-17C,50524,322,1.04 [0.91-1.20],0.5300362286290974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17D,Interleukin-17D,50524,322,0.84 [0.61-1.16],0.2850273656773474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17F,Interleukin-17F,50524,322,1.08 [0.96-1.22],0.187916269813386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RA,Interleukin-17 receptor A,51506,328,1.06 [0.85-1.32],0.6337343140039472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RB,Interleukin-17 receptor B,50771,325,1.09 [0.90-1.31],0.3794667647914408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18,Interleukin-18,51293,328,0.96 [0.77-1.18],0.6750202432648591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18BP,Interleukin-18-binding protein,51698,331,1.26 [0.93-1.71],0.1387925054092118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18R1,Interleukin-18 receptor 1,52056,330,0.95 [0.71-1.28],0.7526874917115304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18RAP,Interleukin-18 receptor accessory protein,50768,326,1.00 [0.94-1.06],0.9625368460610444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL19,Interleukin-19,50211,307,1.14 [0.99-1.31],0.0628332437229158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1A,Interleukin-1 alpha,50524,322,1.03 [0.88-1.22],0.7008726556895111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1B,Interleukin-1 beta,50282,318,1.01 [0.85-1.20],0.9118361359362992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R1,Interleukin-1 receptor type 1,51421,326,1.18 [0.77-1.81],0.43982974460007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R2,Interleukin-1 receptor type 2,51376,328,0.81 [0.50-1.33],0.4108957609092315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RAP,Interleukin-1 receptor accessory protein,51506,328,1.03 [0.83-1.28],0.7827456096304091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL1,Interleukin-1 receptor-like 1,51958,333,0.97 [0.79-1.19],0.7546511519724057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL2,Interleukin-1 receptor-like 2,50524,322,0.99 [0.77-1.29],0.968324228595852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RN,Interleukin-1 receptor antagonist protein,51378,328,1.10 [0.92-1.30],0.3021749357950966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2,Interleukin-2,50524,322,1.03 [0.75-1.41],0.8490539799359589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20,Interleukin-20,50524,322,0.89 [0.72-1.11],0.3158597647392975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RA,Interleukin-20 receptor subunit alpha,50524,322,1.04 [0.85-1.29],0.6900727740294277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RB,Interleukin-20 receptor subunit beta,43466,294,0.76 [0.58-1.00],0.0539786515406925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL21R,Interleukin-21 receptor,43466,294,0.89 [0.71-1.12],0.3098027237434425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22,Interleukin-22,44551,301,1.11 [0.95-1.29],0.1817872942065299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22RA1,Interleukin-22 receptor subunit alpha-1,50524,322,0.89 [0.69-1.13],0.3359159745478302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL24,Interleukin-24,50524,322,0.97 [0.79-1.19],0.7578473175502554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,43008,294,0.63 [0.46-0.87],0.0052312918964138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RA,Interleukin-2 receptor subunit alpha,51126,328,1.19 [0.94-1.50],0.1478964152602791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RB,Interleukin-2 receptor subunit beta,50524,322,1.11 [0.87-1.42],0.3930104696126075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RG,Cytokine receptor common subunit gamma,44551,301,1.11 [0.84-1.45],0.4705816396555629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,43160,294,1.22 [1.00-1.48],0.053002958253136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31,Interleukin-31,43466,294,0.96 [0.78-1.18],0.6730695441411558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31RA,Interleukin-31 receptor subunit alpha,43298,292,0.76 [0.57-1.01],0.0590936971957408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL32,Interleukin-32,51419,328,1.12 [0.90-1.40],0.3178725330646427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL33,Interleukin-33,50524,322,1.02 [0.79-1.31],0.8980154868239691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL34,Interleukin-34,50203,322,1.17 [0.88-1.54],0.2750808139191558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36A,Interleukin-36 alpha,43466,294,0.95 [0.77-1.17],0.6199567119463747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36G,Interleukin-36 gamma,43297,294,1.16 [1.01-1.34],0.0383370987820964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3RA,Interleukin-3 receptor subunit alpha,50524,322,0.86 [0.63-1.18],0.3595480635525726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4,Interleukin-4,50524,322,1.06 [0.94-1.18],0.3493617928458572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4R,Interleukin-4 receptor subunit alpha,51419,328,1.13 [0.87-1.47],0.3620631626038769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5,Interleukin-5,50524,322,1.02 [0.95-1.09],0.5994412792052924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5RA,Interleukin-5 receptor subunit alpha,51419,328,0.92 [0.77-1.09],0.3336404574724304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6,Interleukin-6,51256,329,1.14 [1.02-1.28],0.0200652128369962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6R,Interleukin-6 receptor subunit alpha,51193,330,1.08 [0.81-1.43],0.6056254442298911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6ST,Interleukin-6 receptor subunit beta,51493,323,1.22 [0.70-2.13],0.4923643822476082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7,Interleukin-7,51419,328,0.95 [0.82-1.11],0.5203946687441511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7R,Interleukin-7 receptor subunit alpha,51506,328,0.94 [0.78-1.13],0.5161171918564049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL9,Interleukin-9,43946,299,1.01 [0.83-1.23],0.9408607536509224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,50209,322,1.03 [0.87-1.22],0.7272239213745546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMMT,MICOS complex subunit MIC60,44551,301,1.11 [0.88-1.41],0.3757010831193279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPA1,Inositol monophosphatase 1,51093,326,1.06 [0.91-1.25],0.4477663521245874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPACT,Protein IMPACT,44654,304,0.99 [0.81-1.20],0.9009086119711918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPG1,Interphotoreceptor matrix proteoglycan 1,43318,298,1.20 [0.86-1.67],0.2925614086176675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,50203,323,0.90 [0.72-1.12],0.3353093758371246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBB,Inhibin beta B chain,43784,299,0.93 [0.75-1.15],0.4849481165508573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBC,Inhibin beta C chain,51506,328,1.06 [0.84-1.35],0.6114756247221094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP1,Inositol polyphosphate 1-phosphatase,51256,329,0.98 [0.81-1.17],0.7915252295055084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",43572,301,1.05 [0.86-1.27],0.6368535279017502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",44680,305,1.27 [1.03-1.57],0.0285938002273008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",51256,329,1.03 [0.93-1.14],0.5815028627781735
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,44654,304,0.90 [0.79-1.03],0.1402785757802731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL4,Early placenta insulin-like peptide,44551,301,0.81 [0.62-1.05],0.1065654141755157
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL5,Insulin-like peptide INSL5,44569,304,0.90 [0.80-1.01],0.0784854900579953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,43466,294,0.56 [0.28-1.09],0.0896304977242378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IPCEF1,Interactor protein for cytohesin exchange factors 1,51008,326,1.04 [0.93-1.16],0.5186454566078675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IQGAP2,Ras GTPase-activating-like protein IQGAP2,51256,329,0.97 [0.81-1.16],0.7603866543277291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",50550,323,0.92 [0.82-1.04],0.1687025986455285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK1,Interleukin-1 receptor-associated kinase 1,50524,322,1.04 [0.90-1.20],0.5695445719731336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK4,Interleukin-1 receptor-associated kinase 4,51419,328,1.04 [0.95-1.14],0.3997592784605229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,49563,319,0.91 [0.70-1.19],0.4912540572942933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM1,Isthmin-1,51419,328,0.93 [0.72-1.19],0.5587655820419326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM2,Isthmin-2,44764,304,0.85 [0.65-1.11],0.2423845201269408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IST1,IST1 homolog,44244,303,1.03 [0.92-1.15],0.6543288672445935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA11,Integrin alpha-11,51419,328,0.72 [0.54-0.96],0.025042108093903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,43784,299,0.70 [0.51-0.97],0.0328175018215305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,51506,328,0.68 [0.45-1.01],0.0539150019328072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA6,Integrin alpha-6,51419,328,0.98 [0.82-1.19],0.8661897049801525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,43466,294,0.92 [0.71-1.18],0.4917930129304937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,51506,328,0.57 [0.42-0.78],0.0004773416572691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,51932,332,0.52 [0.34-0.78],0.0016997440279808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAX,Integrin alpha-X,43946,299,0.95 [0.76-1.18],0.640061649481189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1,Integrin beta-1,51445,330,0.99 [0.63-1.57],0.9802618781437716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP1,Integrin beta-1-binding protein 1,50282,316,1.02 [0.80-1.30],0.8787936268793222
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP2,Integrin beta-1-binding protein 2,50550,323,1.06 [0.97-1.16],0.2104555802070176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,51199,329,0.54 [0.38-0.77],0.0006225770927096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,51651,329,0.68 [0.52-0.89],0.0047182180058892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,50524,322,0.71 [0.51-0.98],0.0380052247025402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB7,Integrin beta-7,51932,332,0.95 [0.77-1.17],0.6288060670349782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGBL1,Integrin beta-like protein 1,44764,304,0.92 [0.68-1.25],0.6030826889830649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,44829,305,0.54 [0.30-0.96],0.0374913701485423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,51698,331,1.19 [0.92-1.54],0.1844544570147249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,44829,305,0.85 [0.55-1.32],0.4648517203593401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,44551,301,0.73 [0.55-0.96],0.0231170358181962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITM2A,Integral membrane protein 2A,51419,328,0.99 [0.84-1.16],0.8589212061972967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPA,Inosine triphosphate pyrophosphatase,43292,293,1.02 [0.86-1.20],0.8385705106922766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",43572,301,1.04 [0.89-1.22],0.624960311258661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",43318,298,1.03 [0.81-1.31],0.8323209362475844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",50288,323,0.94 [0.77-1.15],0.5462968767385212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,43160,294,0.83 [0.64-1.09],0.1795198882892987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM2,Junctional adhesion molecule B,51944,331,0.93 [0.64-1.35],0.7008280592972258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,43784,299,0.89 [0.71-1.12],0.3140397600181924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JCHAIN,Immunoglobulin J chain,50524,322,0.98 [0.84-1.15],0.8285243867998643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,43160,294,0.98 [0.80-1.19],0.8073006498706035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JPT2,Jupiter microtubule associated homolog 2,44569,304,1.01 [0.89-1.14],0.8926770039925416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JUN,Transcription factor AP-1,50524,322,0.91 [0.73-1.12],0.3665507521386257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,51256,329,1.12 [0.90-1.39],0.3283502913237662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZN,Kazrin,44569,304,1.01 [0.91-1.12],0.8846240363785426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,43318,298,1.19 [1.01-1.41],0.0375788449324451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNH2,Potassium voltage-gated channel subfamily H member 2,43533,300,0.86 [0.72-1.02],0.0829179380243668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNIP4,Kv channel-interacting protein 4,50288,323,0.91 [0.73-1.12],0.381280490798379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,43812,301,0.81 [0.62-1.06],0.1207009676202415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDM3A,Lysine-specific demethylase 3A,43466,294,0.90 [0.78-1.04],0.1624096414601545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDR,Vascular endothelial growth factor receptor 2,51651,329,0.92 [0.63-1.35],0.6779485380335192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KEL,Kell blood group glycoprotein,50288,323,0.78 [0.60-1.03],0.0798585924853333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHDC3L,KH domain-containing protein 3,43160,294,0.89 [0.74-1.08],0.2286697911707642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHK,Ketohexokinase,43572,301,1.01 [0.84-1.20],0.948549183596562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA0319,Dyslexia-associated protein KIAA0319,44654,304,0.71 [0.49-1.04],0.0769495085086858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549,UPF0606 protein KIAA1549,43946,299,0.89 [0.76-1.04],0.1471148453727164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549L,UPF0606 protein KIAA1549L,43946,299,0.77 [0.51-1.16],0.2140687230224388
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA2013,Uncharacterized protein KIAA2013,44551,301,1.04 [0.86-1.26],0.6951879337339906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF1C,Kinesin-like protein KIF1C,43292,293,1.06 [0.78-1.44],0.6950207847842691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF20B,Kinesin-like protein KIF20B,43318,298,1.07 [0.94-1.23],0.315181712493996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF22,Kinesin-like protein KIF22,43292,293,1.02 [0.93-1.12],0.6897324080707847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIFBP,KIF-binding protein,51256,329,1.03 [0.92-1.16],0.570076020539854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,44551,301,0.94 [0.83-1.07],0.3475437292624381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,50282,316,1.03 [0.91-1.17],0.6633757144926231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,44569,304,0.99 [0.92-1.05],0.644631860256538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,50282,316,0.99 [0.91-1.07],0.7261191130036968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,43160,294,1.03 [0.90-1.17],0.6765029627718733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL1,Kin of IRRE-like protein 1,43318,298,1.07 [0.90-1.28],0.4341139237653624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL2,Kin of IRRE-like protein 2,50288,323,0.93 [0.73-1.20],0.5866013177064586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIT,Mast/stem cell growth factor receptor Kit,51615,331,0.99 [0.71-1.37],0.9326380809469916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KITLG,Kit ligand,51493,323,0.95 [0.73-1.23],0.6928120692164103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLB,Beta-klotho,50288,323,0.99 [0.87-1.14],0.930220209829257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLF4,Krueppel-like factor 4,43318,298,1.09 [0.83-1.42],0.5347112062443051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLHL41,Kelch-like protein 41,44680,305,1.19 [0.97-1.45],0.0925063001432063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK1,Kallikrein-1,50991,326,0.98 [0.91-1.06],0.6554707656103781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK10,Kallikrein-10,51492,329,0.90 [0.70-1.15],0.3924644654959112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK11,Kallikrein-11,51159,325,0.94 [0.68-1.29],0.69789587644514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK12,Kallikrein-12,50282,316,1.04 [0.97-1.12],0.2888925867003995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK13,Kallikrein-13,50347,320,1.24 [1.00-1.54],0.0532168188621403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK14,Kallikrein-14,51932,332,1.13 [0.92-1.39],0.2527649617667273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK15,Kallikrein-15,44471,301,0.90 [0.73-1.11],0.310871985665905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,44764,304,0.90 [0.80-1.02],0.0938231559564871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK4,Kallikrein-4,51932,332,1.13 [0.98-1.31],0.0975751669122479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK6,Kallikrein-6,51566,328,1.03 [0.75-1.41],0.8607656478271646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK7,Kallikrein-7,42657,291,1.29 [0.97-1.71],0.0749901269514601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK8,Kallikrein-8,49768,319,1.02 [0.77-1.34],0.9066692868451058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,43921,300,1.08 [0.69-1.68],0.7362020140563001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRB1,Killer cell lectin-like receptor subfamily B member 1,52056,330,0.88 [0.68-1.14],0.326417847177818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,43318,298,1.03 [0.86-1.23],0.7801433198102525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRD1,Natural killer cells antigen CD94,52056,330,1.02 [0.83-1.26],0.8180214592591204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRF1,Killer cell lectin-like receptor subfamily F member 1,43466,294,0.96 [0.74-1.25],0.7587913350529831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRK1,NKG2-D type II integral membrane protein,44654,304,0.98 [0.78-1.24],0.8985520988119997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT14,"Keratin, type I cytoskeletal 14",48701,312,0.96 [0.67-1.36],0.8039959083844721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",43292,293,1.06 [0.80-1.41],0.6851172155704519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT18,"Keratin, type I cytoskeletal 18",51256,329,1.02 [0.90-1.15],0.8030079058519324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT19,"Keratin, type I cytoskeletal 19",51334,328,0.99 [0.86-1.14],0.8852987736459493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT5,"Keratin, type II cytoskeletal 5",50288,323,0.86 [0.70-1.05],0.1419721373869314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT6C,"Keratin, type II cytoskeletal 6C",43292,293,0.98 [0.73-1.32],0.9000661282807894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT8,"Keratin, type II cytoskeletal 8",43318,298,0.99 [0.85-1.16],0.9126258310011228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYAT1,Kynurenine--oxoglutarate transaminase 1,51408,323,0.96 [0.81-1.15],0.6765057561651058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYNU,Kynureninase,52056,330,0.94 [0.75-1.16],0.547350583087203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L1CAM,Neural cell adhesion molecule L1,51651,329,0.75 [0.54-1.05],0.0903861716660271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,44759,302,0.98 [0.86-1.10],0.7124276402347334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACRT,Extracellular glycoprotein lacritin,44466,301,0.94 [0.74-1.19],0.6178296140568542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACTB2,Endoribonuclease LACTB2,51493,323,1.05 [0.91-1.22],0.5074694523380052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAG3,Lymphocyte activation gene 3 protein,51256,329,0.94 [0.74-1.20],0.6193283312979317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,51461,329,0.93 [0.72-1.21],0.6008656149317095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,51093,326,0.97 [0.88-1.06],0.4870841884041464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA1,Laminin subunit alpha-1,43292,293,1.01 [0.82-1.24],0.9449343612960196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA4,Laminin subunit alpha-4,51715,329,0.93 [0.69-1.24],0.6170915180085466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMB1,Laminin subunit beta-1,43572,301,1.21 [0.84-1.75],0.3141110255739777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,43521,294,0.72 [0.45-1.17],0.1843547002678063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP2,Lysosome-associated membrane glycoprotein 2,49927,320,0.84 [0.51-1.39],0.5055003207511642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP3,Lysosome-associated membrane glycoprotein 3,51971,328,1.05 [0.87-1.26],0.6367596630845153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMTOR5,Ragulator complex protein LAMTOR5,44551,301,0.91 [0.69-1.21],0.5197268493521092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAP3,Cytosol aminopeptidase,50524,322,1.07 [0.88-1.31],0.48991324673118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LARP1,La-related protein 1,44551,301,1.07 [0.90-1.26],0.4508311043391949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT,Linker for activation of T-cells family member 1,52056,330,1.05 [0.93-1.20],0.4420507600523951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT2,Linker for activation of T-cells family member 2,51256,329,1.04 [0.96-1.12],0.3643339723935831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LATS1,Serine/threonine-protein kinase LATS1,43466,294,0.97 [0.85-1.11],0.6456115608015707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAYN,Layilin,51008,326,1.09 [0.83-1.45],0.5372206735068954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBP,Lipopolysaccharide-binding protein,51698,331,1.03 [0.87-1.22],0.7060812629617021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBR,Delta(14)-sterol reductase LBR,51944,331,0.95 [0.82-1.10],0.4749148083245383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCAT,Phosphatidylcholine-sterol acyltransferase,44798,305,0.84 [0.52-1.37],0.4858324258201092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN15,Lipocalin-15,44680,305,0.96 [0.80-1.15],0.6452053168512333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN2,Neutrophil gelatinase-associated lipocalin,49944,320,1.22 [0.95-1.56],0.1139456296859293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,44764,304,0.71 [0.56-0.91],0.0070384016616147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLR,Low-density lipoprotein receptor,51624,329,1.01 [0.84-1.22],0.8842192268091846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLRAP1,Low density lipoprotein receptor adapter protein 1,44680,305,1.01 [0.90-1.13],0.8705667614141703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LECT2,Leukocyte cell-derived chemotaxin-2,44759,302,0.85 [0.72-1.01],0.0641607859883537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEFTY2,Left-right determination factor 2,51855,330,0.79 [0.65-0.95],0.0126414740382638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,42296,281,0.74 [0.62-0.89],0.0010653398735604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LELP1,Late cornified envelope-like proline-rich protein 1,43318,298,1.00 [0.86-1.16],0.9924639872568338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEO1,RNA polymerase-associated protein LEO1,44680,305,0.94 [0.65-1.35],0.7203802947698221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEP,Leptin,51493,323,0.96 [0.83-1.11],0.5533378226545944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEPR,Leptin receptor,51493,323,0.74 [0.53-1.02],0.0671181934053295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LETM1,Mitochondrial proton/calcium exchanger protein,44680,305,1.12 [0.92-1.37],0.2548644706366926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS1,Galectin-1,51493,323,0.98 [0.74-1.31],0.9131441441411648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3,Galectin-3,51626,332,0.82 [0.59-1.13],0.2174128883942573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,44829,305,0.76 [0.52-1.10],0.148745536695571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS4,Galectin-4,51461,329,0.93 [0.78-1.12],0.4547463496519104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS7_LGALS7B,Galectin-7,51348,328,1.21 [0.97-1.50],0.0875675547027003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS8,Galectin-8,51944,331,0.97 [0.82-1.13],0.6721054360194076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS9,Galectin-9,51463,328,0.89 [0.65-1.21],0.4505412990190323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGMN,Legumain,51715,329,1.08 [0.83-1.41],0.5725833652082056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHB,Lutropin subunit beta,50282,316,1.08 [0.97-1.20],0.1473673281222167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,51546,329,1.01 [0.86-1.19],0.8919608973501272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIF,Leukemia inhibitory factor,50288,323,1.03 [0.85-1.24],0.7871357195082633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIFR,Leukemia inhibitory factor receptor,51419,328,1.24 [0.83-1.85],0.2935322131709827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,51506,328,0.90 [0.69-1.17],0.4306057964409003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,44764,304,1.04 [0.96-1.14],0.3164773653871386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,43292,293,0.87 [0.69-1.11],0.2695621891115506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,51417,323,0.77 [0.56-1.04],0.0857506781601606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,44759,302,0.98 [0.85-1.14],0.8399294641892031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,52128,334,0.98 [0.69-1.39],0.909717297565386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,51876,332,1.14 [0.86-1.51],0.3610545856512616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,50524,322,1.15 [0.92-1.43],0.2318802348418569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,52128,334,0.90 [0.79-1.03],0.1189628747099975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIPF,Gastric triacylglycerol lipase,43572,301,0.93 [0.78-1.12],0.4634835811579899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB1,Lamin-B1,44485,304,0.99 [0.83-1.18],0.9063461428543108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB2,Lamin-B2,44654,304,1.15 [0.78-1.69],0.4732641372051716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD1,Leiomodin-1,44680,305,0.85 [0.61-1.19],0.352584091766802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,43318,298,0.82 [0.67-1.00],0.0479655911769492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LONP1,"Lon protease homolog, mitochondrial",43572,301,1.03 [0.90-1.16],0.7018805940959159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),43766,299,0.97 [0.91-1.03],0.2966729273754264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPCAT2,Lysophosphatidylcholine acyltransferase 2,51256,329,0.92 [0.72-1.18],0.5314157552477231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPL,Lipoprotein lipase,51493,323,0.92 [0.75-1.13],0.4064261795032752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPO,Lactoperoxidase,49790,320,0.88 [0.75-1.04],0.1325063720013519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPP,Lipoma-preferred partner,43292,293,1.01 [0.86-1.20],0.8681524587316306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,43292,293,0.98 [0.83-1.15],0.7856830364484505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,43533,300,0.76 [0.57-1.00],0.053041398115867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRG1,Leucine-rich alpha-2-glycoprotein,44829,305,1.11 [0.74-1.68],0.6166827391941083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,51781,329,0.85 [0.64-1.12],0.2529126435604698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,43313,294,1.05 [0.70-1.56],0.8209474149691007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP1,Prolow-density lipoprotein receptor-related protein 1,51256,329,0.96 [0.66-1.39],0.8244408121799216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP11,Low-density lipoprotein receptor-related protein 11,51493,323,1.13 [0.86-1.48],0.3835405557158677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2,Low-density lipoprotein receptor-related protein 2,43533,300,0.79 [0.57-1.10],0.1681002730420516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2BP,LRP2-binding protein,43533,300,0.96 [0.84-1.10],0.572404070210118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,51944,331,1.07 [0.91-1.25],0.4327997659525991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC25,Leucine-rich repeat-containing protein 25,51256,329,0.98 [0.76-1.27],0.8997942395650601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC37A2,Leucine-rich repeat-containing protein 37A2,44569,304,0.74 [0.57-0.95],0.0201108820173802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC38,Leucine-rich repeat-containing protein 38,43533,300,0.77 [0.60-0.99],0.0417284107969929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC59,Leucine-rich repeat-containing protein 59,44759,302,1.00 [0.80-1.26],0.985031263174102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,44551,301,1.10 [0.88-1.37],0.4150094109607065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRN1,Leucine-rich repeat neuronal protein 1,50524,322,0.82 [0.64-1.05],0.1156818400114769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,43533,300,0.96 [0.73-1.26],0.7785142587948373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,44680,305,0.76 [0.50-1.18],0.222791307859843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM1,U6 snRNA-associated Sm-like protein LSm1,50282,316,1.14 [0.97-1.34],0.1023868585020064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM8,U6 snRNA-associated Sm-like protein LSm8,43946,299,1.05 [0.93-1.19],0.4039509284509912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSP1,Lymphocyte-specific protein 1,51419,328,1.07 [0.85-1.36],0.5577219250727787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA,Lymphotoxin-alpha,51419,328,1.20 [0.95-1.52],0.1319789970921852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA4H,Leukotriene A-4 hydrolase,51932,332,1.04 [0.88-1.22],0.6620622474352831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,44551,301,1.35 [1.05-1.72],0.0190165460237927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP2,Latent-transforming growth factor beta-binding protein 2,52128,334,0.95 [0.70-1.30],0.7681629118038573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP3,Latent-transforming growth factor beta-binding protein 3,50282,316,1.01 [0.84-1.22],0.8952184686073597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBR,Tumor necrosis factor receptor superfamily member 3,51209,328,1.00 [0.71-1.41],0.9998039781261836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTO1,Protein LTO1 homolog,50524,322,1.16 [0.94-1.43],0.1785844037031286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LUZP2,Leucine zipper protein 2,44551,301,0.82 [0.63-1.06],0.1322182628109842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LXN,Latexin,50853,326,1.05 [0.91-1.21],0.4797615775816597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY6D,Lymphocyte antigen 6D,51211,328,1.05 [0.81-1.35],0.7195353383217962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY75,Lymphocyte antigen 75,51419,328,1.03 [0.80-1.33],0.7990756418525504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY9,T-lymphocyte surface antigen Ly-9,50892,323,0.99 [0.71-1.38],0.9567041985033627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY96,Lymphocyte antigen 96,51093,326,0.94 [0.71-1.24],0.6650930734937066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYAR,Cell growth-regulating nucleolar protein,50282,316,0.95 [0.78-1.15],0.6070795329733386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYN,Tyrosine-protein kinase Lyn,51256,329,1.05 [0.93-1.17],0.4366541418916971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD1,Ly6/PLAUR domain-containing protein 1,50288,323,0.85 [0.71-1.03],0.0956754982760327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD3,Ly6/PLAUR domain-containing protein 3,51242,327,1.15 [0.86-1.53],0.3385108189140249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD8,Ly6/PLAUR domain-containing protein 8,50282,316,1.06 [0.88-1.29],0.5335647296883544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPLA2,Acyl-protein thioesterase 2,43318,298,1.08 [0.98-1.19],0.1009780760614701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,43533,300,1.08 [0.97-1.19],0.1497050910453336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,44829,305,0.83 [0.47-1.45],0.5033527799313775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYZL2,Lysozyme-like protein 2,43160,294,0.74 [0.53-1.03],0.0773688381588425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LZTFL1,Leucine zipper transcription factor-like protein 1,43784,299,0.99 [0.85-1.16],0.9440654827888244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,M6PR,Cation-dependent mannose-6-phosphate receptor,43572,301,1.00 [0.75-1.32],0.9914715189485168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,50924,325,0.97 [0.80-1.19],0.7841124342108386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAEA,E3 ubiquitin-protein transferase MAEA,50282,316,1.16 [0.91-1.47],0.2318915737546178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAG,Myelin-associated glycoprotein,43533,300,1.07 [0.85-1.35],0.5644152644809604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGEA3,Melanoma-associated antigen 3,43946,299,0.94 [0.83-1.06],0.3207129510450178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGED1,Melanoma-associated antigen D1,50282,316,0.98 [0.79-1.21],0.8359743802669484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC2,MAM domain-containing protein 2,44759,302,0.81 [0.59-1.11],0.1918940351919998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC4,Apical endosomal glycoprotein,44551,301,1.03 [0.85-1.25],0.7745028892358454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",43572,301,1.13 [0.73-1.74],0.5783501129723636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN2B2,Epididymis-specific alpha-mannosidase,44759,302,1.04 [0.86-1.24],0.7108053292206006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",43160,294,0.84 [0.67-1.05],0.1256623612552613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANF,Mesencephalic astrocyte-derived neurotrophic factor,51715,329,1.02 [0.94-1.11],0.5606473340787199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC1,MANSC domain-containing protein 1,51651,329,0.87 [0.61-1.24],0.443825690938614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC4,MANSC domain-containing protein 4,43292,293,0.91 [0.77-1.08],0.2723010743332179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,43318,298,1.30 [0.92-1.83],0.1367298507499048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,43292,293,1.04 [0.88-1.22],0.6326591781566995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2,Microtubule-associated protein 2,44654,304,0.99 [0.78-1.25],0.917149737004036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,44569,304,1.03 [0.86-1.22],0.7746378919482588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,51419,328,1.01 [0.92-1.12],0.780404230460674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,50282,316,0.95 [0.86-1.06],0.3551385315559343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,51008,326,1.01 [0.93-1.11],0.7478822017404613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK13,Mitogen-activated protein kinase 13,43160,294,0.87 [0.66-1.14],0.302971666378578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK9,Mitogen-activated protein kinase 9,51419,328,0.94 [0.75-1.18],0.6045037230057917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPKAPK2,MAP kinase-activated protein kinase 2,43946,299,1.01 [0.87-1.18],0.8517166070146984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPRE3,Microtubule-associated protein RP/EB family member 3,43160,294,0.94 [0.86-1.03],0.1639151115872184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPT,Microtubule-associated protein tau,50288,323,1.05 [0.86-1.27],0.6502480350780568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARCO,Macrophage receptor MARCO,51493,323,1.03 [0.71-1.50],0.8725147094424766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARS1,"Methionine--tRNA ligase, cytoplasmic",43704,299,1.00 [0.88-1.14],0.9519138306232634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MASP1,Mannan-binding lectin serine protease 1,51008,326,1.18 [0.78-1.80],0.4347462651359273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN2,Matrilin-2,51546,329,1.24 [0.89-1.72],0.200456879219748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,51008,326,1.00 [0.74-1.35],0.984529526195189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAVS,Mitochondrial antiviral-signaling protein,50282,316,1.05 [0.94-1.17],0.3951950371718251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAX,Protein max,50288,323,1.05 [0.96-1.16],0.2934930898329362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,52128,334,1.46 [1.25-1.71],2.562936078851317e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MBL2,Mannose-binding protein C,44188,302,0.91 [0.82-1.01],0.0681622918322753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCAM,Cell surface glycoprotein MUC18,51698,331,1.04 [0.78-1.39],0.7926554436564093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",44680,305,1.27 [1.03-1.57],0.0256397173835229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEMP1,Mast cell-expressed membrane protein 1,43466,294,0.94 [0.83-1.07],0.3329442398654064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCFD2,Multiple coagulation factor deficiency protein 2,51253,323,0.97 [0.78-1.21],0.7865542595434774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCTS1,Malignant T-cell-amplified sequence 1,44569,304,0.94 [0.62-1.44],0.7915954427104837
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,51093,326,1.07 [0.92-1.23],0.3817893116245198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDH1,"Malate dehydrogenase, cytoplasmic",44548,304,1.09 [0.83-1.42],0.5269640308913272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDK,Midkine,51494,329,1.16 [0.97-1.38],0.1035607171056621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDM1,Nuclear protein MDM1,43533,300,0.84 [0.58-1.20],0.3367279816583666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",43572,301,1.01 [0.90-1.14],0.8335960792533144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED18,Mediator of RNA polymerase II transcription subunit 18,50282,316,1.05 [0.92-1.19],0.4851567662931494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED21,Mediator of RNA polymerase II transcription subunit 21,43292,293,1.03 [0.83-1.29],0.7907199189163308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,51461,329,1.87 [1.46-2.39],5.304681610660552e-07
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF11,Multiple epidermal growth factor-like domains protein 11,43292,293,1.10 [0.79-1.52],0.5813682058407696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,51958,333,0.80 [0.49-1.30],0.3722599680932779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MELTF,Melanotransferrin,44759,302,1.08 [0.74-1.55],0.6986973093445815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MENT,Protein MENT,43784,299,0.63 [0.39-1.01],0.056756225205925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1A,Meprin A subunit alpha,44569,304,0.92 [0.79-1.07],0.2826396169874066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1B,Meprin A subunit beta,51493,323,0.97 [0.89-1.05],0.4580523038668666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEPE,Matrix extracellular phosphoglycoprotein,51461,329,0.82 [0.56-1.20],0.3048215437824573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MERTK,Tyrosine-protein kinase Mer,52056,330,1.00 [0.68-1.46],0.980575704055734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MESD,LRP chaperone MESD,51506,328,1.03 [0.95-1.11],0.5252993174739078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MET,Hepatocyte growth factor receptor,51626,329,0.71 [0.43-1.16],0.1671941390980347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1,Methionine aminopeptidase 1,50288,323,1.10 [0.80-1.53],0.5476123199536161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",51419,328,1.07 [0.95-1.20],0.2885283737972653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP2,Methionine aminopeptidase 2,51855,330,1.03 [0.87-1.22],0.721945429288762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3,Microfibril-associated glycoprotein 3,50550,323,0.88 [0.71-1.10],0.2626309092031121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3L,Microfibrillar-associated protein 3-like,43533,300,1.00 [0.85-1.18],0.9820094646646712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP4,Microfibril-associated glycoprotein 4,43784,299,0.71 [0.50-1.01],0.05578809779202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP5,Microfibrillar-associated protein 5,52128,334,0.93 [0.73-1.18],0.5441418269798777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFGE8,Lactadherin,51506,328,0.85 [0.68-1.07],0.166403833964349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGLL,Monoglyceride lipase,51631,329,1.02 [0.91-1.14],0.7275131734275149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGMT,Methylated-DNA--protein-cysteine methyltransferase,51419,328,1.06 [0.98-1.15],0.145420607113405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIA,Melanoma-derived growth regulatory protein,51651,329,1.04 [0.80-1.36],0.7435882569482604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICALL2,MICAL-like protein 2,43533,300,0.95 [0.81-1.13],0.5816680788197534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,51419,328,1.02 [0.95-1.09],0.5562213437918387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIF,Macrophage migration inhibitory factor,51421,328,1.07 [0.93-1.24],0.3348493816692335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MILR1,Allergin-1,50524,322,1.16 [0.96-1.41],0.1170366529228654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,44551,301,0.97 [0.87-1.07],0.532484297215853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINK1,Misshapen-like kinase 1,44654,304,0.99 [0.88-1.11],0.8530745659662569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MITD1,MIT domain-containing protein 1,51093,326,1.03 [0.93-1.14],0.5746563284466351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,43466,294,0.71 [0.50-0.99],0.0421148628341563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLLT1,Protein ENL,43160,294,0.86 [0.71-1.03],0.1019072615651871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLN,Promotilin,51419,328,1.00 [0.89-1.11],0.9378664403146082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MME,Neprilysin,51256,329,0.96 [0.85-1.09],0.5234974801450076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP1,Interstitial collagenase,49629,316,1.09 [0.97-1.22],0.1347181507451131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP10,Stromelysin-2,51377,329,0.82 [0.69-0.97],0.0226242973363641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP12,Macrophage metalloelastase,51534,327,0.98 [0.82-1.18],0.8410676934612311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP13,Collagenase 3,50288,323,1.15 [0.85-1.56],0.3699350630241654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP15,Matrix metalloproteinase-15,44759,302,0.84 [0.64-1.10],0.1964500916479652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP3,Stromelysin-1,51506,328,0.94 [0.77-1.15],0.5605808616501775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP7,Matrilysin,50471,321,0.95 [0.78-1.16],0.6138873168143965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP8,Neutrophil collagenase,51860,330,1.15 [1.01-1.31],0.0351041545624005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,51422,328,1.24 [1.06-1.46],0.0082373430698508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",43292,293,0.93 [0.74-1.17],0.5456576359183967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MN1,Transcriptional activator MN1,43533,300,0.98 [0.81-1.19],0.8769692816434691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNAT1,CDK-activating kinase assembly factor MAT1,43946,299,0.85 [0.65-1.12],0.2495905620969339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNDA,Myeloid cell nuclear differentiation antigen,51415,323,0.97 [0.88-1.08],0.6129286820066713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOCS2,Molybdopterin synthase catalytic subunit,43784,299,1.06 [0.90-1.25],0.5121270178847668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOG,Myelin-oligodendrocyte glycoprotein,51932,332,0.94 [0.70-1.26],0.6900314656352512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORC3,MORC family CW-type zinc finger protein 3,44654,304,1.11 [0.76-1.60],0.5973643042314318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L1,Mortality factor 4-like protein 1,43946,299,0.98 [0.74-1.30],0.8941628716084162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L2,Mortality factor 4-like protein 2,43160,294,0.81 [0.58-1.12],0.2032017054764572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORN4,MORN repeat-containing protein 4,43160,294,1.00 [0.87-1.15],0.985387349059148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPHOSPH8,M-phase phosphoprotein 8,50550,323,0.99 [0.87-1.13],0.8466488008748049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPI,Mannose-6-phosphate isomerase,51256,329,1.08 [0.96-1.21],0.1979423153894053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,51631,329,1.06 [0.93-1.20],0.4001000998047733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPO,Myeloperoxidase,51506,328,1.25 [1.03-1.52],0.0214164033648589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,44467,301,0.94 [0.73-1.21],0.6333552400521385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRC1,Macrophage mannose receptor 1,44798,305,1.00 [0.68-1.47],0.991762736834905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRI1,Methylthioribose-1-phosphate isomerase,43533,300,0.97 [0.83-1.15],0.7398630131194442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL24,"39S ribosomal protein L24, mitochondrial",43292,293,0.95 [0.70-1.28],0.7213909725723457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL28,"39S ribosomal protein L28, mitochondrial",44680,305,0.86 [0.61-1.21],0.3822018899165272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL46,"39S ribosomal protein L46, mitochondrial",50288,323,0.87 [0.60-1.26],0.4635766273126828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL52,"39S ribosomal protein L52, mitochondrial",43076,294,0.92 [0.59-1.42],0.6949605679158501
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",44680,305,0.93 [0.80-1.10],0.4052484988603232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPS16,"28S ribosomal protein S16, mitochondrial",43466,294,0.69 [0.44-1.09],0.1104221070919742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLN,Mesothelin,51172,329,0.99 [0.84-1.17],0.9248790421296822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLNL,Mesothelin-like protein,43533,300,0.96 [0.71-1.29],0.7694798312964581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSMB,Beta-microseminoprotein,51377,329,0.94 [0.82-1.08],0.3987623401944263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSR1,Macrophage scavenger receptor types I and II,51944,331,1.03 [0.84-1.28],0.7548777975814998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSRA,Mitochondrial peptide methionine sulfoxide reductase,51651,329,1.01 [0.88-1.16],0.871827940778001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MST1,Hepatocyte growth factor-like protein,44120,299,0.94 [0.81-1.09],0.4172686451822041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,50550,323,0.81 [0.67-0.98],0.0280495481076578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTDH,Protein LYRIC,43466,294,0.99 [0.88-1.12],0.883017301266914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",44654,304,1.36 [0.96-1.92],0.0853642444828737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,43946,299,1.03 [0.94-1.14],0.5244817087191682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTIF3,"Translation initiation factor IF-3, mitochondrial",44569,304,1.01 [0.89-1.14],0.8878937347506071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTPN,Myotrophin,50550,323,0.96 [0.71-1.31],0.8057340122044963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTR,Methionine synthase,43292,293,0.94 [0.78-1.12],0.4768043679379455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS1,Protein MTSS 1,44569,304,0.99 [0.90-1.09],0.8675375235187843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS2,Protein MTSS 2,44551,301,1.02 [0.91-1.14],0.7721173984395012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTUS1,Microtubule-associated tumor suppressor 1,43946,299,1.10 [0.91-1.33],0.334645513094197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC13,Mucin-13,50288,323,0.80 [0.66-0.98],0.0319801862572867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC16,Mucin-16,51256,329,0.98 [0.94-1.04],0.5565687259642134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC2,Mucin-2,44764,304,0.90 [0.80-1.02],0.0956449247555564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUCL3,Mucin-like protein 3,43160,294,0.81 [0.60-1.10],0.177362289790961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MVK,Mevalonate kinase,50524,322,1.06 [0.94-1.20],0.3463236858543399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MXRA8,Matrix remodeling-associated protein 8,43784,299,0.77 [0.54-1.11],0.1607179833816215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",44759,302,1.48 [1.30-1.68],3.394016314653506e-09
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",43572,301,1.18 [1.06-1.31],0.003233650679319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,44680,305,1.03 [0.88-1.22],0.6829316705861795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYDGF,Myeloid-derived growth factor,44759,302,1.01 [0.90-1.13],0.881284302697278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH4,Myosin-4,43292,293,1.02 [0.80-1.30],0.860701847710346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH7B,Myosin-7B,43160,294,0.92 [0.70-1.20],0.5443434606446007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,44764,304,0.98 [0.89-1.08],0.6393945004426715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",43292,293,1.32 [1.07-1.63],0.0105834898479598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,43572,301,1.40 [1.22-1.61],2.747863233057484e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL4,Myosin light chain 4,43572,301,1.17 [0.96-1.41],0.1174513837184289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL6B,Myosin light chain 6B,43533,300,0.92 [0.81-1.05],0.2314290873681807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",43533,300,1.46 [1.25-1.71],2.4762940530707364e-06
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO6,Unconventional myosin-VI,44680,305,0.85 [0.62-1.17],0.3279283747919494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO9B,Unconventional myosin-IXb,50524,322,0.94 [0.81-1.10],0.4366635772376006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOC,Myocilin,51506,328,0.85 [0.69-1.06],0.1491675084997717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM1,Myomesin-1,43318,298,1.14 [0.93-1.41],0.2099009887077603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,43292,293,1.44 [1.20-1.71],5.755060054693291e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,43784,299,1.41 [1.26-1.58],3.951534830120508e-09
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,51630,329,1.00 [0.83-1.21],0.988180126992346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZT1,Mitotic-spindle organizing protein 1,50282,316,0.94 [0.77-1.15],0.5634148268814183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA10,N-alpha-acetyltransferase 10,43292,293,1.04 [0.83-1.29],0.7410497513369242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA80,N-alpha-acetyltransferase 80,43533,300,0.97 [0.89-1.07],0.5886866453221901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAAA,N-acylethanolamine-hydrolyzing acid amidase,50854,325,0.95 [0.80-1.12],0.5497241766091596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NACC1,Nucleus accumbens-associated protein 1,44551,301,0.94 [0.77-1.16],0.5756198550806593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NADK,NAD kinase,51493,323,1.02 [0.86-1.21],0.8173925413566189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGA,Alpha-N-acetylgalactosaminidase,43382,293,0.81 [0.65-1.02],0.0773594835639922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGK,N-acetyl-D-glucosamine kinase,43492,301,1.03 [0.85-1.26],0.7298582579058359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,43784,299,1.31 [0.78-2.20],0.3029692708002104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAMPT,Nicotinamide phosphoribosyltransferase,50282,316,1.08 [0.91-1.28],0.3751952968855303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAP1L4,Nucleosome assembly protein 1-like 4,44484,304,1.04 [0.80-1.36],0.7768294076545041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAPRT,Nicotinate phosphoribosyltransferase,44654,304,0.95 [0.68-1.33],0.7760860508365983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NARS1,"Asparagine--tRNA ligase, cytoplasmic",44680,305,1.06 [0.84-1.34],0.6055046062819068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBL1,Neuroblastoma suppressor of tumorigenicity 1,51651,329,1.04 [0.73-1.50],0.8179911037883009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBN,Nibrin,50524,322,1.07 [0.90-1.26],0.4542501259451665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM1,Neural cell adhesion molecule 1,51698,331,1.23 [0.90-1.69],0.1880579492088585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM2,Neural cell adhesion molecule 2,51506,328,1.06 [0.74-1.52],0.7573421414424117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,51944,331,0.65 [0.51-0.84],0.0009709289471716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCF2,Neutrophil cytosol factor 2,51334,328,1.01 [0.90-1.13],0.8588114078984856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCK2,Cytoplasmic protein NCK2,51715,329,1.04 [0.95-1.14],0.4060156527966077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCLN,Nicalin,50524,322,0.81 [0.64-1.03],0.0825103490418846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR1,Natural cytotoxicity triggering receptor 1,51345,328,0.89 [0.68-1.15],0.3727425006705024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,44569,304,0.97 [0.71-1.35],0.8756730590744525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCS1,Neuronal calcium sensor 1,51932,332,1.12 [0.80-1.57],0.5247927564627232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDRG1,Protein NDRG1,50288,323,1.01 [0.87-1.17],0.9123900128313333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,44551,301,0.91 [0.75-1.10],0.3158005294364884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,43394,293,1.15 [0.84-1.57],0.3879876368769316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,44569,304,0.98 [0.87-1.11],0.7533420783915051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",50282,316,1.10 [0.99-1.24],0.0861990746944851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,43292,293,1.39 [1.10-1.75],0.0053568500486692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECAP2,Adaptin ear-binding coat-associated protein 2,43292,293,1.01 [0.86-1.20],0.871223519345057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN1,Nectin-1,43466,294,1.10 [0.79-1.52],0.5866150112643258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN2,Nectin-2,51417,323,1.00 [0.72-1.40],0.9768623428785888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN4,Nectin-4,51651,329,0.97 [0.72-1.33],0.8707338091113774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,43466,294,0.87 [0.69-1.08],0.2062065165873981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD9,Enhancer of filamentation 1,43466,294,0.94 [0.67-1.31],0.7041722387036446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,50129,321,3.06 [2.74-3.42],4.470843460458548e-87
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEK7,Serine/threonine-protein kinase Nek7,43946,299,0.91 [0.78-1.07],0.2590942857522456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL1,Protein kinase C-binding protein NELL1,51651,329,0.91 [0.73-1.15],0.4350594342421999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,51715,329,0.52 [0.37-0.74],0.0002852187973136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NENF,Neudesin,44551,301,0.96 [0.87-1.07],0.4568445967365698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEO1,Neogenin,44680,305,0.87 [0.53-1.44],0.5849719920078674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEXN,Nexilin,44798,305,0.99 [0.84-1.16],0.8563082955752285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,52056,330,0.62 [0.44-0.89],0.0085427299338439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFAT5,Nuclear factor of activated T-cells 5,43466,294,0.90 [0.78-1.03],0.1356784416866238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",51419,328,1.02 [0.92-1.13],0.7232080180374645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",50524,322,0.93 [0.79-1.11],0.4242806574391757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFE2,Transcription factor NF-E2 45 kDa subunit,43572,301,1.03 [0.89-1.19],0.7195062910895064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFIC,Nuclear factor 1 C-type,44680,305,0.94 [0.72-1.23],0.6496370279116428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB1,Nuclear factor NF-kappa-B p105 subunit,43292,293,0.99 [0.85-1.15],0.8713827044749565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB2,Nuclear factor NF-kappa-B p100 subunit,43946,299,1.11 [0.93-1.31],0.2433768360186792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKBIE,NF-kappa-B inhibitor epsilon,50282,316,0.96 [0.79-1.19],0.7327788801998687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",44569,304,1.03 [0.93-1.15],0.5630087159280881
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFX1,Transcriptional repressor NF-X1,43292,293,1.03 [0.87-1.22],0.7162087006870567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFYA,Nuclear transcription factor Y subunit alpha,43292,293,0.94 [0.70-1.26],0.6829430275928512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGF,Beta-nerve growth factor,51093,326,1.33 [0.61-2.89],0.4776486760577867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGFR,Tumor necrosis factor receptor superfamily member 16,44759,302,0.73 [0.49-1.10],0.1287153614922621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGRN,Neugrin,44654,304,1.30 [0.83-2.04],0.2497016191164658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NHLRC3,NHL repeat-containing protein 3,42726,292,1.10 [0.77-1.57],0.6132498011777667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID1,Nidogen-1,51530,331,1.05 [0.81-1.35],0.7294830590891643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID2,Nidogen-2,51506,328,1.03 [0.90-1.17],0.691636260161574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NINJ1,Ninjurin-1,50282,316,0.91 [0.74-1.11],0.343712471020199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT1,Deaminated glutathione amidase,43572,301,1.07 [0.84-1.36],0.5712617552545001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT2,Omega-amidase NIT2,44589,300,1.05 [0.90-1.22],0.5175378776924933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN1,Neuroligin-1,43533,300,0.98 [0.83-1.16],0.8080597479888603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN2,Neuroligin-2,43318,298,0.81 [0.62-1.06],0.1212071428278451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME1,Nucleoside diphosphate kinase A,43466,294,0.90 [0.53-1.52],0.6935042525187235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME3,Nucleoside diphosphate kinase 3,51546,329,0.91 [0.59-1.38],0.6435414991637594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMI,N-myc-interactor,44382,301,1.00 [0.86-1.17],0.9903257039897394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,51093,326,1.01 [0.89-1.15],0.9123109770690288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMRK2,Nicotinamide riboside kinase 2,43160,294,0.88 [0.65-1.20],0.4258362532829013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,44680,305,1.01 [0.86-1.19],0.9101650057361196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOMO1,Nodal modulator 1,51506,328,0.70 [0.46-1.06],0.08829926055975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOP56,Nucleolar protein 56,43292,293,1.01 [0.92-1.12],0.8178227010581823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",50288,323,1.26 [1.06-1.50],0.0083548358728054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS2,"Nitric oxide synthase, inducible",43292,293,0.97 [0.73-1.29],0.8395646344474267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS3,"Nitric oxide synthase, endothelial",50288,323,1.06 [0.88-1.27],0.5330164563628284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH1,Neurogenic locus notch homolog protein 1,52128,334,0.84 [0.46-1.55],0.5817283734551251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH2,Neurogenic locus notch homolog protein 2,44764,304,1.14 [0.68-1.91],0.6084204491818459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH3,Neurogenic locus notch homolog protein 3,52128,334,0.84 [0.63-1.13],0.25030150416662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPC2,NPC intracellular cholesterol transporter 2,44011,299,1.23 [0.89-1.72],0.2081245850436505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPDC1,Neural proliferation differentiation and control protein 1,51493,323,1.16 [0.85-1.56],0.3472616252253443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS1,Nephrin,43466,294,1.00 [0.72-1.38],0.9764866093494814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS2,Podocin,43466,294,0.95 [0.85-1.06],0.3810988927569516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPL,N-acetylneuraminate lyase,44759,302,0.85 [0.67-1.09],0.1989085460390586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,50550,323,0.94 [0.88-1.01],0.1036976753317592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPC,C-type natriuretic peptide,51419,328,0.96 [0.78-1.17],0.677862654957272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPR1,Atrial natriuretic peptide receptor 1,43292,293,0.75 [0.55-1.03],0.0750017580969597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTN,Neuroplastin,50282,316,1.07 [0.96-1.20],0.2296404383154573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX1,Neuronal pentraxin-1,51506,328,1.05 [0.83-1.34],0.6840268496880542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,44764,304,0.81 [0.58-1.13],0.2088540481989945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,51493,323,0.68 [0.50-0.92],0.0129745700998815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPY,Pro-neuropeptide Y,51932,332,0.93 [0.80-1.07],0.3199288478040046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRCAM,Neuronal cell adhesion molecule,51493,323,1.25 [0.89-1.76],0.1982050366735268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRGN,Neurogranin,44798,305,1.02 [0.91-1.15],0.7386878268995596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRN1,Neuritin,44680,305,1.07 [0.81-1.42],0.6242349440062926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP1,Neuropilin-1,51783,331,1.15 [0.81-1.63],0.4354723081783381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,51506,328,0.74 [0.52-1.05],0.0895833234329125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRTN,Neurturin,50524,322,0.91 [0.74-1.11],0.3392924640897415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRXN3,Neurexin-3,43533,300,0.88 [0.63-1.23],0.4447577054749324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NSFL1C,NSFL1 cofactor p47,51944,331,1.00 [0.86-1.16],0.9846514849482672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",44759,302,1.08 [0.93-1.25],0.3314904047228034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C1A,Cytosolic 5'-nucleotidase 1A,44654,304,1.18 [0.85-1.62],0.3236947785210945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C3A,Cytosolic 5'-nucleotidase 3A,51338,328,1.03 [0.92-1.16],0.5536486011420614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5E,5'-nucleotidase,51651,329,0.99 [0.83-1.18],0.9452059006597386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,51419,328,0.73 [0.55-0.97],0.0312593162525521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF4,Neurotrophin-4,50282,316,0.93 [0.70-1.22],0.5908973651562728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK2,BDNF/NT-3 growth factors receptor,51493,323,1.03 [0.70-1.51],0.8862392073555672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK3,NT-3 growth factor receptor,51944,331,1.12 [0.72-1.76],0.6121881895305115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,51493,323,0.92 [0.83-1.01],0.0763746398436321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUB1,NEDD8 ultimate buster 1,51419,328,1.02 [0.91-1.14],0.7476976146178662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,44551,301,1.04 [0.93-1.15],0.5285596394109298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUCB2,Nucleobindin-2,51847,332,1.06 [0.82-1.38],0.650249108530383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDC,Nuclear migration protein nudC,52056,330,1.02 [0.88-1.19],0.7560601643118241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,43572,301,0.97 [0.63-1.51],0.902038808015996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,43292,293,0.82 [0.64-1.06],0.1329699313574732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT16,U8 snoRNA-decapping enzyme,44493,303,0.98 [0.87-1.12],0.8058124334849496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],51256,329,1.06 [0.89-1.25],0.5114022160202147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT5,ADP-sugar pyrophosphatase,51506,328,1.09 [0.90-1.32],0.3552841702560074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUMB,Protein numb homolog,43466,294,0.97 [0.85-1.11],0.6747441029298746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUP50,Nuclear pore complex protein Nup50,43292,293,0.80 [0.55-1.18],0.2639582913956702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPE4,NXPE family member 4,43292,293,1.24 [0.93-1.64],0.1388855220709229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH1,Neurexophilin-1,50288,323,1.08 [0.84-1.39],0.5605588695611206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH3,Neurexophilin-3,43466,294,0.75 [0.52-1.09],0.129105331788652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OBP2B,Odorant-binding protein 2b,50925,326,0.89 [0.76-1.04],0.1445949329139935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OCLN,Occludin,44680,305,0.85 [0.66-1.11],0.2303131757849843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ODAM,Odontogenic ameloblast-associated protein,50203,322,1.04 [0.87-1.24],0.6758792666456026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OFD1,Oral-facial-digital syndrome 1 protein,43946,299,0.93 [0.77-1.11],0.4270631237978389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGA,Protein O-GlcNAcase,44569,304,1.04 [0.89-1.21],0.6269559894725389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGFR,Opioid growth factor receptor,51256,329,0.94 [0.69-1.27],0.6736371574254798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGN,Mimecan,51506,328,1.25 [1.00-1.57],0.0513811932995706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,43946,299,0.93 [0.77-1.12],0.435469757904556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLFM4,Olfactomedin-4,42151,285,1.03 [0.94-1.13],0.5570656258464943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,50992,321,1.22 [1.05-1.42],0.0098300908938098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMD,Osteomodulin,51715,329,0.87 [0.70-1.09],0.2235215095873829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMG,Oligodendrocyte-myelin glycoprotein,51256,329,0.90 [0.77-1.04],0.1414627156624397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMP,Olfactory marker protein,43318,298,1.10 [0.89-1.36],0.3703558212791596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPHN1,Oligophrenin-1,44654,304,1.01 [0.91-1.12],0.8589488386436457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPLAH,5-oxoprolinase,43572,301,0.99 [0.84-1.16],0.8595253356492224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPTC,Opticin,51256,329,0.89 [0.71-1.11],0.3038989916176005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ORM1,Alpha-1-acid glycoprotein 1,44670,305,1.52 [0.89-2.60],0.1219187076759417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSBPL2,Oxysterol-binding protein-related protein 2,44654,304,0.88 [0.65-1.19],0.4042957150497561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSCAR,Osteoclast-associated immunoglobulin-like receptor,51546,329,1.11 [0.83-1.47],0.4817947728370043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSM,Oncostatin-M,51174,327,1.15 [1.01-1.32],0.0418408845919309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSMR,Oncostatin-M-specific receptor subunit beta,51783,331,1.81 [1.13-2.92],0.0143989322797578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSTN,Osteocrin,43533,300,1.11 [0.86-1.42],0.4165680624017874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTOA,Otoancorin,43318,298,0.90 [0.71-1.13],0.347122615791121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD6B,Deubiquitinase OTUD6B,44569,304,1.02 [0.84-1.23],0.8507484954402483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD7B,OTU domain-containing protein 7B,44680,305,1.08 [0.91-1.29],0.3706065509311836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",43572,301,1.09 [0.93-1.28],0.2628612904329798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXT,Oxytocin-neurophysin 1,51944,331,0.93 [0.87-1.00],0.0490928982494925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,51240,329,0.87 [0.68-1.13],0.3002160014677917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PACS2,Phosphofurin acidic cluster sorting protein 2,43292,293,1.12 [0.94-1.34],0.2185942489104079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI2,Protein-arginine deiminase type-2,50524,322,1.07 [0.91-1.25],0.4114360900448752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI4,Protein-arginine deiminase type-4,50203,322,1.03 [0.91-1.17],0.6599813259992673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAEP,Glycodelin,51093,326,1.03 [0.95-1.12],0.4630768085344776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,44680,305,0.98 [0.89-1.08],0.7381295883808142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",43946,299,1.04 [0.83-1.29],0.7596829506667657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,50550,323,0.93 [0.77-1.11],0.4054533474541327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAGR1,PAXIP1-associated glutamate-rich protein 1,43572,301,0.92 [0.71-1.20],0.5502958020183314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,43082,294,0.93 [0.75-1.16],0.514287716845061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAK4,Serine/threonine-protein kinase PAK 4,50288,323,0.93 [0.79-1.10],0.425565392104124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALLD,Palladin,43466,294,0.77 [0.56-1.07],0.1250622190706889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM,Paralemmin-1,44325,304,0.71 [0.51-1.01],0.0548580595910364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM2,Paralemmin-2,44654,304,1.04 [0.78-1.40],0.7782063299830613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM3,Paralemmin-3,43292,293,0.95 [0.81-1.12],0.5341220100496925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAM,Peptidyl-glycine alpha-amidating monooxygenase,51876,333,0.92 [0.65-1.28],0.6090310218610399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAMR1,Inactive serine protease PAMR1,51506,328,0.88 [0.62-1.26],0.4977352459250073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAPPA,Pappalysin-1,50524,322,0.95 [0.77-1.18],0.6568959926655908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARD3,Partitioning defective 3 homolog,43946,299,0.96 [0.82-1.12],0.618233671057874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARK7,Parkinson disease protein 7,51506,328,1.13 [0.94-1.36],0.2038303817411713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARP1,Poly [ADP-ribose] polymerase 1,51419,328,0.99 [0.83-1.17],0.8799929056568756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,43784,299,0.87 [0.68-1.11],0.2597987170435386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBK,Lymphokine-activated killer T-cell-originated protein kinase,43160,294,0.93 [0.65-1.34],0.7108320403097002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBLD,Phenazine biosynthesis-like domain-containing protein,50288,323,1.02 [0.84-1.24],0.8237659251290167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,44569,304,0.59 [0.39-0.88],0.0105020370850354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCARE,Photoreceptor cilium actin regulator,43318,298,1.01 [0.89-1.15],0.8562522067577787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,43701,298,1.05 [0.83-1.33],0.6819084363096836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBP2,Poly(rC)-binding protein 2,44680,305,1.03 [0.88-1.19],0.7404680547320687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH1,Protocadherin-1,51889,328,0.83 [0.51-1.33],0.4335379286930653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH12,Protocadherin-12,44680,305,1.12 [0.73-1.72],0.6020284486225422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH17,Protocadherin-17,51493,323,1.07 [0.82-1.41],0.6039187881939692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH7,Protocadherin-7,44569,304,0.98 [0.71-1.34],0.8853207680931748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH9,Protocadherin-9,44569,304,0.97 [0.70-1.34],0.8645430851937682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDHB15,Protocadherin beta-15,44551,301,0.91 [0.69-1.21],0.5185144978112105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCNA,Proliferating cell nuclear antigen,43160,294,0.86 [0.70-1.05],0.1423257048411005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK7,Proprotein convertase subtilisin/kexin type 7,44551,301,0.97 [0.75-1.24],0.7816069396289798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK9,Proprotein convertase subtilisin/kexin type 9,52128,334,0.88 [0.69-1.13],0.3149964326540705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCYT2,Ethanolamine-phosphate cytidylyltransferase,44569,304,0.99 [0.86-1.15],0.9425293580152224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDAP1,28 kDa heat- and acid-stable phosphoprotein,44759,302,1.00 [0.90-1.12],0.9633631212273176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1,Programmed cell death protein 1,51847,330,1.10 [0.88-1.37],0.4032516931665468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1LG2,Programmed cell death 1 ligand 2,51256,329,1.36 [1.00-1.84],0.0472789459730787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD5,Programmed cell death protein 5,51944,331,1.06 [0.90-1.25],0.4880782494126178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD6,Programmed cell death protein 6,51493,323,1.00 [0.87-1.15],0.9873604250134784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCL2,Phosducin-like protein 2,43160,294,1.08 [0.89-1.32],0.4142876036720447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",43160,294,1.00 [0.81-1.22],0.9698142334697936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",43292,293,0.86 [0.69-1.06],0.1621771053770281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",43784,299,1.01 [0.90-1.12],0.902481731970604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,52128,334,0.97 [0.85-1.11],0.6448636218829321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFB,Platelet-derived growth factor subunit B,51715,329,1.01 [0.90-1.13],0.8645082775571401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFC,Platelet-derived growth factor C,50282,316,1.20 [0.86-1.69],0.2901242947829091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRA,Platelet-derived growth factor receptor alpha,51493,323,0.82 [0.58-1.17],0.2779792347330472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRB,Platelet-derived growth factor receptor beta,52128,334,0.95 [0.72-1.26],0.7424237614872037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA2,Protein disulfide-isomerase A2,43160,294,1.12 [0.86-1.45],0.3922250431878898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA3,Protein disulfide-isomerase A3,43784,299,0.97 [0.62-1.51],0.8788447335522919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,44764,304,1.00 [0.84-1.20],0.966656086221892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA5,Protein disulfide-isomerase A5,43160,294,0.90 [0.74-1.10],0.3054803048825801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM5,PDZ and LIM domain protein 5,44680,305,1.04 [0.94-1.14],0.4625355581573134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM7,PDZ and LIM domain protein 7,51715,329,1.03 [0.95-1.11],0.5191395436377514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",50282,316,0.96 [0.78-1.18],0.6868941594931524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDRG1,p53 and DNA damage-regulated protein 1,43533,300,0.92 [0.73-1.15],0.4532678543544766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,43160,294,0.85 [0.67-1.09],0.2052212746594084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZD2,PDZ domain-containing protein 2,43292,293,1.03 [0.85-1.24],0.7670484494532721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,43466,294,0.78 [0.59-1.03],0.0788953008104936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEAR1,Platelet endothelial aggregation receptor 1,52128,334,1.05 [0.68-1.60],0.8281868163182142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEBP1,Phosphatidylethanolamine-binding protein 1,51506,328,1.07 [0.91-1.27],0.3948840499639268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,51506,328,0.92 [0.67-1.28],0.6337118387540231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECR,Peroxisomal trans-2-enoyl-CoA reductase,43572,301,1.10 [0.76-1.60],0.6116114362608951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PENK,Proenkephalin-A,43784,299,0.82 [0.57-1.19],0.2992381541200102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEPD,Xaa-Pro dipeptidase,44798,305,0.79 [0.52-1.20],0.2765028939810681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PER3,Period circadian protein homolog 3,43466,294,0.98 [0.89-1.08],0.67935850444219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,44495,305,0.96 [0.86-1.07],0.4818504044782149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN2,Prefoldin subunit 2,50288,323,1.06 [0.89-1.26],0.5248515829219489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN4,Prefoldin subunit 4,43160,294,1.00 [0.81-1.24],0.9924278550234203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN6,Prefoldin subunit 6,43533,300,1.11 [0.95-1.29],0.1858461730418426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",51172,328,1.04 [0.91-1.18],0.5843330569527692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGA4,Pepsin A-4,44798,305,1.04 [0.90-1.21],0.609124256798903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",44759,302,1.15 [0.95-1.41],0.1591961307920587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGF,Placenta growth factor,52056,330,1.07 [0.73-1.57],0.7145713400711211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP1,Peptidoglycan recognition protein 1,51876,332,1.19 [0.96-1.48],0.1163440943020757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,44262,302,0.84 [0.59-1.21],0.3518675210927139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP4,Peptidoglycan recognition protein 4,43292,293,1.06 [0.89-1.26],0.528766725209076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGM2,Phosphoglucomutase-2,43533,300,1.08 [0.91-1.28],0.3798079515432835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGR,Progesterone receptor,43466,294,0.92 [0.81-1.04],0.1870598325366756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHACTR2,Phosphatase and actin regulator 2,44680,305,1.04 [0.94-1.14],0.4634012848693364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB1,Pleckstrin homology-like domain family B member 1,44569,304,1.03 [0.83-1.27],0.791544268034436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB2,Pleckstrin homology-like domain family B member 2,43160,294,0.91 [0.80-1.04],0.1679559864824784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,51093,326,1.46 [1.05-2.02],0.0231604403228158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,43784,299,0.91 [0.70-1.18],0.46925297938121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI16,Peptidase inhibitor 16,44798,305,0.79 [0.51-1.23],0.3060390784610772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI3,Elafin,50815,327,1.24 [1.05-1.46],0.0115215540437228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",44680,305,1.00 [0.87-1.15],0.9621533294132067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIGR,Polymeric immunoglobulin receptor,50837,324,0.92 [0.70-1.20],0.5306429568583542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,51419,328,1.04 [0.89-1.21],0.6595372163669855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,51506,328,0.98 [0.69-1.40],0.9063163150158584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,43466,294,0.89 [0.72-1.11],0.2960990499626723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRA,Paired immunoglobulin-like type 2 receptor alpha,51506,328,0.91 [0.72-1.15],0.433390580227913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRB,Paired immunoglobulin-like type 2 receptor beta,51493,323,0.96 [0.81-1.14],0.6338556935414987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,43784,299,1.01 [0.86-1.18],0.9460274711969668
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PITHD1,PITH domain-containing protein 1,43082,294,1.08 [0.95-1.23],0.267972191626705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD1,Polycystin-1,44759,302,1.06 [0.70-1.60],0.7955195931373595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD2,Polycystin-2,43292,293,0.93 [0.76-1.13],0.4726108839490271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKLR,Pyruvate kinase PKLR,51547,329,1.02 [0.88-1.18],0.7623454928546045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKN3,Serine/threonine-protein kinase N3,43946,299,1.01 [0.87-1.17],0.8973623626810384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G10,Group 10 secretory phospholipase A2,51093,326,1.08 [0.91-1.28],0.363020976932196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G15,Phospholipase A2 group XV,51651,329,1.31 [0.91-1.87],0.1441155334234616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G1B,Phospholipase A2,52044,334,0.93 [0.75-1.16],0.5425768785456231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G2A,"Phospholipase A2, membrane associated",51392,328,0.95 [0.79-1.14],0.5660486691333282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G4A,Cytosolic phospholipase A2,51715,329,1.02 [0.91-1.14],0.7305957393583181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G7,Platelet-activating factor acetylhydrolase,51506,328,1.03 [0.76-1.40],0.8344968192619353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAT,Tissue-type plasminogen activator,51958,333,0.88 [0.72-1.06],0.172422620806174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAU,Urokinase-type plasminogen activator,51506,328,0.97 [0.69-1.35],0.8537826932307198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAUR,Urokinase plasminogen activator surface receptor,51125,327,1.46 [1.04-2.07],0.030069476322868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLB1,"Phospholipase B1, membrane-associated",44654,304,0.98 [0.82-1.18],0.8577242187706471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",43466,294,0.91 [0.70-1.20],0.5023391436990214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",44654,304,0.97 [0.87-1.09],0.5978923580667239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLEKHO1,Pleckstrin homology domain-containing family O member 1,44654,304,0.97 [0.83-1.14],0.7349063456181932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,43688,298,0.75 [0.45-1.24],0.257103320723086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN1,Perilipin-1,50288,323,0.88 [0.65-1.18],0.395691117351226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN3,Perilipin-3,51493,323,0.99 [0.79-1.25],0.92656875088848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLPBP,Pyridoxal phosphate homeostasis protein,51493,323,1.04 [0.90-1.20],0.6330239949432932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLSCR3,Phospholipid scramblase 3,44569,304,1.01 [0.83-1.21],0.95644739108026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLTP,Phospholipid transfer protein,51961,333,1.06 [0.81-1.39],0.6484097496665591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,50282,316,0.55 [0.38-0.79],0.0013518375331466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC2,Plexin domain-containing protein 2,44654,304,0.97 [0.64-1.45],0.8685231074547318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNA4,Plexin-A4,51419,328,0.97 [0.86-1.09],0.6020968437279406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB2,Plexin-B2,51875,333,1.04 [0.69-1.56],0.853389463651975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB3,Plexin-B3,51324,322,1.00 [0.81-1.23],0.998684120606636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,51248,322,1.03 [0.97-1.09],0.3115829637283384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMCH,Pro-MCH,43292,293,1.04 [0.92-1.18],0.5312725736523592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMM2,Phosphomannomutase 2,43292,293,1.09 [0.90-1.31],0.3822271815578814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMS1,PMS1 protein homolog 1,43533,300,0.93 [0.74-1.17],0.5545943052815523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMVK,Phosphomevalonate kinase,50207,323,1.02 [0.93-1.12],0.632856694524963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIP,Pancreatic triacylglycerol lipase,44798,305,0.87 [0.73-1.04],0.1241799822722809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,44654,304,0.83 [0.72-0.95],0.0079683424045264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP2,Pancreatic lipase-related protein 2,51461,329,1.00 [0.97-1.03],0.8562333073685628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA1,Paraneoplastic antigen Ma1,43572,301,1.01 [0.83-1.23],0.9069656269985066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA2,Paraneoplastic antigen Ma2,43318,298,1.16 [0.92-1.47],0.2068064270093676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",50524,322,0.99 [0.91-1.08],0.8722630196258468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL,Podocalyxin,51256,329,0.53 [0.28-1.00],0.0492139675234737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,51651,329,0.68 [0.48-0.96],0.0307400974551082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POF1B,Protein POF1B,43466,294,1.12 [0.89-1.41],0.347947405958794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2A,DNA-directed RNA polymerase II subunit RPB1,43466,294,0.84 [0.56-1.24],0.3706965772000371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",51256,329,0.95 [0.72-1.27],0.7435680646626617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POMC,Pro-opiomelanocortin,43572,301,1.03 [0.88-1.20],0.7547352674713729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON1,Serum paraoxonase/arylesterase 1,44798,305,0.70 [0.48-1.03],0.0703530066329134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON2,Serum paraoxonase/arylesterase 2,50550,323,0.88 [0.66-1.17],0.3792549449742851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON3,Serum paraoxonase/lactonase 3,51715,329,0.77 [0.57-1.03],0.0773187300242996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,44764,304,0.85 [0.64-1.15],0.2969056008330217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,44495,305,0.96 [0.85-1.10],0.5611348137976573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPCDC,Phosphopantothenoylcysteine decarboxylase,51944,331,1.03 [0.84-1.27],0.7581012141613558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIB,Peptidyl-prolyl cis-trans isomerase B,51538,328,1.02 [0.92-1.13],0.7588749406560041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIE,Peptidyl-prolyl cis-trans isomerase E,43946,299,1.00 [0.83-1.19],0.967614879113898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",44764,304,1.05 [0.89-1.25],0.5533742291860915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPL,Periplakin,43466,294,1.07 [0.76-1.50],0.7110330268421765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1A,Protein phosphatase 1A,50282,316,1.07 [0.79-1.45],0.6727934652171879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1B,Protein phosphatase 1B,43466,294,0.92 [0.76-1.12],0.4296074751211295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1F,Protein phosphatase 1F,44759,302,1.02 [0.83-1.26],0.8289260613416365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPME1,Protein phosphatase methylesterase 1,51256,329,1.05 [0.89-1.23],0.5738886451569178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,44551,301,1.04 [0.91-1.18],0.5986502208322331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,51651,329,0.99 [0.90-1.10],0.8633143775525992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,43946,299,0.92 [0.78-1.09],0.3214921458693186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,44680,305,0.96 [0.83-1.11],0.5725659264056625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,44680,305,0.92 [0.69-1.24],0.5825912119678873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R2,Protein phosphatase inhibitor 2,51493,323,1.04 [0.92-1.18],0.5014518659687504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R9B,Neurabin-2,52056,330,1.01 [0.91-1.12],0.8663889663961818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,44569,304,1.01 [0.92-1.10],0.8848104874527937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP3R1,Calcineurin subunit B type 1,51093,326,1.03 [0.81-1.30],0.8320644270233557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPT1,Palmitoyl-protein thioesterase 1,43533,300,0.98 [0.85-1.14],0.8095346562648855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPY,Pancreatic prohormone,51410,329,0.96 [0.87-1.05],0.3610497460606146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,50282,316,0.89 [0.73-1.08],0.2290024536269327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAME,Melanoma antigen preferentially expressed in tumors,43160,294,0.77 [0.49-1.21],0.2591858218916921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAP1,Proline-rich acidic protein 1,44764,304,1.12 [0.85-1.47],0.4312227424160821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRC1,Protein regulator of cytokinesis 1,44551,301,1.07 [0.85-1.33],0.5662068996225256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRCP,Lysosomal Pro-X carboxypeptidase,51803,334,0.90 [0.66-1.23],0.5117463338481587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX1,Peroxiredoxin-1,50034,320,1.02 [0.91-1.14],0.716129008640585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX2,Peroxiredoxin-2,44041,294,0.95 [0.79-1.13],0.543906863222156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",50524,322,1.04 [0.91-1.19],0.5512787842827174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX5,"Peroxiredoxin-5, mitochondrial",52056,330,1.12 [0.96-1.30],0.137073753177968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX6,Peroxiredoxin-6,51932,332,1.01 [0.86-1.19],0.8731880296229342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PREB,Prolactin regulatory element-binding protein,50524,322,1.27 [0.93-1.73],0.1297989212080823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRELP,Prolargin,51461,329,1.24 [0.81-1.90],0.326508119181455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG2,Bone marrow proteoglycan,44764,304,1.07 [0.87-1.32],0.5090251032150523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG3,Proteoglycan 3,44764,304,0.85 [0.69-1.07],0.1624825658817729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,50524,322,1.02 [0.85-1.23],0.8124930416728536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,43533,300,1.11 [0.79-1.54],0.557638445874764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,51493,323,0.99 [0.88-1.11],0.856819524891253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,44569,304,1.02 [0.89-1.17],0.747835505363724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKCQ,Protein kinase C theta type,50524,322,1.03 [0.82-1.29],0.8235094122248521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKD2,Serine/threonine-protein kinase D2,43292,293,0.92 [0.70-1.20],0.52446690353769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKG1,cGMP-dependent protein kinase 1,43784,299,1.01 [0.92-1.10],0.9011215549812333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,50282,316,1.02 [0.88-1.19],0.7506838878846327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRL,Prolactin,51944,331,1.01 [0.88-1.15],0.9184764301950034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRND,Prion-like protein doppel,44654,304,0.99 [0.80-1.22],0.9115791060197184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROC,Vitamin K-dependent protein C,51615,331,1.44 [0.98-2.11],0.0609625893632675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROCR,Endothelial protein C receptor,43292,293,1.01 [0.73-1.39],0.9417916150938048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROK1,Prokineticin-1,51419,328,1.01 [0.85-1.19],0.9476790702520363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROS1,Vitamin K-dependent protein S,44829,305,0.89 [0.58-1.36],0.5823521509683192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,43461,298,0.81 [0.68-0.96],0.0151293949097031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR5,Proline-rich protein 5,43466,294,0.81 [0.63-1.06],0.1286082438116177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,43572,301,0.65 [0.49-0.88],0.0050321695363469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,51698,331,0.98 [0.82-1.17],0.8052766986664883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS22,Brain-specific serine protease 4,43466,294,0.78 [0.55-1.11],0.1710073405407104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS27,Serine protease 27,51325,322,1.03 [0.81-1.32],0.8045456834118287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS53,Serine protease 53,44654,304,0.94 [0.70-1.26],0.6847067583928802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS8,Prostasin,51293,328,0.99 [0.78-1.26],0.9481701936460551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,50288,323,1.02 [0.94-1.12],0.6108295183512152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTG,Protogenin,51932,332,1.05 [0.71-1.55],0.8191820086263546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTN3,Myeloblastin,50204,320,1.12 [0.93-1.36],0.2335806430124277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRUNE2,Protein prune homolog 2,43946,299,0.81 [0.54-1.22],0.3055852925225613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAP,Prosaposin,44344,301,0.99 [0.67-1.46],0.9400143083431978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAPL1,Proactivator polypeptide-like 1,44569,304,0.82 [0.66-1.02],0.072032984059689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSCA,Prostate stem cell antigen,44569,304,0.98 [0.94-1.02],0.3433270626452445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSG1,Pregnancy-specific beta-1-glycoprotein 1,51093,326,1.06 [0.97-1.16],0.1737571981388212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSIP1,PC4 and SFRS1-interacting protein,51419,328,1.01 [0.87-1.17],0.9273507312368972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMA1,Proteasome subunit alpha type-1,50282,316,1.03 [0.83-1.28],0.7644175877709177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMC3,26S proteasome regulatory subunit 6A,43160,294,0.89 [0.61-1.29],0.5247043314561929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD1,26S proteasome non-ATPase regulatory subunit 1,44680,305,0.98 [0.79-1.23],0.8867540941718801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD5,26S proteasome non-ATPase regulatory subunit 5,43533,300,0.95 [0.77-1.17],0.6302995797751825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD9,26S proteasome non-ATPase regulatory subunit 9,51256,329,1.04 [0.87-1.23],0.6768521738956055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME1,Proteasome activator complex subunit 1,51010,325,1.11 [0.86-1.44],0.4313872001273339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME2,Proteasome activator complex subunit 2,50855,326,1.07 [0.82-1.39],0.6391050968052836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG3,Proteasome assembly chaperone 3,51419,328,0.99 [0.82-1.20],0.93473860371531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG4,Proteasome assembly chaperone 4,43466,294,1.06 [0.88-1.28],0.5275581607957951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSPN,Persephin,51419,328,0.94 [0.85-1.05],0.2763195375307067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSRC1,Proline/serine-rich coiled-coil protein 1,50282,316,1.01 [0.86-1.20],0.8809569533413746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,42219,292,1.00 [0.90-1.11],0.974591761790032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",50288,323,1.04 [0.75-1.43],0.8357443909614108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGDS,Prostaglandin-H2 D-isomerase,51109,330,1.28 [0.94-1.74],0.1149976828901455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGES2,Prostaglandin E synthase 2,43133,292,1.17 [0.96-1.43],0.125379095977482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGR1,Prostaglandin reductase 1,44759,302,0.89 [0.78-1.02],0.0891163537606192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH,Parathyroid hormone,43533,300,1.04 [0.91-1.19],0.5906575685089981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,51419,328,1.02 [0.79-1.31],0.895249254629672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTK7,Inactive tyrosine-protein kinase 7,50288,323,1.23 [0.95-1.59],0.1230308802603737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTN,Pleiotrophin,50550,323,1.09 [0.89-1.32],0.4104921873046069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,43466,294,0.85 [0.68-1.07],0.1728993000833285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,51093,326,1.00 [0.88-1.13],0.9679359376546112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,51631,329,1.05 [0.94-1.17],0.4325067688747013
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,43387,294,1.05 [0.79-1.39],0.7584754301324215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRB,Receptor-type tyrosine-protein phosphatase beta,44759,302,0.77 [0.53-1.12],0.1726533930209323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRC,Receptor-type tyrosine-protein phosphatase C,44764,304,0.84 [0.52-1.36],0.4790300616526826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,52128,334,0.67 [0.48-0.94],0.0197329286934697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRH,Receptor-type tyrosine-protein phosphatase H,44569,304,1.23 [0.99-1.53],0.0673611595971552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,44569,304,0.53 [0.30-0.94],0.029234615283441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRM,Receptor-type tyrosine-protein phosphatase mu,51335,327,0.82 [0.55-1.23],0.3475647628530591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,50924,326,0.81 [0.60-1.10],0.1715605421067889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRR,Receptor-type tyrosine-protein phosphatase R,44654,304,0.81 [0.60-1.09],0.1701400183660392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRS,Receptor-type tyrosine-protein phosphatase S,52128,334,0.90 [0.61-1.32],0.585623477780737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,44759,302,0.80 [0.56-1.12],0.1925132154894681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,43784,299,1.04 [0.86-1.25],0.6796504903340965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTS,6-pyruvoyl tetrahydrobiopterin synthase,50051,322,1.00 [0.83-1.20],0.9750622811953688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTTG1,Securin,43946,299,1.10 [0.86-1.42],0.4513619157334714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTX3,Pentraxin-related protein PTX3,51419,328,1.01 [0.83-1.24],0.889892696223343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVALB,Parvalbumin alpha,51696,329,1.07 [0.98-1.17],0.1214946898170139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVR,Poliovirus receptor,51944,331,1.13 [0.87-1.46],0.3585371738804261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXDNL,Peroxidasin-like protein,44551,301,0.97 [0.80-1.19],0.7896363175663025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXN,Paxillin,50288,323,1.05 [0.87-1.26],0.6064050466100699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYDC1,Pyrin domain-containing protein 1,43572,301,0.93 [0.71-1.22],0.6015731969937361
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYY,Peptide YY,43292,293,1.04 [0.93-1.17],0.478152910447543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PZP,Pregnancy zone protein,44829,305,1.07 [0.86-1.33],0.5270854484569545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QDPR,Dihydropteridine reductase,51242,320,1.05 [0.83-1.32],0.6906943110288586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QPCT,Glutaminyl-peptide cyclotransferase,51548,333,0.82 [0.58-1.18],0.2912864579674916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QSOX1,Sulfhydryl oxidase 1,43921,299,0.78 [0.55-1.11],0.1660904291298681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB10,Ras-related protein Rab-10,44759,302,1.02 [0.83-1.25],0.836321913698244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB11FIP3,Rab11 family-interacting protein 3,44759,302,0.98 [0.89-1.09],0.7508518458938618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB27B,Ras-related protein Rab-27B,44759,302,0.96 [0.84-1.10],0.5845352268447183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB2B,Ras-related protein Rab-2B,44551,301,1.06 [0.89-1.27],0.5141448192211611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB33A,Ras-related protein Rab-33A,43292,293,1.03 [0.87-1.22],0.7508568990231786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,50524,322,0.95 [0.84-1.08],0.4634861196356528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB39B,Ras-related protein Rab-39B,43292,293,0.97 [0.85-1.10],0.6202165833761213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,43318,298,0.94 [0.76-1.15],0.548690037792329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB44,Ras-related protein Rab-44,44551,301,0.97 [0.76-1.24],0.8199338643667402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6A,Ras-related protein Rab-6A,51419,328,0.94 [0.76-1.16],0.5705246648466723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6B,Ras-related protein Rab-6B,50288,323,1.06 [0.87-1.30],0.5494265923860979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEP1,Rab GTPase-binding effector protein 1,43784,299,1.01 [0.87-1.16],0.9025694436503988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEPK,Rab9 effector protein with kelch motifs,50282,316,0.92 [0.77-1.11],0.3908680572755758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABGAP1L,Rab GTPase-activating protein 1-like,50524,322,1.12 [0.95-1.31],0.1752690763771393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAC3,Ras-related C3 botulinum toxin substrate 3,43533,300,0.99 [0.84-1.16],0.863142587381986
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD23B,UV excision repair protein RAD23 homolog B,50282,316,1.15 [0.93-1.41],0.1957736248280198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD51,DNA repair protein RAD51 homolog 1,43946,299,0.95 [0.77-1.18],0.6681842705236027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALB,Ras-related protein Ral-B,43466,294,0.82 [0.56-1.20],0.3113931779214042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALY,RNA-binding protein Raly,44551,301,1.01 [0.81-1.26],0.9223980467144846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP1,Ran-specific GTPase-activating protein,43572,301,0.96 [0.78-1.19],0.7120569325947929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP2,E3 SUMO-protein ligase RanBP2,43318,298,0.83 [0.59-1.18],0.303184549582743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANGAP1,Ran GTPase-activating protein 1,50282,316,1.00 [0.82-1.24],0.9637821181116282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAP1A,Ras-related protein Rap-1A,43466,294,1.00 [0.85-1.18],0.9912570057639182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAPGEF2,Rap guanine nucleotide exchange factor 2,43946,299,0.97 [0.78-1.20],0.7553130391739864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES1,Retinoic acid receptor responder protein 1,50282,316,1.08 [0.81-1.44],0.5884634801791205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES2,Retinoic acid receptor responder protein 2,51783,331,1.21 [1.00-1.47],0.0516332631742856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASA1,Ras GTPase-activating protein 1,50288,323,0.87 [0.64-1.18],0.3607510027677969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,43160,294,1.06 [0.83-1.37],0.6381415025814581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASSF2,Ras association domain-containing protein 2,50282,316,0.98 [0.82-1.16],0.8029074246638842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,44680,305,1.59 [1.29-1.97],1.8925026755953653e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBKS,Ribokinase,50290,324,1.03 [0.85-1.25],0.7794313011887726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM17,Splicing factor 45,44680,305,1.01 [0.88-1.17],0.8388833583982716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM19,Probable RNA-binding protein 19,43292,293,1.06 [0.84-1.33],0.6088356092971428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM25,RNA-binding protein 25,43160,294,0.93 [0.73-1.19],0.5646631749694633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP1,Retinol-binding protein 1,43533,300,1.03 [0.89-1.20],0.6793438123620443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,51256,329,0.81 [0.71-0.93],0.0019002547700002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP5,Retinol-binding protein 5,51256,329,1.17 [0.98-1.38],0.0753599846788757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP7,Retinoid-binding protein 7,44569,304,0.90 [0.75-1.08],0.2674356930119346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS,RNA-binding protein with multiple splicing,43466,294,0.83 [0.68-1.02],0.0714063678882238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS2,RNA-binding protein with multiple splicing 2,43572,301,0.99 [0.89-1.10],0.8079930262961613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCC1,Regulator of chromosome condensation,44551,301,0.96 [0.77-1.19],0.6859929788575018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCOR1,REST corepressor 1,50550,323,1.10 [0.90-1.34],0.3596297826261424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,43572,301,0.95 [0.56-1.62],0.8475612884848032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REEP4,Receptor expression-enhancing protein 4,44680,305,0.98 [0.82-1.17],0.8040757316574815
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1A,Lithostathine-1-alpha,51192,329,1.09 [0.90-1.32],0.374473879620753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1B,Lithostathine-1-beta,52128,334,1.10 [0.93-1.29],0.267780663237612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3A,Regenerating islet-derived protein 3-alpha,52128,334,1.00 [0.86-1.16],0.9875422211846244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3G,Regenerating islet-derived protein 3-gamma,44551,301,1.14 [0.87-1.49],0.3333655710773583
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG4,Regenerating islet-derived protein 4,51546,329,0.89 [0.73-1.08],0.2394915695967163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELB,Transcription factor RelB,43466,294,1.06 [0.85-1.32],0.5887400437346924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELT,Tumor necrosis factor receptor superfamily member 19L,51506,328,0.79 [0.56-1.13],0.1989585035300276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REN,Renin,51493,323,0.98 [0.86-1.11],0.7586251782413844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REPS1,RalBP1-associated Eps domain-containing protein 1,43466,294,0.84 [0.62-1.14],0.2589141948287937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REST,RE1-silencing transcription factor,43160,294,0.90 [0.65-1.26],0.5485041707178508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,51256,329,0.85 [0.66-1.09],0.1942674295185728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RETN,Resistin,51377,331,1.06 [0.85-1.33],0.5970135199375988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REXO2,"Oligoribonuclease, mitochondrial",43292,293,0.98 [0.78-1.24],0.8930085311000977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,44551,301,0.68 [0.39-1.17],0.1619660619561311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGCC,Regulator of cell cycle RGCC,44680,305,1.02 [0.88-1.18],0.7902402666048964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,43946,299,0.98 [0.82-1.17],0.7848762521620344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMA,Repulsive guidance molecule A,51944,331,0.74 [0.54-1.00],0.0531956163179484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMB,RGM domain family member B,51944,331,0.81 [0.56-1.16],0.2490509032167907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS10,Regulator of G-protein signaling 10,44680,305,0.98 [0.82-1.18],0.8534274768832435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS8,Regulator of G-protein signaling 8,50524,322,1.10 [0.96-1.26],0.1623945704077807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RHOC,Rho-related GTP-binding protein RhoC,50789,325,1.04 [0.96-1.14],0.3137318816187179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RICTOR,Rapamycin-insensitive companion of mTOR,43466,294,1.04 [0.84-1.30],0.7052503353840146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,43784,299,1.00 [0.80-1.25],0.9722917355482096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILP,Rab-interacting lysosomal protein,51781,329,1.09 [0.93-1.28],0.2838348286035204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILPL2,RILP-like protein 2,44759,302,1.01 [0.90-1.13],0.9064035962813916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,43292,293,0.84 [0.69-1.01],0.068902607083469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN1,Prorelaxin H1,44680,305,0.87 [0.69-1.09],0.2319665339062425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN2,Prorelaxin H2,43703,299,0.97 [0.84-1.10],0.6090649637879008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE1,Ribonuclease pancreatic,44798,305,1.09 [0.71-1.68],0.6862483161452371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE10,Inactive ribonuclease-like protein 10,43572,301,0.90 [0.71-1.15],0.4050331845467915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE3,Eosinophil cationic protein,51247,322,0.98 [0.89-1.07],0.5965799188185484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE4,Ribonuclease 4,43310,295,0.89 [0.58-1.34],0.5708842857135445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE6,Ribonuclease K6,44477,303,1.18 [0.84-1.64],0.3371254588049793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASEH2A,Ribonuclease H2 subunit A,44680,305,0.89 [0.71-1.13],0.341437404139371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASET2,Ribonuclease T2,51882,334,1.06 [0.74-1.52],0.7362498062399356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF149,E3 ubiquitin-protein ligase RNF149,43572,301,1.18 [0.83-1.67],0.3644831400824984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF168,E3 ubiquitin-protein ligase RNF168,43466,294,0.72 [0.52-0.98],0.036033418875343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,43466,294,0.57 [0.39-0.83],0.0038152621723895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF4,E3 ubiquitin-protein ligase RNF4,43946,299,0.96 [0.80-1.14],0.617060193046819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF41,E3 ubiquitin-protein ligase NRDP1,50282,316,0.98 [0.85-1.14],0.814530309902094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF43,E3 ubiquitin-protein ligase RNF43,43946,299,1.13 [0.95-1.33],0.1586768067865623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF5,E3 ubiquitin-protein ligase RNF5,43572,301,1.02 [0.87-1.19],0.8249840754553315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO1,Roundabout homolog 1,51546,329,0.96 [0.64-1.44],0.8314287797311215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO2,Roundabout homolog 2,51944,331,1.03 [0.67-1.56],0.9022414387754188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO4,Roundabout homolog 4,43572,301,1.04 [0.56-1.95],0.892859942363051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,51493,323,1.16 [0.85-1.58],0.3362119865969991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,51256,329,0.93 [0.74-1.18],0.5592068011371052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPA2,Replication protein A 32 kDa subunit,43466,294,1.02 [0.71-1.45],0.9335028333437532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPE,Ribulose-phosphate 3-epimerase,43946,299,0.96 [0.82-1.12],0.5969731564908345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPGR,X-linked retinitis pigmentosa GTPase regulator,43533,300,0.75 [0.55-1.02],0.0640580963697144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPL14,60S ribosomal protein L14,43572,301,0.92 [0.69-1.22],0.5474882760131625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPS10,40S ribosomal protein S10,43292,293,0.99 [0.75-1.30],0.933847384295987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRAS,Ras-related protein R-Ras,43533,300,1.00 [0.92-1.09],0.9125865536020866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2,Ribonucleoside-diphosphate reductase subunit M2,50282,316,1.10 [0.92-1.32],0.3097923893981343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,50282,316,1.03 [0.89-1.19],0.7095775673026158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRP15,RRP15-like protein,43318,298,0.96 [0.85-1.09],0.514494780947124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO1,R-spondin-1,51093,326,1.03 [0.77-1.36],0.8618153959510235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO3,R-spondin-3,51932,332,0.85 [0.60-1.21],0.3659844047808547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,51256,329,0.70 [0.50-0.98],0.0384629083307658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTKN2,Rhotekin-2,43292,293,0.95 [0.76-1.20],0.6864261610144781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",44680,305,1.04 [0.92-1.17],0.5525959716934352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4R,Reticulon-4 receptor,51932,332,1.05 [0.80-1.40],0.710374687743349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RUVBL1,RuvB-like 1,50282,316,1.07 [0.98-1.17],0.1539002272928847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RWDD1,RWD domain-containing protein 1,51944,331,1.02 [0.87-1.19],0.8228064447440118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RYR1,Ryanodine receptor 1,43292,293,1.15 [0.86-1.55],0.3406311005677753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A11,Protein S100-A11,51089,322,0.95 [0.77-1.18],0.6611612024710132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A12,Protein S100-A12,50769,327,1.13 [1.00-1.28],0.0591154457607605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A13,Protein S100-A13,43466,294,1.21 [0.89-1.63],0.2225567644956817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A14,Protein S100-A14,44680,305,0.94 [0.76-1.16],0.5827671982263347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A16,Protein S100-A16,50203,322,0.91 [0.77-1.07],0.2497491038911156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A3,Protein S100-A3,44551,301,0.86 [0.65-1.15],0.3032187598382816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A4,Protein S100-A4,51651,329,1.09 [0.91-1.29],0.3505947400045868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100G,Protein S100-G,44680,305,0.86 [0.67-1.09],0.2098998059621445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100P,Protein S100-P,50550,323,1.09 [0.92-1.28],0.3296344878509654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAA4,Serum amyloid A-4 protein,44829,305,0.85 [0.55-1.32],0.4709287944333973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAFB2,Scaffold attachment factor B2,44680,305,1.10 [0.76-1.61],0.6105676160361155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAG,S-arrestin,43318,298,1.02 [0.82-1.26],0.8713343841243913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAMD9L,Sterile alpha motif domain-containing protein 9-like,51419,328,1.05 [0.92-1.20],0.4550984242172043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAP18,Histone deacetylase complex subunit SAP18,43946,299,0.91 [0.78-1.07],0.2729903149306967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SARG,Specifically androgen-regulated gene protein,44589,301,0.99 [0.90-1.10],0.8631818563685839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SART1,U4/U6.U5 tri-snRNP-associated protein 1,43292,293,1.06 [0.80-1.40],0.6706321760876006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT1,Diamine acetyltransferase 1,43292,293,0.84 [0.65-1.08],0.1642172356955503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT2,Thialysine N-epsilon-acetyltransferase,43946,299,0.95 [0.80-1.12],0.533244526008734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SATB1,DNA-binding protein SATB1,44680,305,1.19 [0.85-1.65],0.3141783058246268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SBSN,Suprabasin,44681,304,0.84 [0.61-1.16],0.2898269041411928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCAMP3,Secretory carrier-associated membrane protein 3,51256,329,0.99 [0.88-1.11],0.8084879081476772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARA5,Scavenger receptor class A member 5,51944,331,1.20 [0.87-1.65],0.275782150813896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB1,Scavenger receptor class B member 1,50288,323,1.01 [0.85-1.20],0.9107169953777972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB2,Lysosome membrane protein 2,50118,321,1.18 [0.86-1.60],0.3065003033884236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF1,Scavenger receptor class F member 1,52128,334,1.06 [0.85-1.33],0.6092759307419136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF2,Scavenger receptor class F member 2,51944,331,1.16 [0.83-1.63],0.3770427179390149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG2,Secretogranin-2,51696,329,0.69 [0.51-0.94],0.0170732870789148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,51546,329,0.69 [0.52-0.92],0.0108000210060489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB1A1,Uteroglobin,51546,329,0.84 [0.70-0.99],0.0392027387977213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB2A2,Mammaglobin-A,43292,293,1.17 [0.84-1.63],0.3576244013945687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A1,Secretoglobin family 3A member 1,43784,299,0.70 [0.45-1.08],0.109541926193195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,51631,329,0.86 [0.76-0.98],0.0258936599806765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,50524,322,0.88 [0.70-1.10],0.2626471323330473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCIN,Adseverin,43318,298,0.80 [0.68-0.95],0.0108432360629201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCLY,Selenocysteine lyase,51781,329,0.95 [0.78-1.17],0.6494967739097788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2A,Sodium channel protein type 2 subunit alpha,43318,298,1.03 [0.82-1.29],0.7896116257568921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2B,Sodium channel subunit beta-2,43533,300,0.70 [0.46-1.06],0.0921010886035923
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3A,Sodium channel protein type 3 subunit alpha,43533,300,0.84 [0.60-1.16],0.2855197854139659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3B,Sodium channel subunit beta-3,43318,298,0.92 [0.72-1.18],0.5016058733919165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN4B,Sodium channel subunit beta-4,43572,301,0.78 [0.60-1.01],0.0585698540706423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCP2,Non-specific lipid-transfer protein,50282,316,0.94 [0.82-1.08],0.3954708421098015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCPEP1,Retinoid-inducible serine carboxypeptidase,43410,300,1.01 [0.81-1.26],0.921053743877628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRG1,Scrapie-responsive protein 1,44759,302,0.78 [0.52-1.18],0.2432070922609669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRIB,Protein scribble homolog,43572,301,0.92 [0.80-1.04],0.188457222865597
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRN1,Secernin-1,51419,328,1.03 [0.86-1.23],0.7455534759732425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCT,Secretin,43533,300,0.85 [0.67-1.08],0.1910214312002373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,51493,323,0.85 [0.66-1.10],0.2207322163755995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,51493,323,0.89 [0.72-1.10],0.2749478753689661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDCCAG8,Serologically defined colon cancer antigen 8,44551,301,0.98 [0.89-1.08],0.6891264117432478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDHB,Succinate dehydrogenase,44569,304,1.01 [0.86-1.19],0.9021811087359076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDK2,Protein sidekick-2,43784,299,0.82 [0.61-1.11],0.2000018465099017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEC31A,Protein transport protein Sec31A,43572,301,0.99 [0.86-1.15],0.9440413552632188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEL1L,Protein sel-1 homolog 1,43572,301,0.92 [0.63-1.33],0.6499018650294707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,52128,334,0.76 [0.63-0.91],0.0034047051655721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELENOP,Selenoprotein P,44829,305,0.65 [0.40-1.06],0.0849623423947882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELL,L-selectin,44829,305,0.97 [0.60-1.55],0.8901959620385778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,51698,331,0.96 [0.81-1.14],0.6185357129023177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELPLG,P-selectin glycoprotein ligand 1,51419,328,0.66 [0.48-0.92],0.0126370336236027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3F,Semaphorin-3F,51493,323,1.58 [1.10-2.28],0.0140029056911268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3G,Semaphorin-3G,43784,299,0.89 [0.69-1.15],0.3760295329652365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4C,Semaphorin-4C,51256,329,1.18 [0.85-1.63],0.3157665398947636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4D,Semaphorin-4D,51944,331,1.06 [0.77-1.46],0.739174674766294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA6C,Semaphorin-6C,43466,294,0.73 [0.46-1.16],0.186187701979265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA7A,Semaphorin-7A,51958,333,0.99 [0.70-1.40],0.9526043046365305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,44680,305,0.92 [0.79-1.07],0.2795560010789841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN7,Septin-7,43946,299,0.89 [0.70-1.12],0.311381458171415
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN8,Septin-8,44569,304,1.02 [0.73-1.43],0.9167727548927656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN9,Septin-9,51256,329,1.06 [0.76-1.47],0.7462947614324362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA1,Alpha-1-antitrypsin,43988,299,1.14 [0.29-4.46],0.849579718033962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA11,Serpin A11,52128,334,1.19 [0.94-1.51],0.1541627219334377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA12,Serpin A12,50010,317,1.02 [0.93-1.12],0.6103542394538142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA3,Alpha-1-antichymotrypsin,44665,304,2.20 [1.20-4.04],0.0110914698799638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA4,Kallistatin,44008,301,0.97 [0.61-1.54],0.8837555385732171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA5,Plasma serine protease inhibitor,44177,303,0.61 [0.41-0.89],0.0113641492375615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA6,Corticosteroid-binding globulin,44829,305,0.59 [0.30-1.16],0.1260250594736653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA7,Thyroxine-binding globulin,44829,305,0.62 [0.34-1.11],0.1094646420758376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA9,Serpin A9,51014,327,0.92 [0.80-1.06],0.2461763938180439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB1,Leukocyte elastase inhibitor,51337,328,1.03 [0.92-1.14],0.6214465833812471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB5,Serpin B5,50550,323,1.02 [0.83-1.25],0.8768687616089205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB6,Serpin B6,51775,330,1.07 [0.91-1.26],0.4033486711833656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB8,Serpin B8,52056,330,0.91 [0.77-1.09],0.3062720847175172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB9,Serpin B9,51093,326,1.08 [0.80-1.45],0.6083149917864263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINC1,Antithrombin-III,44744,305,0.97 [0.46-2.02],0.9284691275754692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPIND1,Heparin cofactor 2,44744,305,1.12 [0.76-1.66],0.5564072302536389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,52128,334,0.96 [0.83-1.11],0.5664597552906393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,44759,302,0.92 [0.77-1.09],0.3256464404361616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF1,Pigment epithelium-derived factor,44150,296,0.91 [0.60-1.39],0.6627400652860946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF2,Alpha-2-antiplasmin,43987,299,0.73 [0.32-1.64],0.4394487304652932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPING1,Plasma protease C1 inhibitor,44744,305,1.03 [0.57-1.85],0.92166170629794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINH1,Serpin H1,43946,299,0.99 [0.91-1.08],0.7940056322595419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI1,Neuroserpin,43704,299,0.87 [0.60-1.27],0.4683353065307569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI2,Serpin I2,44569,304,0.87 [0.71-1.06],0.1747430207198186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,50288,323,0.96 [0.82-1.12],0.6116332270108054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SETMAR,Histone-lysine N-methyltransferase SETMAR,50925,325,1.00 [0.72-1.38],0.9969736284032394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6,Seizure protein 6 homolog,43533,300,0.63 [0.43-0.93],0.018837650281129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,51651,329,0.68 [0.48-0.97],0.0335194148787298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L2,Seizure 6-like protein 2,51256,329,1.04 [0.69-1.57],0.8549772329799952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SF3B4,Splicing factor 3B subunit 4,51256,329,1.04 [0.91-1.18],0.5581439101703239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP1,Secreted frizzled-related protein 1,50924,326,1.16 [0.93-1.45],0.180728661717015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP4,Secreted frizzled-related protein 4,43784,299,1.33 [1.01-1.75],0.0389182234015015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA1,Pulmonary surfactant-associated protein A1,50282,316,0.97 [0.81-1.17],0.7757657368854713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA2,Pulmonary surfactant-associated protein A2,50282,316,0.99 [0.82-1.21],0.9574275959903912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPD,Pulmonary surfactant-associated protein D,51493,323,1.03 [0.89-1.20],0.668913374455947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SGSH,N-sulphoglucosamine sulphohydrolase,44011,300,1.02 [0.84-1.24],0.8526831821854981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2B3,SH2B adapter protein 3,50282,316,1.01 [0.91-1.11],0.8997241394015989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2D1A,SH2 domain-containing protein 1A,51419,328,1.03 [0.88-1.22],0.6873164342320429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,43318,298,1.11 [0.94-1.31],0.2022087673806924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BP1,SH3 domain-binding protein 1,44569,304,1.03 [0.83-1.27],0.8097240727843122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GL3,Endophilin-A3,43697,298,0.97 [0.85-1.10],0.6107468174458971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GLB2,Endophilin-B2,44654,304,1.02 [0.87-1.20],0.7752906329713765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHBG,Sex hormone-binding globulin,44798,305,0.76 [0.62-0.94],0.0103923525157114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHC1,SHC-transforming protein 1,43160,294,0.98 [0.89-1.08],0.664858251698065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHD,SH2 domain-containing adapter protein D,43207,292,0.93 [0.80-1.07],0.3119914431413009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHH,Sonic hedgehog protein,43466,294,0.86 [0.66-1.13],0.2828865159575028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHISA5,Protein shisa-5,44764,304,0.93 [0.61-1.44],0.7596319149532451
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHMT1,"Serine hydroxymethyltransferase, cytosolic",51631,329,1.06 [0.94-1.19],0.3273977062215051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHPK,Sedoheptulokinase,43946,299,0.95 [0.72-1.25],0.6925458401580129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,51568,329,0.98 [0.80-1.21],0.8836696907781444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC1,Sialoadhesin,51715,329,1.05 [0.83-1.32],0.70357938485123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC10,Sialic acid-binding Ig-like lectin 10,51419,328,1.14 [0.86-1.51],0.3637273383381959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC15,Sialic acid-binding Ig-like lectin 15,50288,323,1.04 [0.92-1.18],0.5127673634720955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC5,Sialic acid-binding Ig-like lectin 5,51506,328,1.03 [0.95-1.13],0.4704880809128416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC6,Sialic acid-binding Ig-like lectin 6,51932,332,1.10 [0.82-1.46],0.5362486916376281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC7,Sialic acid-binding Ig-like lectin 7,51493,323,1.15 [0.81-1.63],0.4365489010092586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC8,Sialic acid-binding Ig-like lectin 8,43572,301,1.30 [1.02-1.65],0.0345668732883356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC9,Sialic acid-binding Ig-like lectin 9,51858,331,1.18 [0.85-1.64],0.3170455679744351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIL1,Nucleotide exchange factor SIL1,43572,301,1.04 [0.75-1.45],0.7988689061967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,51625,331,0.95 [0.81-1.12],0.5544132578559233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPB1,Signal-regulatory protein beta-1,51377,329,1.10 [0.90-1.36],0.3502928049827756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT1,NAD-dependent protein deacetylase sirtuin-1,43466,294,0.91 [0.79-1.05],0.2109259736364652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT2,NAD-dependent protein deacetylase sirtuin-2,51256,329,1.05 [0.94-1.18],0.3518656036892127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",50288,323,1.06 [0.89-1.26],0.5272342266583905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIT1,Signaling threshold-regulating transmembrane adapter 1,50524,322,0.97 [0.82-1.17],0.7794421925080833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP1,Src kinase-associated phosphoprotein 1,51008,326,0.97 [0.85-1.11],0.678030621247231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP2,Src kinase-associated phosphoprotein 2,51715,329,0.98 [0.89-1.07],0.6591061740685135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKIV2L,Helicase SKI2W,43292,293,0.96 [0.72-1.28],0.7753210502339066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLA2,Src-like-adapter 2,44680,305,1.00 [0.91-1.12],0.92557942862232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF1,Signaling lymphocytic activation molecule,50524,322,1.07 [0.91-1.27],0.4102329948311723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF6,SLAM family member 6,50282,316,0.98 [0.75-1.28],0.9016560944814276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF7,SLAM family member 7,51419,328,0.94 [0.79-1.11],0.4472836405683109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF8,SLAM family member 8,50282,316,0.98 [0.81-1.18],0.8108229828976814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC12A2,Solute carrier family 12 member 2,43292,293,0.97 [0.64-1.47],0.8936521093380345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC13A1,Solute carrier family 13 member 1,44551,301,0.87 [0.71-1.08],0.216365242126553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC16A1,Monocarboxylate transporter 1,50288,323,1.00 [0.84-1.19],0.9756092783369432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC1A4,Neutral amino acid transporter A,43533,300,0.94 [0.75-1.18],0.6158349726379746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC27A4,Long-chain fatty acid transport protein 4,50288,323,1.05 [0.91-1.21],0.534211124784165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC28A1,Sodium/nucleoside cotransporter 1,43160,294,0.99 [0.82-1.19],0.8933759748333067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC34A3,Sodium-dependent phosphate transport protein 2C,43160,294,0.87 [0.67-1.12],0.2811755344118019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A14,Zinc transporter ZIP14,50288,323,0.99 [0.74-1.34],0.9659191580576304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A5,Zinc transporter ZIP5,51419,328,0.99 [0.82-1.19],0.9269959676930464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC44A4,Choline transporter-like protein 4,43533,300,1.06 [0.91-1.23],0.4377559738822084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC4A1,Band 3 anion transport protein,44764,304,1.11 [0.89-1.39],0.3686267172119168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC51B,Organic solute transporter subunit beta,43292,293,0.89 [0.76-1.04],0.1548174566367336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,43784,299,1.00 [0.88-1.14],0.9824173815184216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,44569,304,1.00 [0.80-1.24],0.9818610579595096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",43160,294,1.01 [0.83-1.23],0.8893105063186126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIT2,Slit homolog 2 protein,50288,323,0.99 [0.82-1.20],0.954480154538662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,43466,294,0.56 [0.40-0.80],0.0012484970845046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK2,SLIT and NTRK-like protein 2,51932,332,1.06 [0.83-1.35],0.6392451244825688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK6,SLIT and NTRK-like protein 6,50550,323,0.90 [0.68-1.20],0.4792120483901368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,43946,299,1.09 [0.97-1.24],0.1510227568429497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLMAP,Sarcolemmal membrane-associated protein,44569,304,1.01 [0.89-1.16],0.8464809097241555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLURP1,Secreted Ly-6/uPAR-related protein 1,44434,304,0.95 [0.70-1.28],0.7192899340475687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD1,Mothers against decapentaplegic homolog 1,50282,316,1.01 [0.89-1.14],0.8779385515775237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD2,Mothers against decapentaplegic homolog 2,44551,301,1.03 [0.88-1.21],0.6986126475223056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD3,Mothers against decapentaplegic homolog 3,44551,301,1.02 [0.82-1.26],0.8579126811972266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD5,Mothers against decapentaplegic homolog 5,51256,329,1.01 [0.62-1.65],0.9673316774049258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMARCA2,Probable global transcription activator SNF2L2,50288,323,1.09 [0.95-1.24],0.2110241217919944
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMC3,Structural maintenance of chromosomes protein 3,43160,294,1.01 [0.82-1.24],0.9301903023798056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMNDC1,Survival of motor neuron-related-splicing factor 30,44569,304,0.96 [0.81-1.15],0.697303230831214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC1,SPARC-related modular calcium-binding protein 1,51932,332,1.05 [0.78-1.40],0.7676970470470398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC2,SPARC-related modular calcium-binding protein 2,51715,329,1.30 [1.01-1.66],0.0379203080797495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD1,Sphingomyelin phosphodiesterase,51690,328,0.94 [0.77-1.14],0.5256016646534993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD3,Sphingomyelin phosphodiesterase 3,43466,294,0.82 [0.65-1.04],0.1064113205832615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,51631,329,0.94 [0.81-1.08],0.3706890042474638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,44551,301,1.14 [1.01-1.29],0.0370216651032283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMS,Spermine synthase,43318,298,0.91 [0.75-1.09],0.3060095056541024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMTN,Smoothelin,44569,303,1.00 [0.89-1.12],0.96226666170574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP23,Synaptosomal-associated protein 23,51493,323,1.00 [0.90-1.12],0.944419352341876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP25,Synaptosomal-associated protein 25,43318,298,0.97 [0.76-1.22],0.7750196789452534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP29,Synaptosomal-associated protein 29,51651,329,1.00 [0.90-1.12],0.9441821519707008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAPIN,SNARE-associated protein Snapin,44680,305,1.02 [0.84-1.23],0.8528732017171785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCA,Alpha-synuclein,43784,299,1.01 [0.92-1.12],0.7768100653832105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCG,Gamma-synuclein,51093,326,0.94 [0.81-1.09],0.4273699494423791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",43572,301,1.04 [0.74-1.46],0.8089341298921459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNRPB2,U2 small nuclear ribonucleoprotein B'',44654,304,0.92 [0.71-1.20],0.542308179576336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNU13,NHP2-like protein 1,43292,293,0.85 [0.69-1.04],0.1041686441191156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX15,Sorting nexin-15,43784,299,1.03 [0.84-1.27],0.7547515198775823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX18,Sorting nexin-18,44569,304,1.14 [0.91-1.44],0.255363897961049
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX2,Sorting nexin-2,44551,301,1.04 [0.91-1.18],0.5714270967950397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX5,Sorting nexin-5,43572,301,0.91 [0.63-1.33],0.6377352850115574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX9,Sorting nexin-9,51493,323,1.03 [0.90-1.19],0.6435086697728725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD1,Superoxide dismutase [Cu-Zn],50459,324,1.14 [0.93-1.39],0.2009043232861333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD2,"Superoxide dismutase [Mn], mitochondrial",51506,328,1.07 [0.83-1.38],0.6104314092782456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD3,Extracellular superoxide dismutase,44798,305,1.03 [0.86-1.23],0.7356978789615715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,44680,305,1.46 [1.22-1.75],4.2817454947217045e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORCS2,VPS10 domain-containing receptor SorCS2,50282,316,0.97 [0.73-1.28],0.8197296446228567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORD,Sorbitol dehydrogenase,51696,328,1.03 [0.89-1.20],0.6555542729225344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORT1,Sortilin,51417,323,0.94 [0.72-1.23],0.6570002429204858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOST,Sclerostin,51417,323,0.74 [0.58-0.95],0.0191989885394287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,43533,300,0.92 [0.72-1.16],0.477119891372166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX2,Transcription factor SOX-2,44596,305,0.89 [0.55-1.42],0.6230076356538056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX9,Transcription factor SOX-9,43533,300,0.95 [0.63-1.43],0.8056699431685771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,44680,305,1.08 [0.75-1.54],0.6778390558582739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPAG1,Sperm-associated antigen 1,44680,305,1.07 [0.90-1.28],0.428811225145455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARC,SPARC,51651,329,0.99 [0.86-1.13],0.860579317202578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARCL1,SPARC-like protein 1,51528,329,1.10 [0.78-1.56],0.5777736894985032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPART,Spartin,43784,299,0.98 [0.85-1.14],0.8065978621091544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPESP1,Sperm equatorial segment protein 1,44759,302,1.25 [0.89-1.75],0.1982433951570966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK1,Serine protease inhibitor Kazal-type 1,51506,328,0.94 [0.74-1.19],0.6159977116800954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK2,Serine protease inhibitor Kazal-type 2,43784,299,1.07 [0.79-1.45],0.6527893125949855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK4,Serine protease inhibitor Kazal-type 4,51419,328,0.94 [0.81-1.09],0.4042161331757773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK5,Serine protease inhibitor Kazal-type 5,51506,328,1.14 [0.85-1.51],0.3809545146932636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK6,Serine protease inhibitor Kazal-type 6,51932,332,1.03 [0.86-1.23],0.7635134131956864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK8,Serine protease inhibitor Kazal-type 8,43292,293,1.04 [0.77-1.40],0.7917093687951717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT1,Kunitz-type protease inhibitor 1,51336,326,1.14 [0.78-1.67],0.5025538419786146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT2,Kunitz-type protease inhibitor 2,51715,329,0.95 [0.74-1.20],0.653881316385508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT3,Kunitz-type protease inhibitor 3,44569,304,0.99 [0.92-1.07],0.8099453239387939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPOCK1,Testican-1,51093,326,0.95 [0.65-1.39],0.777846934325435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON1,Spondin-1,51546,329,0.83 [0.62-1.13],0.2418991273561319
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON2,Spondin-2,51249,323,1.02 [0.76-1.36],0.8978197532384593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPP1,Osteopontin,52046,333,0.92 [0.74-1.14],0.4348549710665644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",43466,294,0.79 [0.60-1.04],0.0899826200925504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRING1,SREBP regulating gene protein,43160,294,0.89 [0.72-1.09],0.2575117499538201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR1B,Cornifin-B,43946,299,1.08 [0.96-1.22],0.1992109470331345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR3,Small proline-rich protein 3,44654,304,1.11 [0.95-1.30],0.2020138870226465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRY2,Protein sprouty homolog 2,50524,322,1.03 [0.93-1.14],0.596286672322359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",43318,298,0.86 [0.60-1.24],0.4262934234740961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,44654,304,0.78 [0.56-1.08],0.135986492609472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRC,Proto-oncogene tyrosine-protein kinase Src,51566,328,1.01 [0.93-1.10],0.766953395744309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRP14,Signal recognition particle 14 kDa protein,51256,329,0.98 [0.83-1.15],0.7851764730670396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPK2,SRSF protein kinase 2,51419,328,1.02 [0.91-1.15],0.7339364955705794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPX,Sushi repeat-containing protein SRPX,44759,302,0.94 [0.70-1.27],0.7011325064138239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSB,Lupus La protein,50288,323,0.94 [0.79-1.13],0.5367463459102892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",43466,294,0.82 [0.58-1.16],0.2601527617494219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,51417,323,0.98 [0.90-1.07],0.6493789637575769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,51698,331,1.13 [0.90-1.42],0.2930798145836168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSH3,Protein phosphatase Slingshot homolog 3,43160,294,0.66 [0.44-1.00],0.0526380937690261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSNA1,Sjoegren syndrome nuclear autoantigen 1,44569,304,0.96 [0.77-1.19],0.689742801852509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST13,Hsc70-interacting protein,43784,299,1.01 [0.83-1.23],0.9188864220426934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",51256,329,0.97 [0.77-1.23],0.8077770716811155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",52128,334,1.04 [0.75-1.43],0.832394438398433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",43466,294,0.71 [0.53-0.96],0.0278877578318286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAB2,Stabilin-2,44764,304,1.14 [0.77-1.68],0.509129441593938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAM,Signal transducing adapter molecule 1,44551,301,0.98 [0.72-1.32],0.8710963374582352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAMBP,STAM-binding protein,51008,326,1.10 [0.95-1.28],0.2163367049747132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT2,Signal transducer and activator of transcription 2,43466,294,0.95 [0.82-1.11],0.5399673658126284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT5B,Signal transducer and activator of transcription 5B,51256,329,1.03 [0.96-1.10],0.4832433733232956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,43160,294,0.85 [0.71-1.03],0.0999182250592216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC1,Stanniocalcin-1,51944,331,1.03 [0.83-1.28],0.8008929806955309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC2,Stanniocalcin-2,51435,328,0.99 [0.67-1.47],0.9709841342615956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STEAP4,Metalloreductase STEAP4,43318,298,0.92 [0.78-1.09],0.3410326387030454
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STIP1,Stress-induced-phosphoprotein 1,51421,328,1.07 [0.93-1.24],0.3489109401106571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK11,Serine/threonine-protein kinase STK11,50550,323,1.06 [0.93-1.21],0.3889083342569974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK24,Serine/threonine-protein kinase 24,50288,323,1.07 [0.91-1.25],0.4131466906433055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK4,Serine/threonine-protein kinase 4,51493,323,1.00 [0.90-1.12],0.9397282482612428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STOML2,"Stomatin-like protein 2, mitochondrial",43160,294,0.92 [0.81-1.05],0.2062985663205674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX16,Syntaxin-16,50282,316,1.01 [0.85-1.20],0.928448498956492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX1B,Syntaxin-1B,43533,300,0.81 [0.60-1.11],0.1910725728473005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX3,Syntaxin-3,44654,304,0.87 [0.64-1.19],0.3904301289155849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX4,Syntaxin-4,51256,329,0.95 [0.80-1.13],0.5653624470462921
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX5,Syntaxin-5,43466,294,0.86 [0.63-1.16],0.3165443746661858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX6,Syntaxin-6,50282,316,0.88 [0.75-1.04],0.1367951724338814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX7,Syntaxin-7,43466,294,1.01 [0.80-1.27],0.9399213000325148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX8,Syntaxin-8,51419,328,0.89 [0.72-1.09],0.2570045777510244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP1,Syntaxin-binding protein 1,44680,305,0.99 [0.86-1.14],0.8481605238609033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP3,Syntaxin-binding protein 3,50282,316,1.02 [0.82-1.29],0.8352835718916714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGP1,SURP and G-patch domain-containing protein 1,44569,304,0.89 [0.68-1.18],0.4299817061700354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGT1,Protein SGT1 homolog,50282,316,1.08 [0.96-1.23],0.2076480431418431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT1A1,Sulfotransferase 1A1,51944,331,1.01 [0.94-1.09],0.7881611265508239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT2A1,Bile salt sulfotransferase,51419,328,0.87 [0.72-1.05],0.1387402297332139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF1,Formylglycine-generating enzyme,43466,294,0.93 [0.77-1.12],0.4555591083153729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,51944,331,0.94 [0.78-1.13],0.4905849176377173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUOX,"Sulfite oxidase, mitochondrial",44680,305,0.89 [0.74-1.07],0.2261711087956729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD1,Sushi domain-containing protein 1,50550,323,1.07 [0.87-1.31],0.5071887872968539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD2,Sushi domain-containing protein 2,51506,328,1.14 [0.82-1.59],0.4368754527935024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD4,Sushi domain-containing protein 4,44551,301,1.07 [0.82-1.38],0.6253866845923948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD5,Sushi domain-containing protein 5,43541,298,0.94 [0.68-1.30],0.6911331670160703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SV2A,Synaptic vesicle glycoprotein 2A,43533,300,0.93 [0.77-1.12],0.4178734955643316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,44569,304,0.71 [0.51-1.00],0.0496050144336825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYAP1,Synapse-associated protein 1,43784,299,1.04 [0.85-1.26],0.7154008860570544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,43318,298,1.21 [1.03-1.42],0.0217126610007499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYT1,Synaptotagmin-1,44654,304,1.06 [0.82-1.38],0.6402340320699342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYTL4,Synaptotagmin-like protein 4,44759,302,1.02 [0.88-1.19],0.7816932214542817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,43946,299,1.01 [0.91-1.12],0.9101792733066736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACC3,Transforming acidic coiled-coil-containing protein 3,51256,329,1.02 [0.94-1.11],0.6224944810951627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACSTD2,Tumor-associated calcium signal transducer 2,45619,282,0.96 [0.67-1.38],0.8253224324965276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TADA3,Transcriptional adapter 3,44551,301,1.04 [0.79-1.37],0.7806428928423066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAFA5,Chemokine-like protein TAFA-5,51256,329,0.89 [0.68-1.17],0.3994299399646633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,43160,294,0.85 [0.70-1.03],0.0996086710898045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TALDO1,Transaldolase,44597,304,1.06 [0.83-1.35],0.6187054399793971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TANK,TRAF family member-associated NF-kappa-B activator,50524,322,1.05 [0.91-1.21],0.4819655936842465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAP1,Antigen peptide transporter 1,43946,299,0.82 [0.66-1.03],0.0907511804886999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARBP2,RISC-loading complex subunit TARBP2,50288,323,1.04 [0.92-1.18],0.5385399844961225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",43533,300,0.98 [0.85-1.14],0.7915141254943903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",44551,301,0.86 [0.64-1.17],0.3408563751510528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAX1BP1,Tax1-binding protein 1,44654,304,0.97 [0.81-1.15],0.7064237127026647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D17,TBC1 domain family member 17,50288,323,1.05 [0.84-1.30],0.6745783603732902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D23,TBC1 domain family member 23,51256,329,0.99 [0.89-1.10],0.8465716299952573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D5,TBC1 domain family member 5,51419,328,0.93 [0.82-1.06],0.2748978001512343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCA,Tubulin-specific chaperone A,43784,299,1.01 [0.89-1.15],0.8752398342232365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCB,Tubulin-folding cofactor B,51093,326,1.06 [0.96-1.16],0.2877817566383387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCC,Tubulin-specific chaperone C,51093,326,1.08 [0.96-1.22],0.2062352975440397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBL1X,F-box-like/WD repeat-containing protein TBL1X,50282,316,0.99 [0.88-1.11],0.8175367713619189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBR1,T-box brain protein 1,43533,300,1.07 [0.87-1.33],0.5097320394437725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1A,T-cell leukemia/lymphoma protein 1A,51017,325,0.99 [0.90-1.09],0.8381274591462277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,50550,323,1.05 [0.94-1.18],0.3960370104520788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN1,Transcobalamin-1,43892,299,0.83 [0.60-1.17],0.2920601929334686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN2,Transcobalamin-2,52046,333,0.77 [0.56-1.06],0.1138681901242954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCOF1,Treacle protein,44759,302,0.99 [0.70-1.40],0.9539657311819704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCP11,T-complex protein 11 homolog,43946,299,0.85 [0.68-1.07],0.1704034268267741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,44759,302,0.99 [0.69-1.43],0.9691922780410656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDGF1,Teratocarcinoma-derived growth factor 1,50288,323,1.02 [0.96-1.09],0.5163042480496182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDO2,"Tryptophan 2,3-dioxygenase",43533,300,0.77 [0.56-1.07],0.1180673265859512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDP1,Tyrosyl-DNA phosphodiesterase 1,44551,301,0.99 [0.84-1.15],0.8662547696023197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDRKH,Tudor and KH domain-containing protein,50288,323,1.00 [0.89-1.13],0.9400815834666404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEF,Thyrotroph embryonic factor,43292,293,0.95 [0.73-1.24],0.7027213597549051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEK,Angiopoietin-1 receptor,51651,329,0.96 [0.62-1.50],0.8675613799796613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TERF1,Telomeric repeat-binding factor 1,43466,294,0.60 [0.39-0.90],0.013618230633549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TET2,Methylcytosine dioxygenase TET2,43864,298,1.00 [0.90-1.12],0.957720277285296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX101,Testis-expressed protein 101,43533,300,0.96 [0.78-1.19],0.7348294134102229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX33,Testis-expressed protein 33,43946,299,0.81 [0.59-1.12],0.209310941713499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TF,Serotransferrin,44829,305,1.03 [0.62-1.71],0.9053200001084468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFAP2A,Transcription factor AP-2-alpha,43318,298,1.00 [0.83-1.21],0.9812144178299088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF1,Trefoil factor 1,51252,327,0.98 [0.87-1.11],0.7556179320080267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF2,Trefoil factor 2,51631,329,1.00 [0.85-1.19],0.9663153376458042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF3,Trefoil factor 3,51445,328,1.06 [0.85-1.32],0.6218010664915314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI,Tissue factor pathway inhibitor,51361,330,1.25 [0.93-1.68],0.1322966795865243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI2,Tissue factor pathway inhibitor 2,51494,329,0.84 [0.64-1.10],0.2012520242949038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFRC,Transferrin receptor protein 1,51699,329,1.13 [0.88-1.46],0.3249164438921861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TG,Thyroglobulin,44551,301,1.01 [0.91-1.11],0.9036425177471882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFA,Protransforming growth factor alpha,51419,328,1.17 [0.96-1.44],0.1278103592442494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB1,Transforming growth factor beta-1 proprotein,51971,328,0.91 [0.71-1.18],0.4843849182628842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB2,Transforming growth factor beta-2 proprotein,44551,301,1.04 [0.84-1.27],0.7427147161033414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBI,Transforming growth factor-beta-induced protein ig-h3,51193,330,0.79 [0.55-1.14],0.2066781175221237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR1,TGF-beta receptor type-1,43466,294,1.09 [0.66-1.79],0.738928482638814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR2,TGF-beta receptor type-2,51651,329,1.09 [0.81-1.46],0.5589003152019816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR3,Transforming growth factor beta receptor type 3,52128,334,0.81 [0.60-1.09],0.163139283339938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGM2,Protein-glutamine gamma-glutamyltransferase 2,51408,323,0.99 [0.87-1.13],0.910134916222911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGOLN2,Trans-Golgi network integral membrane protein 2,44798,305,1.13 [0.75-1.71],0.5614216679273749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THAP12,52 kDa repressor of the inhibitor of the protein kinase,43082,294,0.88 [0.76-1.02],0.0811623702167233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBD,Thrombomodulin,51493,323,0.89 [0.63-1.25],0.4956275255914799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS2,Thrombospondin-2,51506,328,0.96 [0.73-1.25],0.7416189561228809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,51530,331,1.46 [1.18-1.80],0.0004821914502988
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THOP1,Thimet oligopeptidase,51248,319,1.17 [0.86-1.60],0.3181160708102264
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,50550,323,0.87 [0.68-1.13],0.3001119729455423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THRAP3,Thyroid hormone receptor-associated protein 3,43292,293,1.02 [0.92-1.12],0.698854823915378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THSD1,Thrombospondin type-1 domain-containing protein 1,43133,292,0.73 [0.52-1.04],0.0787908749969356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THTPA,Thiamine-triphosphatase,44467,301,1.02 [0.90-1.16],0.7154858791657462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THY1,Thy-1 membrane glycoprotein,51944,331,1.29 [0.92-1.81],0.1333542461475075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIA1,Nucleolysin TIA-1 isoform p40,49984,316,1.05 [0.96-1.13],0.2902027641182849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIE1,Tyrosine-protein kinase receptor Tie-1,52128,334,1.15 [0.90-1.47],0.2586314121313522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",50203,323,0.93 [0.75-1.15],0.5167137651757387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,43946,299,0.81 [0.59-1.12],0.2109996325699519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,51698,331,1.23 [0.99-1.53],0.063297982357515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,44759,302,0.99 [0.75-1.31],0.9585250006374136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,44654,304,1.01 [0.89-1.14],0.9245843761982596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP1,Metalloproteinase inhibitor 1,50938,327,1.35 [0.97-1.88],0.0769780301630152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP2,Metalloproteinase inhibitor 2,44759,302,0.55 [0.33-0.93],0.0253241376462855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP3,Metalloproteinase inhibitor 3,51715,329,1.00 [0.93-1.08],0.925432915388092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP4,Metalloproteinase inhibitor 4,51506,328,1.05 [0.83-1.34],0.6665224969923208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TINAGL1,Tubulointerstitial nephritis antigen-like,51332,322,1.29 [0.83-2.02],0.2539248486877061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJAP1,Tight junction-associated protein 1,51651,329,1.00 [0.89-1.12],0.9940579742467822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJP3,Tight junction protein ZO-3,43318,298,0.89 [0.67-1.18],0.4161875029143933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TK1,"Thymidine kinase, cytosolic",43946,299,0.89 [0.68-1.15],0.3729616467063912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR1,Toll-like receptor 1,43466,294,1.09 [0.72-1.66],0.6755898007074763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR2,Toll-like receptor 2,43946,299,0.86 [0.53-1.39],0.535045484158337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR3,Toll-like receptor 3,52056,330,0.93 [0.79-1.08],0.338802001751513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR4,Toll-like receptor 4,43466,294,0.72 [0.48-1.08],0.112486492767929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,43533,300,1.09 [0.90-1.33],0.3759695654095427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED1,Transmembrane emp24 domain-containing protein 1,43946,299,0.92 [0.74-1.13],0.4228613503418752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED10,Transmembrane emp24 domain-containing protein 10,43292,293,1.12 [0.93-1.37],0.2383963650545958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED4,Transmembrane emp24 domain-containing protein 4,43292,293,0.92 [0.74-1.14],0.4399929309848959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED8,Protein TMED8,44569,304,1.01 [0.90-1.12],0.9048097273191722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM106A,Transmembrane protein 106A,44551,301,0.98 [0.83-1.14],0.7538729539182886
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM132A,Transmembrane protein 132A,43572,301,0.89 [0.74-1.06],0.1939393892556653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM25,Transmembrane protein 25,44680,305,1.13 [0.91-1.41],0.2586873616594856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMOD4,Tropomodulin-4,43160,294,1.01 [0.77-1.34],0.928686706460103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11B,Transmembrane protease serine 11B,43318,298,1.00 [0.86-1.15],0.955426837213196
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11D,Transmembrane protease serine 11D,44569,304,0.87 [0.65-1.16],0.3520756624923713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS15,Enteropeptidase,51256,329,0.95 [0.86-1.06],0.394929898100145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS5,Transmembrane protease serine 5,50847,324,1.04 [0.81-1.35],0.7536256883022493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMSB10,Thymosin beta-10,51506,328,1.08 [0.95-1.22],0.2587440114640608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNC,Tenascin,51698,331,1.16 [0.95-1.41],0.1511112966871745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNF,Tumor necrosis factor,50472,323,1.08 [0.84-1.38],0.5435267026541419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,44569,304,0.94 [0.74-1.18],0.5727456190845936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,50524,322,0.86 [0.65-1.13],0.2878411515876383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,43784,299,0.99 [0.83-1.18],0.9223171994647926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,51093,326,1.15 [0.86-1.54],0.341636298281931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,51093,326,1.20 [1.02-1.42],0.0326474932492744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,51623,332,0.88 [0.72-1.07],0.1878681105176593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,52056,330,0.97 [0.75-1.24],0.7901947050579462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,51461,329,1.01 [0.72-1.41],0.9690928545090712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,51651,329,1.35 [1.04-1.76],0.0259901698252188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,51546,329,0.89 [0.66-1.19],0.4327811333590805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,50524,322,1.04 [0.83-1.31],0.7322041840437599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,51546,329,1.09 [0.80-1.50],0.5807054890480104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,43784,299,0.79 [0.60-1.03],0.0836500588839073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,51932,332,1.05 [0.78-1.42],0.7432133692646442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,51506,328,1.22 [0.89-1.67],0.2256215965714806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,51506,328,1.06 [0.82-1.37],0.6698764221252238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,51944,331,0.92 [0.65-1.31],0.6588761863249564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,51971,328,1.06 [0.82-1.37],0.6482599498832967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,51093,326,0.97 [0.81-1.16],0.723191391932742
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,51944,331,1.01 [0.82-1.26],0.9070389852135364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,51093,326,1.09 [0.87-1.37],0.4605506287555404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF10,Tumor necrosis factor ligand superfamily member 10,52056,330,0.85 [0.59-1.24],0.4098340700216029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF11,Tumor necrosis factor ligand superfamily member 11,51419,328,1.00 [0.86-1.18],0.959168410162866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF12,Tumor necrosis factor ligand superfamily member 12,52056,330,1.01 [0.72-1.41],0.9679496684046516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13,Tumor necrosis factor ligand superfamily member 13,51715,329,1.40 [0.98-2.00],0.0667615756011633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,52043,334,1.15 [0.82-1.62],0.4086158435321547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF14,Tumor necrosis factor ligand superfamily member 14,51093,326,1.06 [0.90-1.25],0.5008630000646046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF8,Tumor necrosis factor ligand superfamily member 8,44764,304,0.99 [0.73-1.35],0.969741930011386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNIP1,TNFAIP3-interacting protein 1,44654,304,1.00 [0.88-1.13],0.9974428293716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNN,Tenascin-N,44764,304,0.99 [0.77-1.27],0.9461363000450016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNNI3,"Troponin I, cardiac muscle",50550,323,1.01 [0.90-1.14],0.8232110487003814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNPO1,Transportin-1,43946,299,0.68 [0.49-0.95],0.0215008158782902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,51093,326,0.86 [0.68-1.08],0.1939623774781461
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNXB,Tenascin-X,51506,328,0.85 [0.58-1.24],0.393460698311022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,44759,302,1.01 [0.88-1.16],0.902357395209074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1,DNA topoisomerase 1,44569,304,1.07 [0.97-1.18],0.1569586806959413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1MT,"DNA topoisomerase I, mitochondrial",43160,294,1.00 [0.79-1.25],0.9690673327861088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP2B,DNA topoisomerase 2-beta,43466,294,0.97 [0.84-1.12],0.6832631306858351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOR1AIP1,Torsin-1A-interacting protein 1,43572,301,0.99 [0.81-1.22],0.9363929622982528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53,Cellular tumor antigen p53,50282,316,0.94 [0.75-1.19],0.6300418216516142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53BP1,TP53-binding protein 1,43466,294,0.91 [0.80-1.04],0.1778353968560511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53I3,Quinone oxidoreductase PIG3,42831,290,1.08 [0.87-1.34],0.4725923274627271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53INP1,Tumor protein p53-inducible nuclear protein 1,50550,323,0.90 [0.64-1.26],0.5472095939244703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP73,Tumor protein p73,43533,300,0.81 [0.59-1.13],0.2151884077442312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPBGL,Trophoblast glycoprotein-like,43533,300,0.84 [0.63-1.12],0.2317137620113442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPD52L2,Tumor protein D54,43784,299,1.01 [0.91-1.12],0.8199167675135322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,44759,302,0.63 [0.42-0.94],0.0240055535125245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPM3,Tropomyosin alpha-3 chain,43292,293,1.28 [1.02-1.60],0.0332242282335282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPMT,Thiopurine S-methyltransferase,50282,316,1.10 [0.97-1.26],0.1486082231016022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPP1,Tripeptidyl-peptidase 1,51123,328,0.99 [0.80-1.23],0.9575275993333066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP2,Tubulin polymerization-promoting protein family member 2,43946,299,1.03 [0.90-1.18],0.6894240088689803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP3,Tubulin polymerization-promoting protein family member 3,50288,323,1.02 [0.79-1.30],0.8973595160989247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPR,Nucleoprotein TPR,43292,293,0.99 [0.80-1.24],0.954732160584683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPRKB,EKC/KEOPS complex subunit TPRKB,43160,294,0.90 [0.74-1.09],0.2659920146404245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSAB1,Tryptase alpha/beta-1,51971,330,0.92 [0.76-1.10],0.3458862391145356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSD1,Tryptase delta,44680,305,0.97 [0.72-1.30],0.8179438877733851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSG1,Tryptase gamma,43466,294,0.68 [0.43-1.06],0.0886871723464769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPT1,Translationally-controlled tumor protein,50524,322,0.98 [0.84-1.15],0.8316235465496838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF2,TNF receptor-associated factor 2,51419,328,1.00 [0.87-1.15],0.9656034322571464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3,"TNF receptor-associated factor 3, Isoform 2",43466,294,0.92 [0.68-1.26],0.6046770257441868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,43292,293,1.10 [0.89-1.36],0.3894807297100545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,43946,299,0.94 [0.82-1.07],0.3565292390538039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,44764,304,0.89 [0.78-1.03],0.1278847832982317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREM2,Triggering receptor expressed on myeloid cells 2,51461,329,0.96 [0.79-1.15],0.6292268688626629
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,44798,305,0.93 [0.76-1.15],0.4955654763052258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML2,Trem-like transcript 2 protein,51506,328,0.94 [0.70-1.25],0.6521310916085026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIAP1,TP53-regulated inhibitor of apoptosis 1,51932,332,1.08 [0.92-1.25],0.3446500427775029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM21,E3 ubiquitin-protein ligase TRIM21,51419,328,1.01 [0.89-1.15],0.8378637565686058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM24,Transcription intermediary factor 1-alpha,43862,299,1.01 [0.85-1.19],0.947317014147757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,44569,304,0.96 [0.87-1.06],0.4044968321562756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM26,Tripartite motif-containing protein 26,43160,294,0.82 [0.66-1.02],0.0775998793327915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM40,E3 ubiquitin ligase TRIM40,43533,300,0.99 [0.85-1.16],0.9214914543572698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM5,Tripartite motif-containing protein 5,51419,328,1.00 [0.90-1.12],0.9539934657865854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM58,E3 ubiquitin-protein ligase TRIM58,44551,301,1.01 [0.89-1.15],0.8677491010683784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,43292,293,0.71 [0.54-0.93],0.0119673565144947
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC1,Hamartin,43466,294,0.83 [0.69-0.99],0.0411391687508505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC22D1,TSC22 domain family protein 1,44680,305,1.06 [0.90-1.25],0.4654417719280687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSHB,Thyrotropin subunit beta,51493,323,1.00 [0.88-1.14],0.9981666084850238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSLP,Thymic stromal lymphopoietin,50550,323,0.86 [0.71-1.03],0.1034579825448493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSNAX,Translin-associated protein X,43292,293,1.05 [0.79-1.39],0.7419406807677007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN1,Tetraspanin-1,50550,323,1.02 [0.88-1.19],0.7666706869469485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,43292,293,1.19 [0.98-1.43],0.0803378588018659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN7,Tetraspanin-7,43318,298,0.97 [0.86-1.09],0.5959712973141791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN8,Tetraspanin-8,44569,304,0.94 [0.84-1.05],0.2572490349007693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPYL1,Testis-specific Y-encoded-like protein 1,43466,294,0.85 [0.64-1.13],0.2624941247676731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TST,Thiosulfate sulfurtransferase,50205,322,0.99 [0.87-1.13],0.8477968540361812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTF2,Transcription termination factor 2,43533,300,1.02 [0.81-1.27],0.8822036366258632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTN,Titin,43292,293,1.19 [1.03-1.37],0.0146613192598509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTR,Transthyretin,44342,304,0.91 [0.59-1.41],0.6857350363480578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TUBB3,Tubulin beta-3 chain,43318,298,0.95 [0.64-1.42],0.8068532275239673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,44764,304,0.97 [0.85-1.11],0.669658153707448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXK,Tyrosine-protein kinase TXK,43946,299,1.13 [1.00-1.29],0.0509241504007801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXLNA,Alpha-taxilin,51093,326,1.04 [0.93-1.16],0.5280975706387936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXN,Thioredoxin,44062,300,0.99 [0.77-1.27],0.9133656322984656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC15,Thioredoxin domain-containing protein 15,51651,329,0.85 [0.59-1.21],0.3571603786600581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC5,Thioredoxin domain-containing protein 5,51944,331,1.00 [0.86-1.15],0.9600960443384816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC9,Thioredoxin domain-containing protein 9,44654,304,0.95 [0.77-1.17],0.6208829604223405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNL1,Thioredoxin-like protein 1,43235,297,0.95 [0.84-1.07],0.4128579426670318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",51506,328,1.03 [0.83-1.27],0.7969636265206632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYMP,Thymidine phosphorylase,51164,322,0.99 [0.85-1.15],0.8978362191301132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,51493,323,0.83 [0.59-1.17],0.2858050697474995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",43466,294,0.95 [0.80-1.14],0.5758414571142789
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBAC1,Ubiquitin-associated domain-containing protein 1,51256,329,0.96 [0.73-1.28],0.8001749291338023
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2B,Ubiquitin-conjugating enzyme E2 B,44551,301,0.99 [0.68-1.45],0.9786766348967106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,44759,302,1.01 [0.85-1.21],0.8993616427388513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,43466,294,0.89 [0.73-1.09],0.2613096234966386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBQLN3,Ubiquilin-3,43292,293,1.06 [0.86-1.30],0.6076770850088045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBXN1,UBX domain-containing protein 1,43784,299,1.01 [0.86-1.18],0.9340717899067396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,44569,304,1.01 [0.94-1.09],0.7599186698569843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UGDH,UDP-glucose 6-dehydrogenase,43292,293,0.95 [0.84-1.07],0.3894110848348739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UHRF2,E3 ubiquitin-protein ligase UHRF2,43292,293,0.90 [0.64-1.26],0.5279783889269302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ULBP2,UL16-binding protein 2,51093,326,1.23 [0.95-1.58],0.1097690403950985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UMOD,Uromodulin,51965,334,1.07 [0.89-1.28],0.4725985424189457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,43466,294,0.55 [0.35-0.86],0.00831497867278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC79,Protein unc-79 homolog,43160,294,0.82 [0.66-1.01],0.0634556542669516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,44551,301,0.76 [0.54-1.07],0.1117243432168417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPB1,Beta-ureidopropionase,44759,302,0.98 [0.87-1.11],0.7443171492544045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3A,Uroplakin-3a,43318,298,0.98 [0.78-1.23],0.8812346580237398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3BL1,Uroplakin-3b-like protein 1,43861,299,0.82 [0.64-1.06],0.1283568296634328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROD,Uroporphyrinogen decarboxylase,43784,299,1.03 [0.87-1.20],0.754998157648497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROS,Uroporphyrinogen-III synthase,43533,300,1.03 [0.88-1.21],0.688258976973057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USO1,General vesicular transport factor p115,51256,329,1.04 [0.93-1.16],0.518109584461576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP25,Ubiquitin carboxyl-terminal hydrolase 25,44551,301,1.01 [0.86-1.18],0.917967548982004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP28,Ubiquitin carboxyl-terminal hydrolase 28,44654,304,1.12 [0.85-1.47],0.4210707645072116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP47,Ubiquitin carboxyl-terminal hydrolase 47,43292,293,0.93 [0.81-1.07],0.3042984317995392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP8,Ubiquitin carboxyl-terminal hydrolase 8,50550,323,1.02 [0.92-1.13],0.760458739983489
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UXS1,UDP-glucuronic acid decarboxylase 1,50282,316,1.12 [0.94-1.35],0.2074693535167262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP5,Vesicle-associated membrane protein 5,50550,323,1.01 [0.84-1.21],0.9537410085569398
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP8,Vesicle-associated membrane protein 8,43466,294,1.01 [0.89-1.14],0.9273306372403672
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASH1,Tubulinyl-Tyr carboxypeptidase 1,51419,328,1.01 [0.89-1.13],0.9298579417567848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASN,Vasorin,50689,326,1.20 [0.84-1.72],0.309553114060933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASP,Vasodilator-stimulated phosphoprotein,44798,305,0.99 [0.85-1.15],0.9209016468470346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,51256,329,0.67 [0.41-1.11],0.1176933820762574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAV3,Guanine nucleotide exchange factor VAV3,43318,298,0.99 [0.88-1.11],0.8363400816012628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAM1,Vascular cell adhesion protein 1,51615,331,1.37 [0.97-1.94],0.0783993413347533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,51944,331,0.76 [0.55-1.05],0.0950943146667748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,43160,294,0.83 [0.71-0.97],0.0227301146388536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFA,Vascular endothelial growth factor A,51887,329,1.02 [0.86-1.20],0.8246092060981228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,43466,294,0.94 [0.64-1.39],0.7595255405018847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFC,Vascular endothelial growth factor C,51651,329,0.98 [0.82-1.16],0.7826818208190981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFD,Vascular endothelial growth factor D,51971,330,0.98 [0.75-1.28],0.9105127213392404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,44680,305,0.63 [0.44-0.90],0.0119510141495893
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIM,Vimentin,50550,323,0.98 [0.90-1.07],0.6837476425652527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIPR1,Vasoactive intestinal polypeptide receptor 1,43572,301,0.93 [0.59-1.48],0.7718479390729418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIT,Vitrin,44759,302,0.94 [0.70-1.25],0.6522974268795905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VMO1,Vitelline membrane outer layer protein 1 homolog,51256,329,1.01 [0.88-1.17],0.8682662696368195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN1,Pantetheinase,44798,305,0.95 [0.81-1.10],0.456289508397495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN2,Vascular non-inflammatory molecule 2,51256,329,1.03 [0.84-1.28],0.7510955838213857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS28,Vacuolar protein sorting-associated protein 28 homolog,43946,299,1.01 [0.85-1.19],0.9493029957099164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS37A,Vacuolar protein sorting-associated protein 37A,51256,329,1.05 [0.93-1.19],0.3926786273608152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS4B,Vacuolar protein sorting-associated protein 4B,44551,301,1.00 [0.89-1.12],0.9524462168453304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS53,Vacuolar protein sorting-associated protein 53 homolog,51256,329,1.01 [0.89-1.14],0.8978212961775018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,44551,301,0.62 [0.43-0.89],0.0099895063291291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,43292,293,1.09 [0.78-1.52],0.6049717459152111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG2,V-set and immunoglobulin domain-containing protein 2,44551,301,1.08 [0.91-1.29],0.3761756242317566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG4,V-set and immunoglobulin domain-containing protein 4,51435,328,1.10 [0.87-1.39],0.4410807676360653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,51415,323,1.00 [0.85-1.17],0.9934550623468758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSNL1,Visinin-like protein 1,44654,304,1.02 [0.76-1.36],0.9020718305422164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM1,V-set and transmembrane domain-containing protein 1,50288,323,1.06 [0.88-1.29],0.5287587702870276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2B,V-set and transmembrane domain-containing protein 2B,43946,299,0.71 [0.51-0.98],0.0374505660023445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,50550,323,1.05 [0.89-1.24],0.5745537285912132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,51944,331,0.99 [0.87-1.14],0.9230454070791638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTCN1,V-set domain-containing T-cell activation inhibitor 1,50282,316,0.99 [0.72-1.37],0.9690188340500044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,43784,299,0.93 [0.77-1.14],0.4974443929268515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,51855,330,0.94 [0.75-1.19],0.6027224369971456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,43160,294,0.75 [0.62-0.91],0.0042278545214685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2,Brorin,50923,326,0.89 [0.70-1.15],0.3752399454407538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2L,von Willebrand factor C domain-containing protein 2-like,44680,305,0.79 [0.59-1.05],0.1046897649603038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWF,von Willebrand factor,52128,334,0.97 [0.85-1.11],0.6677250339719041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WARS,"Tryptophan--tRNA ligase, cytoplasmic",51506,328,1.03 [0.80-1.33],0.8135720076036412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WAS,Wiskott-Aldrich syndrome protein,50524,322,0.99 [0.86-1.15],0.9152968102121216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF1,Wiskott-Aldrich syndrome protein family member 1,50550,323,1.02 [0.92-1.14],0.6540147818767488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF3,Wiskott-Aldrich syndrome protein family member 3,50288,323,0.96 [0.86-1.08],0.5068578714630081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASHC3,WASH complex subunit 3,44654,304,0.94 [0.81-1.09],0.3811190059685243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASL,Neural Wiskott-Aldrich syndrome protein,43466,294,0.86 [0.70-1.06],0.1543178828491097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,44551,301,0.89 [0.65-1.21],0.4480022778674448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC1,WAP four-disulfide core domain protein 1,43651,296,0.89 [0.71-1.12],0.306410500757129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC12,WAP four-disulfide core domain protein 12,51847,331,1.06 [0.91-1.23],0.4290689997806178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC2,WAP four-disulfide core domain protein 2,48875,311,1.15 [0.90-1.48],0.2606939026661449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",50925,325,1.18 [0.93-1.49],0.1725189333615899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",51546,329,0.81 [0.61-1.08],0.1462030207734441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,51932,332,0.76 [0.57-1.01],0.0600777822939547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WNT9A,Protein Wnt-9a,50524,322,1.06 [0.75-1.50],0.7288086307577208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,51093,326,1.07 [0.89-1.28],0.4845921086472524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XCL1,Lymphotactin,51932,332,0.99 [0.83-1.19],0.9470266684033268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XG,Glycoprotein Xg,51876,334,1.06 [0.79-1.43],0.6944803410865963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XIAP,E3 ubiquitin-protein ligase XIAP,43466,294,0.95 [0.78-1.16],0.645996029537071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XPNPEP2,Xaa-Pro aminopeptidase 2,51651,329,0.97 [0.88-1.07],0.5154617541842154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XRCC4,DNA repair protein XRCC4,50288,323,0.92 [0.70-1.21],0.5537997490293678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YAP1,Transcriptional coactivator YAP1,44654,304,1.05 [0.70-1.56],0.8267840633259708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",44569,304,1.00 [0.93-1.08],0.9025357846470848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YES1,Tyrosine-protein kinase Yes,51256,329,1.04 [0.96-1.14],0.3268901561812288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YJU2,Splicing factor YJU2,44551,301,0.75 [0.53-1.07],0.1113820087063717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YOD1,Ubiquitin thioesterase OTU1,43292,293,1.04 [0.87-1.25],0.6428870519713519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YTHDF3,YTH domain-containing family protein 3,50524,322,1.03 [0.92-1.16],0.6336459993070691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YWHAQ,14-3-3 protein theta,43784,299,1.02 [0.88-1.19],0.7549113264887243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,43466,294,0.72 [0.47-1.08],0.1144391785063896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBP1,Z-DNA-binding protein 1,43466,294,0.90 [0.67-1.20],0.4620489967363664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB16,Zinc finger and BTB domain-containing protein 16,50282,316,0.99 [0.86-1.14],0.8703824216243325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB17,Zinc finger and BTB domain-containing protein 17,50550,323,0.92 [0.72-1.17],0.4817631232722904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZCCHC8,Zinc finger CCHC domain-containing protein 8,43292,293,1.02 [0.85-1.22],0.8628853224583857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZFYVE19,Abscission/NoCut checkpoint regulator,44569,304,0.99 [0.88-1.12],0.9294213184175784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZHX2,Zinc fingers and homeoboxes protein 2,44654,304,1.08 [0.80-1.45],0.6209334332907601
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF174,Zinc finger protein 174,43466,294,0.95 [0.70-1.30],0.7589287469434456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF75D,Zinc finger protein 75D,43946,299,1.05 [0.88-1.25],0.5992474354365024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF830,Zinc finger protein 830,44551,301,0.95 [0.82-1.10],0.4568047743542932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,44569,304,0.97 [0.82-1.13],0.6734289472724458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,44551,301,0.96 [0.78-1.18],0.7042764632451002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP3,Zona pellucida sperm-binding protein 3,43572,301,1.01 [0.96-1.05],0.8069998501292225
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP4,Zona pellucida sperm-binding protein 4,43160,294,0.78 [0.53-1.16],0.2209611252531467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZPR1,Zinc finger protein ZPR1,43318,298,0.92 [0.81-1.05],0.1973017453698473
